<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31213978</article-id>
<article-id pub-id-type="pmc">6555388</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2019.00121</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Qu</surname>
<given-names>Liang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/657992/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pan</surname>
<given-names>Chao</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Shi-Ming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lang</surname>
<given-names>Bing</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/348229/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Guo-Dong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xue-Lian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/657678/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/674605/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Neurosurgery, Tangdu Hospital, Air Force Military Medical University</institution>, <addr-line>Xi’an</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Beijing Institute of Biotechnology</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Neurosurgery, Xi’an International Medical Center</institution>, <addr-line>Xi’an</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>The School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen</institution>, <addr-line>Aberdeen</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Psychiatry, The Second Xiangya Hospital, Central South University</institution>, <addr-line>Changsha</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Jean-Marc Taymans, Institut National de la Santé et de la Recherche Médicale (INSERM), France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Michael E. Cahill, University of Wisconsin–Madison, United States; Silvia Bassani, Institute of Neuroscience (IN), Italy</p>
</fn>
<corresp id="c001">*Correspondence: Xue-Lian Wang, <email>xuelianwang3@126.com</email> Yuan Wang, <email>bladerunnerwang@gmail.com</email></corresp>
<fn fn-type="other" id="fn002">
<p><sup>†</sup>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>12</volume>
<elocation-id>121</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>4</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Qu, Pan, He, Lang, Gao, Wang and Wang.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Qu, Pan, He, Lang, Gao, Wang and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The small GTPases from the Ras superfamily play crucial roles in basic cellular processes during practically the entire process of neurodevelopment, including neurogenesis, differentiation, gene expression, membrane and protein traffic, vesicular trafficking, and synaptic plasticity. Small GTPases are key signal transducing enzymes that link extracellular cues to the neuronal responses required for the construction of neuronal networks, as well as for synaptic function and plasticity. Different subfamilies of small GTPases have been linked to a number of non-neoplastic cerebral diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), intellectual disability, epilepsy, drug addiction, Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS) and a large number of idiopathic cerebral diseases. Here, we attempted to make a clearer illustration of the relationship between Ras superfamily GTPases and non-neoplastic cerebral diseases, as well as their roles in the neural system. In future studies, potential treatments for non-neoplastic cerebral diseases which are based on small GTPase related signaling pathways should be explored further. In this paper, we review all the available literature in support of this possibility.</p>
</abstract>
<kwd-group>
<kwd>small GTPases</kwd>
<kwd>Ras superfamily</kwd>
<kwd>Rho subfamily</kwd>
<kwd>Rab subfamily</kwd>
<kwd>Arf subfamily</kwd>
<kwd>Ran subfamily</kwd>
<kwd>non-neoplastic cerebral diseases</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></funding-source>
<award-id rid="cn001">81671366</award-id>
<award-id rid="cn001">81572470</award-id>
<award-id rid="cn001">81601100</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="3"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="298"></ref-count>
<page-count count="21"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Small GTPases are defined by their basic biochemical activity of binding GTP and hydrolyzing it to GDP, which is called the guanosine triphosphate (GTP)/guanosine diphosphate (GDP) cycle (<xref ref-type="bibr" rid="B25">Bourne et al., 1991</xref>). Although similar to the heterotrimeric G protein α subunits in biochemistry and function, small GTPases function as monomeric G proteins (<xref ref-type="bibr" rid="B43">Claing, 2013</xref>). In addition to their high affinity and hydrolysis activity for GTP, small GTPases have two states, a GTP-bound state and a GDP-bound state. The activated small G-proteins are mainly regulated by three crucial factors: Guanosine nucleotide dissociation inhibitors (GDIs), guanine nucleotide exchange factors (GEFs) and GTPase activator proteins (GAPs) (<xref ref-type="bibr" rid="B27">Buday and Downward, 2008</xref>; <xref ref-type="bibr" rid="B263">Vigil et al., 2010</xref>; <xref ref-type="bibr" rid="B142">Liu et al., 2017</xref>). <xref ref-type="fig" rid="F1">Figure 1</xref> shows a simple schematic diagram of their function. In this cycle, GAPs promote GTP hydrolysis, and GEFs stimulate the exchange of GDP for GTP (<xref ref-type="bibr" rid="B153">McCormick, 1998</xref>). GDIs can be defined as a class of proteins interacted with small GTPases, which not only prevent exchange (maintaining the small GTPases in an off-state), but also prevent the small GTPase from localizing at the membrane (<xref ref-type="bibr" rid="B38">Cherfils and Zeghouf, 2013</xref>). Importantly, these molecular switches affect almost all cellular processes such as gene expression, microtubule organization, cytoskeleton reorganization, and vesicular and nuclear transport (<xref ref-type="bibr" rid="B107">Johnson and Chen, 2012</xref>). Small GTPases can also be influenced by post-translational modifications such as phosphorylation or ubiquitination, which can regulate protein stability and subcellular localization (<xref ref-type="bibr" rid="B1">Ahearn et al., 2011</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The two state of small GTPases. GTP- and GDP-bound state are regulated by GEFs and GAPs. GEFs stimulate the exchange of GDP for GTP, resulting activation of Ras (“ON”). GAPs promote GTP hydrolysis, and return Ras to GDP-bound state (“OFF”).</p>
</caption>
<graphic xlink:href="fnmol-12-00121-g001"></graphic>
</fig>
<p>To date, 167 small GTPases have been identified in humans (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>) (<xref ref-type="bibr" rid="B195">Rojas et al., 2012</xref>; <xref ref-type="bibr" rid="B142">Liu et al., 2017</xref>). We compared the G-domin region of those small GTPases, and found that there exist 5 repeated sequences. After removing 5 repeated amino acid sequences that are identical, the resulting 162 amino acid sequences were analyzed and a sequence-homology based phylogenetic tree (<xref ref-type="fig" rid="F2">Figure 2</xref>) was constructed using the Neighbor-Joining method (<xref ref-type="bibr" rid="B200">Saitou and Nei, 1987</xref>). According to sequence and functional similarity, small GTPases can be divided into five main families whose eponymous members are Ras, Rho, Rab, ADP-ribosylation factor (Arf) and Ran (<xref ref-type="bibr" rid="B272">Wennerberg et al., 2005</xref>). Ras family members, the first members of the superfamily to be discovered, are signal nodes mediating the responses to various extracellular stimuli and can regulate cell proliferation, differentiation, morphology, and apoptosis by binding to a variety of effector molecules with different catalytic activities to regulate the cytoplasmic signaling network (<xref ref-type="bibr" rid="B114">Karnoub and Weinberg, 2008</xref>). The Rho family includes more than 20 proteins. This family is known for its role in actin cytoskeleton remodeling and cell polarity (<xref ref-type="bibr" rid="B71">Fransson et al., 2003</xref>; <xref ref-type="bibr" rid="B97">Heo and Meyer, 2003</xref>). The three best known members are Rho (A, B, C), Rac and Cdc42 (<xref ref-type="bibr" rid="B246">Takai et al., 2001</xref>; <xref ref-type="bibr" rid="B220">Shenoy and Lefkowitz, 2011</xref>; <xref ref-type="bibr" rid="B190">Reiter et al., 2012</xref>; <xref ref-type="bibr" rid="B43">Claing, 2013</xref>). Among them, RhoA, Rac1, and Cdc42 have been studied the most (<xref ref-type="bibr" rid="B211">Schwartz and Shattil, 2000</xref>; <xref ref-type="bibr" rid="B196">Rolfe et al., 2005</xref>; <xref ref-type="bibr" rid="B85">Grosshans et al., 2006</xref>). The Rab family is by far the largest family of the Ras superfamily in humans (<xref ref-type="bibr" rid="B195">Rojas et al., 2012</xref>). Proteins of this family participate in vesicle formation, movement and fusion, and vesicular cargo trafficking (<xref ref-type="bibr" rid="B174">Pereira-Leal and Seabra, 2001</xref>; <xref ref-type="bibr" rid="B213">Segev, 2001</xref>). The Arf family includes 30 proteins and is also involved in vesicle trafficking. Ran is the only member found in the Ran family, which is present in all eukaryotic lineages and involved in nuclear transport (<xref ref-type="bibr" rid="B271">Weis, 2003</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Evolutionary relationships of human Ras superfamily. The evolutionary history was inferred using the Neighbor-Joining method. After removing identical sequences, 162 amino acid sequences (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>) are used for the analysis. All ambiguous positions were removed for each sequence pair. The original classification was indicated by different colors: Ras (lilac), Rho (cyan), Rab (purple), Arf (red), Ran (green), and Unclassified members (blank). Evolutionary analyses were conducted in MEGA7.</p>
</caption>
<graphic xlink:href="fnmol-12-00121-g002"></graphic>
</fig>
<p>All the proteins have a GTP-binding domain of about 20 kDa, also known as the G-domain (<xref ref-type="bibr" rid="B25">Bourne et al., 1991</xref>; <xref ref-type="bibr" rid="B246">Takai et al., 2001</xref>). As shown in <xref ref-type="fig" rid="F3">Figure 3</xref>, this domain consists of five α helices (A1–A5), six β-strands (B1–B6) and five polypeptide loops (G1–G5). This domain is highly conserved overall, and especially the loops (<xref ref-type="bibr" rid="B170">Paduch et al., 2001</xref>). When bound to GDP, small GTPases are inactive. The two states have similar conformations and can be distinguished by two functional loop regions: switch I (corresponds to the G2 loop) and switch II (corresponds to the G3 loop and part of the A2 helix) (<xref ref-type="fig" rid="F3">Figure 3</xref>) (<xref ref-type="bibr" rid="B109">Jurnak, 1985</xref>; <xref ref-type="bibr" rid="B170">Paduch et al., 2001</xref>). The G1 loop is located between the B1 strands and A1 helix with the motif X<sub>1</sub>X<sub>1</sub>X<sub>1</sub>GXXXXGK (S/T), where X<sub>1</sub> is leucine (L), valine (V) or isoleucine (I), and X is any amino acid. The α- and β-phosphate groups can be bound to this motif (<xref ref-type="bibr" rid="B117">Knihtila et al., 2015</xref>). The G2 loop, with only one conserved threonine (T), that connects the A1 helix and the B2 strand is responsible for the binding of Mg<sup>2+</sup> via conserved amino acid residues. The G3 loop is at the N-terminus of the A2 helix with the motif XXXXDXXGX. Its main function is to bind Mg<sup>2+</sup> and the γ-phosphoric acid group of GTP or GDP. The G4 loop containing the motif XXX (G/A) (T/N) KXD and the G5 loop are mainly responsible for the recognition of the guanine base (<xref ref-type="fig" rid="F4">Figure 4</xref>). Although the G-domain is conserved in the superfamily, there are also individual difference among the different small GTPase families. For example, in G1 loop, the sixth position G is only conserved in the Rho, Rab, and Arf families. On the other hand, covalent post-translational modification by lipids is another feature of small GTPases. These modifications are essential for facilitating membrane association and subcellular localization, which is critical for their respective biological activities (<xref ref-type="bibr" rid="B91">Hancock, 2003</xref>; <xref ref-type="bibr" rid="B182">Prior and Hancock, 2012</xref>). The C-terminal cysteine residue of the motif can be prenylated by farnesyltransferase or geranylgeranyltransferase. This modification was observed for most Ras, Rho, and Rab family members despite the different motifs, which is composed of CAAX (C is Cys, A is aliphatic and X is any amino acid) for Ras and Rho family proteins, and CC, CXC, CCX, CCXX, or CCXXX for the Rab family (<xref ref-type="bibr" rid="B46">Cox and Der, 2002</xref>; <xref ref-type="bibr" rid="B272">Wennerberg et al., 2005</xref>). Some Ras superfamily members without lipid modification, such as Rit, RhoBTB, Miro, and Sar1, can also associate with membranes (<xref ref-type="bibr" rid="B272">Wennerberg et al., 2005</xref>). Arf family proteins lack C-terminal lipid modification signals and some members are modified at their N-termini by a myristoylation (<xref ref-type="bibr" rid="B44">Colicelli, 2004</xref>). By contrast, Ran does not exhibit any detectable modification by lipids and binding to membranes (<xref ref-type="bibr" rid="B272">Wennerberg et al., 2005</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Structures analysis of Ras. The crystal structures of Ras GDP Mg<sup>2+</sup> complex (PDB 4q21) is showed (upper). This structure contains five α-helices (A1–A5), six β-strands (B1–B6), and five polypeptide loops (G1–G5) and the position relationship among various parts is displayed (below).</p>
</caption>
<graphic xlink:href="fnmol-12-00121-g003"></graphic>
</fig>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Conservation analysis of the 167 human G-domain of Ras superfamily and its subfamilies (<ext-link ext-link-type="uri" xlink:href="http://meme-suite.org/">http://meme-suite.org/</ext-link>). Considering that the Ran only has one sequence and is a branch of Rab subfamily, we incorporate Ran into Rab family.</p>
</caption>
<graphic xlink:href="fnmol-12-00121-g004"></graphic>
</fig>
<p>Studies of the functions of Ras superfamily proteins in modulating the diverse signaling cascades have established many current fundamental paradigms of signal transduction, mainly based on decades of oncological investigations. The awareness of aberrant Ras-related signaling in the pathogenesis of other human disorders has also risen in recent years. Here we highlight the critical roles of each family of the Ras superfamily in non-neoplastic cerebral diseases (<xref ref-type="table" rid="T1">Tables 1</xref>–<xref ref-type="table" rid="T3">3</xref>), which in turn may suggest novel therapeutic targets for developmental diseases and cognitive impairments.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Gene mutations related to Small GTPases (Ras family).</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Gene mutations</th>
<th align="left" colspan="1" rowspan="1" valign="top">Related disease</th>
<th align="left" colspan="1" rowspan="1" valign="top">Proteins</th>
<th align="left" colspan="1" rowspan="1" valign="top">Pathway/mechanism</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PTPN11</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS</td>
<td align="left" colspan="1" rowspan="1" valign="top">SHIP2: Protein tyrosine phosphatase</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B226">Siegfried et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PTPN11</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS-ML</td>
<td align="left" colspan="1" rowspan="1" valign="top">SHIP2: Protein tyrosine phosphatase</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased AKT/mTOR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B244">Tajan et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SOS1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Son of sevenless homolog 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK, Rac, and Stat3</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B260">Van Trier et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RAF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS</td>
<td align="left" colspan="1" rowspan="1" valign="top">v-Raf-1 murine leukemia viral oncogene homolog 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B280">Yin et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RAF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS-ML</td>
<td align="left" colspan="1" rowspan="1" valign="top">v-Raf-1 murine leukemia viral oncogene homolog 1</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KRAS</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS</td>
<td align="left" colspan="1" rowspan="1" valign="top">V-Ki-Ras2 Kirsten rat sarcoma viral oncogene homolog</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B249">Tartaglia et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KRAS</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CFCS</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NRAS</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroblastoma Ras viral (V-Ras) oncogene homolog</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B65">Ekvall et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SHOC2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS</td>
<td align="left" colspan="1" rowspan="1" valign="top">soc-2 suppressor of clear homolog</td>
<td align="left" colspan="1" rowspan="1" valign="top">SHOC2-MRAS-PP1 complex positively regulates RAF activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B282">Young et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SHOC2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS-LAH</td>
<td align="left" colspan="1" rowspan="1" valign="top">soc-2 suppressor of clear homolog</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>BRAF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Serine/Threonine-Protein Kinase B-Raf</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B249">Tartaglia et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>BRAF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CFCS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Serine/Threonine-Protein Kinase B-Raf</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK, Decreased p38 and AKT</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B249">Tartaglia et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RIT1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ras-Like Without CAAX 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B5">Aoki et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RRAS</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Related Ras viral (R-Ras) Oncogene Homolog</td>
<td align="left" colspan="1" rowspan="1" valign="top">Related RAS Viral (R-Ras) Oncogene Homolog; Increased RAS/MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B69">Flex et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MAP3K8</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NS</td>
<td align="left" colspan="1" rowspan="1" valign="top">RAS/MARK pathway</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B251">Tidyman and Rauen, 2016a</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MEK1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CFCS</td>
<td align="left" colspan="1" rowspan="1" valign="top">MEK 1: Mitogen-activated protein kinase kinase 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B53">Dentici et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NF1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NF-1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurofibromin</td>
<td align="left" colspan="1" rowspan="1" valign="top">PI3K/mTOR/AKT pathway</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B7">Arun et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SPRED1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">LS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sprouty-related EVH1 domain containing protein 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK and JAK2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B98">Hirata et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SPRED2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">OCD</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sprouty-related EVH1 domain containing protein 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Loss of SPRED2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B256">Ullrich et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HRAS</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Harvey rat sarcoma viral oncogene homolog</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B16">Bertola et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RIT2</italic> (rs12456492)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Parkinson’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">CD33</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs12456492 polymorphism is associated with increased CD33 expression</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B144">Liu et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RIT2</italic> (rs12456492)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Essential tremor</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B66">Emamalizadeh et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RIT2</italic> (rs16976358)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism spectrum disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulatory motif of the SOX transcription factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs16976358 variant</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B89">Hamedani et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RIT2</italic> (rs16976358)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">CNV</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B187">Rees et al., 2014</xref>; <xref ref-type="bibr" rid="B248">Tansey et al., 2016</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RIT2</italic> (rs16976358)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bipolar disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B66">Emamalizadeh et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RIT2</italic> (rs4130047)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism spectrum disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B89">Hamedani et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic><italic>NS, Noonan syndrome; NS-ML, Noonan syndrome with multiple lentigines; NS-LAH, Noonan-like syndrome disorder with loose anagen hair; CS, Costello syndrome; CFCS, Cranio-facio-cutaneous syndrome; LS, Legius syndrome; OCD, Obsessive compulsive disorder; NF-1, Type 1 neurofibromatosis; CNVs, Copy number variations</italic>.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Interacting proteins related to Small GTPases (Ras family).</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Small GTPase</th>
<th align="left" colspan="1" rowspan="1" valign="top">Interacting proteins</th>
<th align="left" colspan="1" rowspan="1" valign="top">Related diseases/function</th>
<th align="left" colspan="1" rowspan="1" valign="top">Pathway/mechanism</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rit2 (Rin)</td>
<td align="left" colspan="1" rowspan="1" valign="top">NGF</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B17">Besga et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Huntington’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased AKT/mTOR</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B34">Chaldakov et al., 2009</xref>; <xref ref-type="bibr" rid="B291">Zhang et al., 2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RIT1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Noonan syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK, Rac, and Stat3</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B278">Yaoita et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mental retardation, microcephaly, and epilepsy</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B231">Sonmez et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">TECR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non-syndromic mental retardation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased RAS/MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B30">Caliskan et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NTRK1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hereditary sensory and autonomic neuropathy type V</td>
<td align="left" colspan="1" rowspan="1" valign="top">A mutation in the <italic>NTRK1</italic>/high-affinity nerve growth factor (TrkA) gene</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B100">Houlden et al., 2001</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Congenital insensitivity to pain with anhidrosis</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">POU4F1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">Copy number variations (CNVs)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B102">Indo, 2001</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rit1 (Rit)</td>
<td align="left" colspan="1" rowspan="1" valign="top">B-Raf</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuronal development and regeneration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Activation of the B-Raf/ERK and p38 MAP kinase cascades</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B201">Salyakina et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">p38 MAPK</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurite outgrowth and cell survival</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">MK2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell survival</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rit GTPase-p38-MK2-AKT 9 kinase survival pathway</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B221">Shi and Andres, 2005</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">HSP27</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell survival</td>
<td align="left" colspan="1" rowspan="1" valign="top">MK2 signaling complex</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B222">Shi et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Akt</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell survival</td>
<td align="left" colspan="1" rowspan="1" valign="top">p38–MK2–HSP27-Akt activation</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B223">Shi et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RGL3</td>
<td align="left" colspan="1" rowspan="1" valign="top">RalA activation</td>
<td align="left" colspan="1" rowspan="1" valign="top">A candidate effector for Rit and Ras</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B216">Shao and Andres, 2000</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rheb</td>
<td align="left" colspan="1" rowspan="1" valign="top">mTOR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoting growth, cell cycle progression and inhibition of autophagy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Growth factor-induced mTORC1 activation</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B230">Sokolov et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">TSC complex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Form a complex with Rheb at the lysosomal membranes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Growth factor-induced mTORC1 activation</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B139">Lim and Crino, 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PLD1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rheb binds and activates phospholipase D1 (PLD1) in a GTP-dependent manner</td>
<td align="left" colspan="1" rowspan="1" valign="top">mTORC1 activation</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B295">Zheng et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">GAPDH</td>
<td align="left" colspan="1" rowspan="1" valign="top">GAPDH regulates mTOR activity by sequestering the Rheb.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rheb–GAPDH interaction</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B129">Lee et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">FKBP38</td>
<td align="left" colspan="1" rowspan="1" valign="top">Coordinate membrane targeting of Rheb</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rheb interacts with FKBP38 and prevents its association with mTOR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B51">De Cicco et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RASSF1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rheb form complex with RASSF1A to coordinate Hippo and TOR signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippo pathway activator</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B166">Nelson and Clark, 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NIX<break></break>LC3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rheb interacts with mitochondrial autophagic receptor Nix and the autophagosomal protein LC3-II.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Activation of mitophagy</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B154">Melser et al., 2013</xref>
<break></break>
<xref ref-type="bibr" rid="B240">Sugiura et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Syntenin</td>
<td align="left" colspan="1" rowspan="1" valign="top">PDZ protein syntenin preferentially binds to the GDP-bound form of Rheb.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rheb-syntenin signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B206">Sato et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CAD</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rheb binds to CAD protein, a multifunctional enzyme required for the synthesis of pyrimidine nucleotides.</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAD binding is more pronounced with Rheb2 than with Rheb1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B254">Tyagi et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PERK</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rheb inhibits protein synthesis by activating the PERK-eIF2α signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phosphorylation of eIF2α and PERK interplay</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B214">Shahani et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">BACE1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aging and Alzheimer’s disease. Forebrain Rheb promotes aging-associated cognitive defects</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rheb depletion increased the levels of BACE1</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Small GTPases and Related Diseases (Rho, Arf, Rab, and Ran families).</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Small GTPase</th>
<th align="left" colspan="1" rowspan="1" valign="top">Related disease</th>
<th align="left" colspan="1" rowspan="1" valign="top">Pathway/mechanism</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rac3</td>
<td align="left" colspan="1" rowspan="1" valign="top">A novel neurodevelopmental syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">De novo monoallelic missense variants in Rac3, including one recurrent change</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B45">Costain et al., 2019</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">RhoA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Diabetic Parkinson’s disease or dementia</td>
<td align="left" colspan="1" rowspan="1" valign="top">Accelerated neuron loss via the 5-hydroxytryptamine 2 receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B298">Zimering, 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cdc42</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epileptic-seizures</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulating synaptic inhibition</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B290">Zhang Y. et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rac1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fragile X syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rac1 is necessary for normal spine development and long-term synaptic plasticity</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B18">Bongmba et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rac1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Patients suffering from temporal lobe epilepsy (TLE) and experimental epileptic rats</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B137">Li et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">RhoB</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glioblastoma</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cytokine-induced STAT3 activation, activated p53 and p21</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B146">Ma et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rac1 and Cdc42</td>
<td align="left" colspan="1" rowspan="1" valign="top">Developmental delay, secondary macrocephaly, seizures, and ataxic gait</td>
<td align="left" colspan="1" rowspan="1" valign="top">De novo PAK1 mutations c.392A&gt;G (p.Tyr131Cys) and c.1286A&gt;G (p.Tyr429Cys)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B94">Harms et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rac1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Drug withdrawal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rac1-dependent GABAAR endocytosis, synaptic plasticity as well as learning and memory</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B268">Wang et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rac1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alcohol use disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rac1/Arfaptin/Arf6 pathway</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B175">Peru Y Colón de Portugal et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">RhoA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cocaine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phosphorylated ERM levels and synaptic changes in the NAcc</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B116">Kim et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab7</td>
<td align="left" colspan="1" rowspan="1" valign="top">Parkinson’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Clearance of α-synuclein aggregates</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B203">Saridaki et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab11</td>
<td align="left" colspan="1" rowspan="1" valign="top">Parkinson’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduces α-synuclein aggregation and toxicity</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B41">Chutna et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab39b</td>
<td align="left" colspan="1" rowspan="1" valign="top">Parkinson’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduce steady-state levels of α-synuclein</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B274">Wilson et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab</td>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile encephalopathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rab GTPase-Activating Protein dysregulates mTOR signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B40">Chong et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab1A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mediates Golgi dynamics</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B157">Mohamed et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab3A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Localizes in presynaptic vesicles and regulates exocytosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B255">Udayar et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates endosomal recycling</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B77">Ginsberg et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Modulates endosomal membrane trafficking, sorting and endosomal fusion</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B75">Ginsberg et al., 2010a</xref>,<xref ref-type="bibr" rid="B76">b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates retrograde Golgi-ER trafficking</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B209">Scheper et al., 2007</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab7A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Controls transport to late endosomes and lysosomes/regulates tau secretion</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B77">Ginsberg et al., 2011</xref>; <xref ref-type="bibr" rid="B192">Rodriguez et al., 2017</xref>; <xref ref-type="bibr" rid="B285">Zafar et al., 2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab8</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Modulates polarized trafficking</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B224">Shimohama et al., 1999</xref>; <xref ref-type="bibr" rid="B111">Kametani et al., 2004</xref>; <xref ref-type="bibr" rid="B136">Li et al., 2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab10</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">pRab10-T73, decrease in Aβ42 and Aβ42/Aβ40 ratio</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B191">Ridge et al., 2017</xref>; <xref ref-type="bibr" rid="B277">Yan et al., 2018</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab11A/Rab11B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates both endocytic and exocytic trafficking pathways</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B255">Udayar et al., 2013</xref>; <xref ref-type="bibr" rid="B28">Buggia-Prevot et al., 2014</xref>; <xref ref-type="bibr" rid="B276">Xu et al., 2015</xref>; <xref ref-type="bibr" rid="B294">Zhao et al., 2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab14</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Endocytic recycling and Golgi-endosome trafficking</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B141">Linford et al., 2012</xref>; <xref ref-type="bibr" rid="B181">Prekeris, 2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab17</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Involved in phagocytic removal of apoptotic cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B255">Udayar et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab24</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Involved in autophagy</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B75">Ginsberg et al., 2010a</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab27</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates exocytosis, endocytosis and phagocytosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B77">Ginsberg et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab36</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Involved in late endosome and lysosome distribution</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B255">Udayar et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab3a</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glioma</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increases cyclin D1 expression</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B115">Kim et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab38</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glioblastomas</td>
<td align="left" colspan="1" rowspan="1" valign="top">Whole genome mRNA expression microarray data on 220 glioma samples from the Chinese glioma genome atlas</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B266">Wang and Jiang, 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rab28</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cone-rod dystrophy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retinal dystrophies</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B198">Roosing et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Arf1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Creutzfeldt-Jakob disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Arf/Rho/MLC signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B284">Zafar et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Arl2 and Arl3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retina disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Participate in the trafficking of lipidated membrane-associated proteins and colocalize in the inner segment with UNC119A and PDEδ</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B261">Veltel et al., 2008a</xref>; <xref ref-type="bibr" rid="B289">Zhang H. et al., 2015</xref>; <xref ref-type="bibr" rid="B92">Hanke-Gogokhia et al., 2016a</xref>,<xref ref-type="bibr" rid="B93">b</xref>; <xref ref-type="bibr" rid="B160">Moshiri et al., 2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Arf6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alcohol use disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rac1/Arfaptin/Arf6 pathway</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B175">Peru Y Colón de Portugal et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Arl6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Diabetic retinopathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates VEGFR2 trafficking and signal transduction</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B296">Zhu et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Arl6</td>
<td align="left" colspan="1" rowspan="1" valign="top">ALS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Potential driver pathophysiological events involving endoplasmic reticulum stress and autophagy</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B288">Zhai et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Arf72A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retina disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rescues the ninaE(D1)-related membrane accumulation and suppresses ninaE(D1)-triggered retinal degeneration</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B127">Lee et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Arl2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bardet–Biedl syndrome type 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Disrupt a threonine residue important for GTP binding and function of several related small GTP-binding proteins</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B67">Fan et al., 2004</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ran</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frontotemporal dementia</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates nuclear import via TDP-43 pathway</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B269">Ward et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ran</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription regulators in the nucleus</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B152">Mastroeni et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ran</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glioblastoma multiforme</td>
<td align="left" colspan="1" rowspan="1" valign="top">The Survivin-Ran complex</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B86">Guvenc et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>ALS, amyotrophic lateral sclerosis.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>The Ras Family in Non-Neoplastic Cerebral Diseases</title>
<sec>
<title>The Ras Family</title>
<p>As the first described and prototypical members of the small GTPase superfamily, Ras family proteins are almost universal components of signaling pathways in eukaryotic organisms, including vertebrates, invertebrates, and yeasts (<xref ref-type="bibr" rid="B80">Goitre et al., 2014</xref>). Ras genes were first identified as oncogenes, and were named after the Rat Sarcoma gene in the 1970s during the extensive study of acutely transforming retroviruses isolated from mice, rats, and other animals (<xref ref-type="bibr" rid="B47">Cox and Der, 2010</xref>). Following years of investigation, the widespread prevalence of Ras mutations in the context of carcinogenesis has now been widely recognized. This has inspired multiple attempts to find Ras inhibitors. However, as for the role of the Ras family in non-neoplastic diseases, we are still at the beginning stage of discovering how the related proteins and their precise mechanisms control and modulate non-oncogenic processes (<xref ref-type="bibr" rid="B107">Johnson and Chen, 2012</xref>).</p>
<p>According to their evolutionarily conservation in structural, biochemical, and functional levels, the Ras family is composed of over 36 members, with six major subfamilies: Ras subfamily (H-Ras, K-Ras, N-Ras, etc.), Ral (RalA, RalB), Rap (Rap1, Rap2), Rad (Rad, Gem, etc.), Rheb (Rheb1, and Rheb2 or RhebL1) and Rit (Rit1 or Rit, Rit2 or Rin, and <italic>Drosophila dRic</italic>) (<xref ref-type="bibr" rid="B80">Goitre et al., 2014</xref>).</p>
<p>Most Ras family proteins are predominantly localized on the intracellular surface of the plasma membrane as a result of C-terminal prenylation (<xref ref-type="bibr" rid="B44">Colicelli, 2004</xref>). They can be activated in response to multiple extracellular stimuli in the form of growth factors and small molecules, which thereby transduce signals to the intracellular environment to regulate cytoplasmic signaling networks (<xref ref-type="bibr" rid="B279">Ye and Carew, 2010</xref>).</p>
<p>The best-characterized downstream signaling cascade of Ras family proteins is the Mitogen-Activated Protein Kinase (MAPK) cascade, mainly the Extracellular signal-Regulated Kinase 1/2 (ERK) of the MAPK family (<xref ref-type="bibr" rid="B279">Ye and Carew, 2010</xref>). Ras family proteins can directly bind to the regulatory domain of Raf (c-Raf or b-Raf) and subsequently phosphorylate and dephosphorylate it at multiple sites for full activation. In turn, activated Raf phosphorylates and activates MAP Kinase or ERK Kinase (MEK), and finally targets transcription factors to induce gene expression (<xref ref-type="bibr" rid="B124">Lange-Carter and Johnson, 1994</xref>). Take Rap subfamily members for example. Rap1 can activate ERK by activating b-Raf (expressed predominantly in the brain) and p38MAPK, which implies a pivotal role in synaptic depression (<xref ref-type="bibr" rid="B83">Grewal et al., 2000</xref>; <xref ref-type="bibr" rid="B112">Kanda and Watanabe, 2007</xref>). Furthermore, Rap2 is involved in the activation of c-Jun N-terminal Kinase (JNK) (<xref ref-type="bibr" rid="B148">Machida et al., 2004</xref>). In addition to the Raf–MEK–ERK cascade, other well-known pathways include the phosphatidylinositol 3-kinase (PI3K), RalGEF-Ral, and phospholipase C epsilon (PLCε) pathways (<xref ref-type="bibr" rid="B184">Pulciani et al., 1982</xref>; <xref ref-type="bibr" rid="B202">Santos et al., 1984</xref>).</p>
<p>The Rit subfamily is composed of two classes, Rit and Rin (Ras like without CAAX2, Rit2), each containing a well-conserved GTPase core (G1–G5). Distinct patterns of developmental expression for both proteins were found, whereby Rit is widely expressed throughout development, while Rin shows delayed expressed limited to later stages of embryonic neuronal development (E14), with highest Rin expression found in the adult brain (<xref ref-type="bibr" rid="B222">Shi et al., 2013</xref>; <xref ref-type="bibr" rid="B89">Hamedani et al., 2017</xref>). Activated Rit was identified as playing a critical role in the regulation of neuronal morphogenesis, especially enhancing axonal growth, but with the opposite effect on dendritic growth (<xref ref-type="bibr" rid="B132">Lein et al., 2007</xref>).</p>
<p>Rin is involved in calcium-mediated processes in cells and binds to calmodulin through a C-terminal binding motif, regulating the Rin-mediated pathway (<xref ref-type="bibr" rid="B99">Hoshino and Nakamura, 2002</xref>; <xref ref-type="bibr" rid="B48">Daneshmandpour et al., 2018</xref>). Rin has an important role in intracellular signaling and interacts with DAT (dopamine active transporter) in lipid raft microdomains (<xref ref-type="bibr" rid="B165">Navaroli et al., 2011</xref>).</p>
<p>The Rheb subfamily (Ras homolog protein enriched in the brain) is a member of the Ras family that is highly conserved among different organisms (<xref ref-type="bibr" rid="B258">Urano et al., 2001</xref>; <xref ref-type="bibr" rid="B210">Schoneborn et al., 2018</xref>). Two different Rheb genes have been identified in mammalians, <italic>RHEB1</italic> (from here on <italic>REHB</italic>), and <italic>RHEB2</italic> (also as <italic>RHEBL1</italic>). RHEB is expressed in various human tissues, but RHEB2 is mainly expressed in the brain tissue, such as cerebral cortex, occipital pole, frontal, and temporal lobes (<xref ref-type="bibr" rid="B199">Saito et al., 2005</xref>; <xref ref-type="bibr" rid="B210">Schoneborn et al., 2018</xref>).</p>
<p>Mammalian target of rapamycin (mTOR) is a serine-threonine kinase that integrates signals to regulate cell growth and metabolism. In the brain, Rheb functions as a key activator of mTORC1, and deletion of RHEB causes decreased cortical thickness and defective myelination (<xref ref-type="bibr" rid="B128">Lee et al., 2015</xref>).</p>
<p>RalA and RalB are monomeric GTPases belonging to the Ral subclass, and both are expressed in the nervous system (<xref ref-type="bibr" rid="B250">Teodoro et al., 2013</xref>). Ral can be activated either by Ras indirectly via a Ral-GEF (Guanine nucleotide Exchange Factor) or by Ca<sup>2+</sup>/calmodulin binding, and it is inactivated by PKC phosphorylation of the effector Sec5 (<xref ref-type="bibr" rid="B95">Harvey et al., 2008</xref>; <xref ref-type="bibr" rid="B37">Chen et al., 2011</xref>). During brain development, it is considered that Ral is involved in the asymmetric division of neuroblasts, neuronal migration in the neocortex, neurite branching, and activity-dependent spine growth (<xref ref-type="bibr" rid="B50">Das et al., 2014</xref>). RalA regulates axon initiation in cortical neurons by promoting an interaction between the exocyst protein complex, which is one of its major effectors, and the Par3–Par6–aPKC complex, an evolutionarily conserved master regulator of cell polarity. However, in other cell migration process, such as tumor metastasis, it seems that RalB may play a more important role than RalA (<xref ref-type="bibr" rid="B286">Zago et al., 2017</xref>).</p>
<p>The Rap subfamily is composed of five related proteins, Rap1 (A and B) and Rap2 (A, B, and C), which have overlapping functions and expression patterns (<xref ref-type="bibr" rid="B162">Nakamura et al., 2013</xref>; <xref ref-type="bibr" rid="B292">Zhang L. et al., 2018</xref>). Similar to other members of the Ras family, Rap proteins work as molecular switches of multiple signal transduction cascades and are linked to several genetic defects related to mental, neurological and psychiatric disorders (<xref ref-type="bibr" rid="B264">Volk et al., 2015</xref>). Rap1 has been intensively investigated for its function in integrin-mediated cell adhesion and the regulation of cell–cell junction integrity (<xref ref-type="bibr" rid="B108">Jossin, 2011</xref>). A recent study indicates that Rap1 and Rap2 predominantly signal synaptic depression via the lysosomal p38MAPK and the bulk membrane JNK pathway, respectively, regulating different forms of synaptic plasticity (<xref ref-type="bibr" rid="B292">Zhang L. et al., 2018</xref>). Especially, Rap1B acts as a core molecule in the signaling network responsible for neuronal polarization (<xref ref-type="bibr" rid="B162">Nakamura et al., 2013</xref>).</p>
</sec>
<sec>
<title>Diseases Related to the Ras Family</title>
<p>Owing to the Ras family proteins’ essential role in modulating a wide range of cellular processes, several human diseases are caused by the dysregulation or dysfunction of related signaling pathways. These include cancer, developmental-, neurocognitive- and neurodegenerative disorders, as well as metabolic and cardiovascular diseases (<xref ref-type="bibr" rid="B163">Nakhaei-Rad et al., 2018</xref>). In this section, we reviewed some Ras family related developmental disorders and neurological diseases.</p>
<sec>
<title>RASopathies</title>
<p>The RASopathies are the largest known group of rare human developmental disorders that are caused by germline mutations in genes that encode proteins of the RAS/MAPK pathway, resulting in its hyperactivation (<xref ref-type="bibr" rid="B245">Tajan et al., 2018</xref>). As mentioned above, the RAS/MAPK pathway is essential for the development of mammalian tissues, controlling a variety of cellular activities, such as cell cycle and growth, differentiation, metabolism and senescence (<xref ref-type="bibr" rid="B228">Slack, 2017</xref>). Although this signaling pathway is often summarized as a well-established cascade, there are still many gray areas and multilevel regulations, such as transcriptional control, posttranslational modifications, protein-protein interactions, and crosstalk with other signaling pathways. In this section, we mainly focus on individual symptoms, phenotypes and most evidenced gene mutations to the RASopathies. Further detailed information on comprehensive functional and pathophysiological consequences could be referred to suggested reviews (<xref ref-type="bibr" rid="B10">Atay and Skotheim, 2017</xref>; <xref ref-type="bibr" rid="B227">Simanshu et al., 2017</xref>).</p>
<p>The RASopathies includes neurofibromatosis type 1 (NF1), Legius syndrome (LS), capillary malformation–arterio-venous malformation syndrome (CM-AVM), Costello syndrome (CS), cardio-facio-cutaneous syndrome (CFC), Noonan syndrome (NS) and Noonan syndrome with multiple lentigines (NS-ML) (<xref ref-type="bibr" rid="B227">Simanshu et al., 2017</xref>; <xref ref-type="bibr" rid="B49">Dard et al., 2018</xref>). Although RASopathies exhibit unique phenotypes, they share many overlapping clinical characteristics due to the common pathway dysregulation, such as partial facial anomalies, cognitive impairment, and congenital heart defects (<xref ref-type="bibr" rid="B163">Nakhaei-Rad et al., 2018</xref>). As a whole, the RASopathies affect approximately 1 per 1,000 live births (<xref ref-type="bibr" rid="B245">Tajan et al., 2018</xref>). The initial diagnosis of a RASopathy patient is based on the clinical recognition of phenotypic features, and the clinical diagnosis is then confirmed by molecular genetic tests. To date, with the accumulation of genotype and phenotype correlation data, there are more than 20 gene mutations has been associated with RASopathies. Most mutations causing RASopathies occur at conserved positions within the RAS/MAPK pathway, providing a genetic foundation for their diagnosis and pathophysiology (<xref ref-type="bibr" rid="B227">Simanshu et al., 2017</xref>). <xref ref-type="table" rid="T1">Table 1</xref> has listed several gene mutations related to small GTPases, especially the Ras family and RASopathies. However, considering the heterogeneity of a given syndrome and the pleiotropic roles during development and homeostasis maintenance, it is still difficult and fragmental to classify the causal genes and mutations involved with the genotype/phenotype correlations based on current progress.</p>
<p>NS was first described by Jacqueline Noonan about 50 years ago, and is also the most frequent RASopathy. Its estimated prevalence is between 1 in 2,000–2,500 newborns (<xref ref-type="bibr" rid="B168">Noonan, 1968</xref>; <xref ref-type="bibr" rid="B245">Tajan et al., 2018</xref>). It is an autosomal dominant disorder and the most genetically diverse RASopathy, which is clinically characterized by facial dysmorphic features, congenital heart defects, and growth retardation. More than half of patients with NS are identified as having mild to moderate developmental delay/learning disability, notably with social and communication difficulties, attention deficit, and language impairment (<xref ref-type="bibr" rid="B33">Cesarini et al., 2009</xref>). Most of the mutations responsible for NS affect familiar components of Ras pathways. The protein tyrosine phosphatase non-receptor type (<italic>PTPN11</italic>), encoding SHP2, is the first and major NS disease gene, which was found mutated in 50–60% of patients with NS (<xref ref-type="bibr" rid="B10">Atay and Skotheim, 2017</xref>). Other less common or rare mutation genes are related to the RAS/MAPK pathway as well, including SOS1, SOS2, H-Ras, K-Ras, R-Ras, N-Ras, M-Ras and Rit1, the GAP RasA2, the kinases CRAF, BRAF, MEK1, MEK2, and MAP3K8, CBL, MYST4, A2ML1, SHOC2, and its binding partner PP1 (<xref ref-type="bibr" rid="B252">Tidyman and Rauen, 2016b</xref>). SHOC2 mutations have been reported in combination with mutations in PTPN11 (SHP2) in NS (<xref ref-type="bibr" rid="B64">Ekvall et al., 2011</xref>). The diversity of the affected genes has determined the NS is the most genetically heterogeneous RASopathy. However, the role of these proteins in regulating the RAS/MAPK pathway is still not clear, and the underlying functional mechanisms and genotype/phenotype correlations remain to be elucidated (<xref ref-type="bibr" rid="B252">Tidyman and Rauen, 2016b</xref>; <xref ref-type="bibr" rid="B227">Simanshu et al., 2017</xref>).</p>
<p>NS-ML, formerly known as LEOPARD syndrome, is an autosomal dominant disorder that has a prevalence of fewer than 1 in 100,000 newborns (<xref ref-type="bibr" rid="B204">Sarkozy et al., 2008</xref>). However, considering that the phenotype of NS-ML is very close to that of NS, the diagnosis can be more difficult (<xref ref-type="bibr" rid="B204">Sarkozy et al., 2008</xref>). Distinctive clinical features for NS-ML are a high prevalence of hearing deficits (20%) and multiple pigmented skin lesions called lentigines, mostly starting at school age (90%) (<xref ref-type="bibr" rid="B204">Sarkozy et al., 2008</xref>). Missense mutations in PTPN11 (<xref ref-type="bibr" rid="B131">Legius et al., 1993</xref>; <xref ref-type="bibr" rid="B56">Digilio et al., 2006</xref>) and rarely in RAF1 (<xref ref-type="bibr" rid="B172">Pandit et al., 2007</xref>) and BRAF (<xref ref-type="bibr" rid="B56">Digilio et al., 2006</xref>) are associated with NSML. Loss of function mutations in the PTPN11 gene result in reduced SHP2 activity, which is not found in NS (<xref ref-type="bibr" rid="B55">Digilio et al., 2002</xref>; <xref ref-type="bibr" rid="B120">Kontaridis et al., 2006</xref>). A recent study implied that the Ras-related Akt-mTOR signaling pathway is implicated in NS-ML phenotypes (<xref ref-type="bibr" rid="B151">Marin et al., 2011</xref>).</p>
<p>Noonan-like syndrome with loose anagen hair (NSLAH), also known as Mazzanti syndrome, is phenotypically close to NS, but patients display distinctive hyperactive behavior and pathognomonic hair anomalies (<xref ref-type="bibr" rid="B84">Gripp et al., 2016</xref>). SHOC2 and PPP1CB have been indicated with the onset of the disease (<xref ref-type="bibr" rid="B10">Atay and Skotheim, 2017</xref>). NF1, the second-most frequent RASopathy, is an autosomal dominant genetic disorder that was first described in 1882 (<xref ref-type="bibr" rid="B74">Garcia-Romero et al., 2016</xref>; <xref ref-type="bibr" rid="B227">Simanshu et al., 2017</xref>). The incidence of NF1 is 1 per 2,500–3,000 in newborns, with approximately 50% of NF1 patients inheriting the mutation from a parent (<xref ref-type="bibr" rid="B273">Williams et al., 2009</xref>). The characteristic feature used for NF1 diagnosis is the presence of café-au-lait macules. Benign tumors (neurofibromas and optic pathway gliomas), iris Lisch nodules, bone malformations (limb pseudarthrosis), cardiac malformations, brain malformations, seizures, and mild neurocognitive impairment can aid the diagnosis (<xref ref-type="bibr" rid="B101">Huffmeier et al., 2006</xref>; <xref ref-type="bibr" rid="B236">Stevenson et al., 2006</xref>). NF1 is caused by mutations in the NF1 gene on chromosome 17q11.2, which encodes neurofibromin, a GAP that negatively regulates Ras (<xref ref-type="bibr" rid="B32">Cawthon et al., 1990</xref>; <xref ref-type="bibr" rid="B131">Legius et al., 1993</xref>). NF1 mutations result in the loss of function of neurofibromin, which in turn reduces Ras GTPase activity and finally increases the levels of active GTP-bound Ras. Studies have suggested that neurofibromin can act on M-Ras, R-Ras, and R-Ras2 (a.k.a. TC21) (<xref ref-type="bibr" rid="B169">Ohba et al., 2000</xref>). R-Ras and N-Ras activate PI3Kγ, while M-Ras recruits SHOC2/PP1c to the plasma membrane to regulate SCRIB activity (<xref ref-type="bibr" rid="B193">Rodriguez-Viciana et al., 2004</xref>; <xref ref-type="bibr" rid="B283">Young et al., 2013</xref>). As a consequence, the loss of neurofibromin may have broader impacts on cells than the activation of H-Ras, N-Ras, and K-Ras proteins themselves (<xref ref-type="bibr" rid="B227">Simanshu et al., 2017</xref>).</p>
<p>Legius syndrome is a milder form of neurofibromatosis type 1, which shares phenotypic features with NF1, albeit in less severe form (<xref ref-type="bibr" rid="B245">Tajan et al., 2018</xref>). However, the NF1 gene is intact and heterozygous inactivating mutations in the SPRED1 gene on chromosome 15q13.2 occur in LS (<xref ref-type="bibr" rid="B26">Brems et al., 2007</xref>). SPRED1 functions as a negative regulator of Ras by inhibiting the phosphorylation of Raf (<xref ref-type="bibr" rid="B265">Wakioka et al., 2001</xref>). The SPRED1 proteins are essential for the interaction of neurofibromin with Ras at the plasma membrane. It is suggested that SPRED2 and SPRED3 proteins can partially compensate the loss of SPRED1 function (<xref ref-type="bibr" rid="B227">Simanshu et al., 2017</xref>). Although SPRED1 binding does not affect neurofibromin’s GAP activity, it nevertheless plays an important role in enabling neurofibromin to downregulate Ras activity at the plasma membrane.</p>
<p>CFCS is a rare autosomal dominant disease with multiple congenital anomalies that affects 1/800,000 newborns (<xref ref-type="bibr" rid="B177">Pierpont et al., 2014</xref>). It shares many overlapping features with NS (e.g., heart defects, short stature, and facial features) but is additionally characterized by thick scaly skin, delayed growth and cardiac malformations (<xref ref-type="bibr" rid="B186">Rauen, 2007</xref>). Affected individuals frequently have severe neurological disturbances and mental retardation (<xref ref-type="bibr" rid="B281">Yoon et al., 2007</xref>). CFCS is caused by heterozygous mutations in BRAF (75% of cases), and less frequently in the MAP2K1 (MEK1), MAP2K2 (MEK2) (20% of cases) and <italic>k-ras</italic> genes (<xref ref-type="bibr" rid="B194">Rodriguez-Viciana et al., 2006</xref>). BRAF is a downstream effector of Ras, and activating BRAF can increase the activation of the MAPK pathway by CRAF (<xref ref-type="bibr" rid="B96">Heidorn et al., 2010</xref>).</p>
<p>Costello syndrome is a multiple congenital anomaly syndrome caused by heterozygous activating germline mutations in HRAS. A common and distinctive feature of CS among RASopathies is an increased risk of developing cancers such as rhabdomyosarcomas and neuroblastomas. A recent study has found an increased energy expenditure (EE) in patients with CS, resulting in growth failure (<xref ref-type="bibr" rid="B134">Leoni et al., 2016</xref>).</p>
<p>CM-AVM is associated with arteriovenous malformations and fistulas, and is caused by heterozygous inactivating mutations in RASA1 (<xref ref-type="bibr" rid="B62">Eerola et al., 2003</xref>). RASA1 encodes p120-RasGAP, which is a negative regulator of the RAS/MAPK signal transduction pathway. RASA1 mutations have also been associated with the related condition known as Parkes Weber syndrome (<xref ref-type="bibr" rid="B13">Banzic et al., 2017</xref>).</p>
<p>From the functional perspective, the global relationship for different syndromes could emerged as this: NS and NS-ML are mainly related with activators of the RAS/MAPK cascade (i.e., RAS or RAF activators), but NF and LS are associated to RAS inhibitors. In addition, CS and CFCS mutations hit the backbone of the pathway, while CS being centered on RAS and CFCS on downstream kinases (<xref ref-type="bibr" rid="B10">Atay and Skotheim, 2017</xref>).</p>
<sec>
<title>Future prospective</title>
<p>With the continuous investigation and further understanding of causal mutations and functional analysis of pathophysiological consequences of RASopathies, tremendous advances have been made in the past 30 years. Whereas, given the current fragmentary view, the complexity of RASopathies determined that more issues and challenges lie ahead, such as unidentified causal genes in patients with RASopathies, further functional analyses of the newly discovered mutations, the precise mechanisms underlying the RASopathies (similarities and differences between RASopathies), and the variable expression of a gene mutation (<xref ref-type="bibr" rid="B10">Atay and Skotheim, 2017</xref>). In addition, we should take into account of the endocrine and metabolic prospective to interrogate the interactions and contributions of different mutations to the homeostasis imbalance and global phenotype. Moreover, additional factors, such as environmental, age-related and sex-related modifiers, may multifold the difficulty to decipher its pathophysiological process.</p>
</sec>
</sec>
<sec>
<title>Neurological and Psychiatric Disorders</title>
<p>Alzheimer’s disease (AD) is the most common progressive neurodegenerative disorder, affecting more than 30 million people worldwide (<xref ref-type="bibr" rid="B237">Stornetta and Zhu, 2011</xref>). The disorder is characterized by early deficits in learning and memory followed by loss of other higher cognitive functions, which is correlated with synaptic depression and then neuronal degeneration (<xref ref-type="bibr" rid="B87">Haass and Selkoe, 2007</xref>). It is still unclear that what factors determined the age of onset and how the selective dysfunction of neurons in the brain been affected. A hallmark of AD pathology is the generation of amyloid beta (Aβ) from the amyloid precursor protein (APP) by APP-cleaving enzyme 1 (β-secretase, BACE1) (<xref ref-type="bibr" rid="B210">Schoneborn et al., 2018</xref>). Studies showed the underlying mechanism for physiological regulating BACE1 stability and activity in its GTP-bound state was Rheb GTPase, which induced mammalian target of rapamycin (mTOR) activity. Protein levels of BACE1 and Aβ generation are suppressed upon Rheb overexpression (<xref ref-type="bibr" rid="B210">Schoneborn et al., 2018</xref>). The interaction of GTP-activated Rheb with BACE1 stimulates its degradation via the proteasomal and lysosomal pathways (<xref ref-type="bibr" rid="B215">Shahani et al., 2014</xref>). Recently correlation study implied that the nutrient signaling might regulate cognitive functions in mammals by regulating Rheb–BACE1 and Rheb–mTOR pathways activity, which also orchestrated a potential new therapeutic target for Alzheimer’s-associated memory dysfunction (<xref ref-type="bibr" rid="B214">Shahani et al., 2017</xref>).</p>
<p>Parkinson’s disease (PD) is the second most common neurodegenerative disorder following Alzheimer’s disease, affecting 1–2% of the population above 60 years of age (<xref ref-type="bibr" rid="B113">Karimi-Moghadam et al., 2018</xref>). Although most PD cases occur sporadically, mutations in several genes, such as <italic>SNCA</italic> (α-synuclein), <italic>PARK2</italic> (parkin), <italic>DJ-1</italic>, <italic>PINK1</italic>, <italic>ATP13A2</italic>, <italic>VPS35</italic> (vacuolar protein sorting 35), <italic>EIF4G1</italic> (eukaryotic initiation factor 4G1) and <italic>LRRK2</italic> (leucine-rich repeat kinase 2), have been identified in hereditary PD (<xref ref-type="bibr" rid="B253">Tsika and Moore, 2013</xref>). LRRK2 is a large, multifunctional protein with a central catalytic GTPase/kinase core flanked by several protein-binding domains. Seven missense mutations, clustered in the Ras-of-complex (ROC) GTPase domain, C-terminal-of-ROC (COR) and kinase domains, segregate with PD in affected families (<xref ref-type="bibr" rid="B9">Atashrazm et al., 2018</xref>; <xref ref-type="bibr" rid="B176">Pfeffer, 2018</xref>). Dopaminergic signaling also plays a critical role in the pathogenesis of PD, and dopamine transporter (DAT) serves as a primary mechanism for terminating dopaminergic signaling (<xref ref-type="bibr" rid="B222">Shi et al., 2013</xref>). Rit2 (Rin) was recently identified as a protein that interacts with the DAT C-terminal endocytic domain, implying a role of Rin signaling in the regulation of DAT trafficking (<xref ref-type="bibr" rid="B165">Navaroli et al., 2011</xref>). In addition, studies from the perspective of immunity have also indicated that Rit2 polymorphisms affect the innate immune system, which in turn is responsible for some PD symptoms (<xref ref-type="bibr" rid="B35">Chan et al., 2016</xref>). Recent genome wide association study (GWAS) and meta-analysis results introduced Rit2 as a novel susceptibility locus, in association with decreased Rin expression in the substantia nigra pars compacta (SNc) of PD patients (<xref ref-type="bibr" rid="B21">Bossers et al., 2009</xref>; <xref ref-type="bibr" rid="B125">Latourelle et al., 2012</xref>; <xref ref-type="bibr" rid="B173">Pankratz et al., 2012</xref>). However, the results of RIT2 polymorphisms studies in different populations are controversial, which may be due to genetic context difference and environmental factors (<xref ref-type="bibr" rid="B48">Daneshmandpour et al., 2018</xref>). Therefore, further functional study, animal study and larger study with various population samples might give more detailed role of RIT2 in cells and groups in PD pathogenesis.</p>
<p>Huntington’s disease (HD) is a fatal autosomal-dominant neurodegenerative disease caused by CAG repeat expansion in exon 1 of <italic>huntingtin</italic>, which encodes the protein huntingtin (Htt). HD results in early loss of medium spiny neurons in the striatum, which impairs motor and cognitive functions (<xref ref-type="bibr" rid="B147">MacDonald et al., 1993</xref>). In HD, Htt contains an expanded poly-glutamine (poly-Q) tract. Under healthy conditions, Htt promotes signaling through mTORC1 (mammalian target of rapamycin complex 1). In the case of HD, the poly-Q tract potentiates the signaling by promoting the formation of a ternary complex of Htt-Rheb-mTOR, leading to enhanced mTORC1 activity (<xref ref-type="bibr" rid="B205">Sathasivam et al., 2013</xref>). In the striatum, Rhes (Ras homolog enriched in the striatum) serves as a key activator of mTORC1 (<xref ref-type="bibr" rid="B183">Pryor et al., 2014</xref>). Knockout of Rhes reduces mTORC1 activity and attenuates the adverse responses of L-DOPA-induced dyskinesia (<xref ref-type="bibr" rid="B238">Subramaniam et al., 2011</xref>; <xref ref-type="bibr" rid="B128">Lee et al., 2015</xref>). In addition, Rhes facilitates SUMOylation, a process implicated in HD pathogenesis (<xref ref-type="bibr" rid="B239">Subramaniam et al., 2009</xref>). Because Rhes is highly expressed in the striatum (<xref ref-type="bibr" rid="B232">Spano et al., 2004</xref>), it has been proposed that Rhes-Mutant Htt interactions may underlie the prominent striatal degeneration observed in HD. There is evidence that impaired Rhes/mTORC1 activity is relevant to the notable striatal pathogenesis in HD, which suggests that impaired mTORC1 function may represent a fundamental mechanism underlying the complex disease phenotypes of HD (<xref ref-type="bibr" rid="B128">Lee et al., 2015</xref>).</p>
<p>Autism spectrum disorders (ASD) are a continuum of complex neurological disorders interfering with normal social behavior and cognitive development (<xref ref-type="bibr" rid="B89">Hamedani et al., 2017</xref>). They are common neurodevelopmental diseases with onset prior to the age of three, affecting almost 1% of individuals worldwide (<xref ref-type="bibr" rid="B143">Liu et al., 2016</xref>). Children with ASD often show a large head circumference and develop epilepsy, and nearly half display severe intellectual disability (<xref ref-type="bibr" rid="B237">Stornetta and Zhu, 2011</xref>). ASD has a strong but complex genetic component. A recent study identified an increase in RIT1 transcript levels in patients with autism, implying that Rit may represent an ASD susceptibility gene (<xref ref-type="bibr" rid="B73">Garbett et al., 2008</xref>). Considering that several factors, such as abnormal assembly of synapses and dendritic spines, contribute to autism’s pathogenesis, the Rit signal pathway that regulates synaptic development and function might be a novel potential therapeutic target (<xref ref-type="bibr" rid="B61">Ebert and Greenberg, 2013</xref>).</p>
<p>Schizophrenia is a devastating psychiatric disorder characterized by reality distortion, with onset in late adolescence and unclear etiology (<xref ref-type="bibr" rid="B79">Glessner et al., 2010</xref>). Common features are positive symptoms, such as hallucinations, delusions, disorganized speech, and negative symptoms, such as social deficits, lack of motivation, anhedonia, and impaired emotion processing, as well as cognitive deficits with occupational dysfunction (<xref ref-type="bibr" rid="B6">Arajarvi et al., 2005</xref>). Previous studies have reported various copy number variations (CNVs) related to schizophrenia (<xref ref-type="bibr" rid="B178">Piluso et al., 2017</xref>; <xref ref-type="bibr" rid="B297">Zhuo et al., 2017</xref>). Several recent studies have suggested that the <italic>rit2</italic> gene might be involved in the pathogenesis of schizophrenia (<xref ref-type="bibr" rid="B79">Glessner et al., 2010</xref>). When compared with control subjects, patients with schizophrenia present a significant enrichment of common interstitial deletions (<xref ref-type="bibr" rid="B22">Bouquillon et al., 2011</xref>). Among the deleted genes, <italic>rit2</italic> was identified as a candidate gene for language delay, mental retardation, and behavioral abnormalities (<xref ref-type="bibr" rid="B22">Bouquillon et al., 2011</xref>). Evidence indicates that <italic>ret</italic> and <italic>rit2</italic>, both Ras-related genes important for neural crest development, are significantly affected by CNVs (<xref ref-type="bibr" rid="B79">Glessner et al., 2010</xref>). Rit2 is involved in the ubiquitin E3 ligase growth factor pathway that affects mitochondrial dysfunction, which is linked with both schizophrenia and autism (<xref ref-type="bibr" rid="B180">Prabakaran et al., 2004</xref>).</p>
<p>The protein interactions in the cells are common. Malfunction or alterations in the protein-protein interaction may influence vast biological functions. Selected members of Ras subfamily and their related possible interacting proteins are listed in the <xref ref-type="table" rid="T2">Table 2</xref>. Specifically for RIT2, evidence suggests that proteins interacting with RIT2 may cause or relate to similar clinical signs or diseases, which implied that RIT2 might be a potential candidate gene underlying several neurological diseases, such as PD, schizophrenia and autism (<xref ref-type="bibr" rid="B48">Daneshmandpour et al., 2018</xref>).</p>
<p>Considering the new insight of the role of members of Ras subfamily in neuro- psychiatric disorders and metabolic regulation, substantial novel therapies might be developed or repurposed based on the extensive studies of Ras subfamily signaling in the context of cancer. For example, evidence suggests trametinib, a small molecule inhibitor targets the MEK kinase with high specificity, extends lifespan in <italic>Drosophila</italic> and protects against the malfunction of genetic induced obesity in mice (<xref ref-type="bibr" rid="B229">Slack et al., 2015</xref>).</p>
</sec>
</sec>
</sec>
<sec>
<title>The Rho Subfamily in Non-Neoplastic Cerebral Diseases</title>
<p>In the mid-1980s, <xref ref-type="bibr" rid="B149">Madaule and Axel (1985)</xref> serendipitously identified the first Ras homolog in <italic>Aplysia</italic> sea slugs, and named it Rho. In recent decades, the Rho subfamily of small GTPases has been shown to regulate many aspects of basic cellular processes such as cell polarity, cell movement, cell–cell interaction, cell proliferation and differentiation, cell morphology, secretion, adhesion, gene expression and survival (<xref ref-type="bibr" rid="B270">Watabe-Uchida et al., 2006</xref>; <xref ref-type="bibr" rid="B24">Boureux et al., 2007</xref>; <xref ref-type="bibr" rid="B42">Cingolani and Goda, 2008</xref>; <xref ref-type="bibr" rid="B175">Peru Y Colón de Portugal et al., 2012</xref>; <xref ref-type="bibr" rid="B80">Goitre et al., 2014</xref>). More than 20 Rho members, which are structured into six subclasses, are found in all eukaryotic cells as a molecular switch for actin cytoskeleton reorganization (<xref ref-type="bibr" rid="B88">Hall, 2012</xref>; <xref ref-type="bibr" rid="B164">Narumiya and Thumkeo, 2018</xref>). The Rho subfamily of small GTPases plays essential roles from changes in intracellular cytoskeleton dynamics to extracellular message exchange (<xref ref-type="bibr" rid="B287">Zamboni et al., 2018</xref>). In particular, Rho GTPases regulate dendritic arborization, spine morphogenesis, growth cone development, and axon guidance (<xref ref-type="bibr" rid="B233">Stankiewicz and Linseman, 2014</xref>). The Rho subclass, including RhoA, RhoB, and RhoC, predominantly promotes the formation of actin stress fibers and focal adhesion (<xref ref-type="bibr" rid="B8">Aspenstrom et al., 2004</xref>; <xref ref-type="bibr" rid="B68">Fernandez-Sauze et al., 2009</xref>). The Rac subclass (Rac1, Rac2, Rac3, and RhoG) promotes actin chain formation during the branching of lamellipodia, and the cell division cycle. 42 GTP-binding protein (Cdc42) subclass (Cdc42, TC10/RhoQ and TCL/RhoJ) mainly controls the formation of actin microspikes and filopodia (<xref ref-type="bibr" rid="B12">Azzarelli et al., 2014</xref>; <xref ref-type="bibr" rid="B80">Goitre et al., 2014</xref>).</p>
<p>Rho signaling is involved in several cerebral diseases, including intellectual disability (ID), epilepsy, drug addiction, HD, amyotrophic lateral sclerosis (ALS), and AD, and it acts by regulating axonogenesis, neuronal migration and synaptic plasticity (<xref ref-type="table" rid="T3">Table 3</xref>) (<xref ref-type="bibr" rid="B155">Mendoza-Naranjo et al., 2007</xref>; <xref ref-type="bibr" rid="B145">Locke et al., 2009</xref>; <xref ref-type="bibr" rid="B290">Zhang Y. et al., 2015</xref>; <xref ref-type="bibr" rid="B137">Li et al., 2016</xref>; <xref ref-type="bibr" rid="B268">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="B298">Zimering, 2018</xref>; <xref ref-type="bibr" rid="B45">Costain et al., 2019</xref>). Rac1 and Rac3 are associated with intelligence by regulating key cellular functions in the central nervous system (<xref ref-type="bibr" rid="B188">Reijnders et al., 2017</xref>; <xref ref-type="bibr" rid="B45">Costain et al., 2019</xref>). Moreover, it was confirmed that missense mutations in Rac3 cause severe intellectual disability and brain malformations in humans (<xref ref-type="bibr" rid="B45">Costain et al., 2019</xref>). Previous studies have shown that X-linked ID is related to mutations in genes that code for regulators of the small-GTPase family such as Rac/Cdc42 guanine nucleotide exchange factor 6 (αPIX), RhoGEF and trio Rho guanine nucleotide exchange factor (TRIO) (<xref ref-type="bibr" rid="B133">Lelieveld et al., 2016</xref>; <xref ref-type="bibr" rid="B188">Reijnders et al., 2017</xref>; <xref ref-type="bibr" rid="B287">Zamboni et al., 2018</xref>).</p>
<p>Rac1 is essential for diverse forms of learning, and contributes to extinction of an established memory during drug withdrawal or alcohol use disorders (<xref ref-type="bibr" rid="B175">Peru Y Colón de Portugal et al., 2012</xref>; <xref ref-type="bibr" rid="B268">Wang et al., 2017</xref>). A recent study provided evidence that Rac1-dependent GABA-A receptor endocytosis plays a crucial role in the extinction of aversive memories (<xref ref-type="bibr" rid="B268">Wang et al., 2017</xref>). Furthermore, Rho signaling is involved in regulating neuronal synaptic plasticity in the nucleus accumbens (NAc) and ventral tegmental area (VTA), which both play crucial roles in the reward circuitry (<xref ref-type="bibr" rid="B52">Deguchi et al., 2016</xref>). These actions of Rho-associated kinase (ROCK) signaling might also be related to synaptic plasticity in the lateral amygdala and prelimbic prefrontal cortex, which were also identified as regulators in reward circuits (<xref ref-type="bibr" rid="B123">Lamprecht et al., 2002</xref>; <xref ref-type="bibr" rid="B242">Swanson et al., 2017</xref>). Furthermore, these studies have shown that Rac1 plays a role in drug addiction by regulating synaptic plasticity and the neuronal projection network. It has also been observed that cocaine reduces the phosphorylation of Ezrin/Radixin/Moesin proteins (ERM) in the NAc by downregulating RhoA-Rho kinase signaling, which may importantly contribute to the initiation of synaptic changes in this site, leading to drug addiction (<xref ref-type="bibr" rid="B116">Kim et al., 2009</xref>).</p>
<p>Cdc42 is a small GTPase of the Rho-subfamily that acts as a multifaceted key regulator of neuronal structure and function (<xref ref-type="bibr" rid="B29">Bustelo et al., 2007</xref>; <xref ref-type="bibr" rid="B82">Govek et al., 2011</xref>; <xref ref-type="bibr" rid="B290">Zhang Y. et al., 2015</xref>). Cdc42 plays an important role in regulating epileptic seizures (<xref ref-type="bibr" rid="B290">Zhang Y. et al., 2015</xref>). Cdc42 regulates the availability of presynaptic sites for CaV2.1 calcium channel incorporation (<xref ref-type="bibr" rid="B36">Chen et al., 2003</xref>; <xref ref-type="bibr" rid="B70">Frank et al., 2009</xref>), and presynaptic activation of Cdc42 can mimic the effects of electrical activity that promotes synaptic maturation and plasticity (<xref ref-type="bibr" rid="B218">Shen et al., 2006</xref>). Cdc42 is over-expressed in the human cortex of the temporal lobe and in the hippocampus of intractable epilepsy patients after an anterior temporal lobectomy (<xref ref-type="bibr" rid="B275">Xiao et al., 2007</xref>). <xref ref-type="bibr" rid="B290">Zhang Y. et al. (2015)</xref> demonstrated the effect of Cdc42 on the function of hippocampal CA1 pyramidal neurons and revealed that blocking Cdc42 decreases the spontaneous action potentials (APs), and increases both the miniature inhibitory postsynaptic current (mIPSC) and evoked inhibitory postsynaptic current (eIPSC) (<xref ref-type="bibr" rid="B290">Zhang Y. et al., 2015</xref>).</p>
<p>Although Rho subfamily has gained the most attention for its putative role in numerous neurodegenerative diseases, the precise mechanisms as a therapeutic target remain controversial and uncertain. In PD, Rho signaling pathway is a promising therapeutic target (<xref ref-type="bibr" rid="B121">Labandeira-Garcia et al., 2015</xref>). Some studies also suggest that mutations in LRRK2 can lead to a decrease in activation of Rac1 related Rho signaling, which causes disassembly of actin filaments leading to modulate cytoskeletal outgrowth and vesicular dynamics, including autophagy (<xref ref-type="bibr" rid="B19">Boon et al., 2014</xref>). These functions likely impact modulation of α-synuclein aggregation and associated toxicity in the pathophysiology of PD (<xref ref-type="bibr" rid="B119">Konno et al., 2012</xref>). A previous study revealed that ROCK inhibition protects against neuronal death induced by neurotoxins (<xref ref-type="bibr" rid="B20">Borrajo et al., 2014</xref>). ROCK regulation may provide a new neuroprotective strategy for neurodegenerative diseases, and it has to be settled urgently to develop more potent and selective ROCK regulators.</p>
</sec>
<sec>
<title>The Rab Subfamily in Non-Neoplastic Cerebral Diseases</title>
<p>The Rab subfamily, which comprises more than 60 members, is currently the largest branch of the Ras superfamily of small GTPases (<xref ref-type="bibr" rid="B272">Wennerberg et al., 2005</xref>; <xref ref-type="bibr" rid="B54">Diekmann et al., 2011</xref>). This protein family is primarily related to various aspects of membrane and protein traffic in the endocytic and secretory pathways (<xref ref-type="bibr" rid="B272">Wennerberg et al., 2005</xref>; <xref ref-type="bibr" rid="B38">Cherfils and Zeghouf, 2013</xref>; <xref ref-type="bibr" rid="B80">Goitre et al., 2014</xref>; <xref ref-type="bibr" rid="B72">Gao et al., 2018</xref>). Therefore, dysregulation of Rab GTPases may lead to the pathogenesis of some diseases (<xref ref-type="table" rid="T3">Table 3</xref>). Many neurodegenerative diseases are characterized by dysfunction of membrane and protein traffic in neurons (<xref ref-type="bibr" rid="B293">Zhang X. et al., 2018</xref>). The Rab subfamily has also been related to neurodegenerative disorders such as Alzheimer’s disease and PD (<xref ref-type="bibr" rid="B274">Wilson et al., 2014</xref>; <xref ref-type="bibr" rid="B203">Saridaki et al., 2018</xref>; <xref ref-type="bibr" rid="B277">Yan et al., 2018</xref>). Previous studies have shown that Rab3A, Rab6, Rab8A/Rab8, Rab23, and Rab27b are highly expressed in the brain and participate in synaptic vesicle exocytosis, postsynaptic glutamate receptor dynamics, neurite growth and neural development (<xref ref-type="bibr" rid="B247">Takamori et al., 2006</xref>; <xref ref-type="bibr" rid="B167">Ng and Tang, 2008</xref>; <xref ref-type="bibr" rid="B257">Uno et al., 2016</xref>). Rab3 is the most abundant Rab protein in the brain. It is localized in synaptic vesicles and participates in their fusion and neurotransmitter release (<xref ref-type="bibr" rid="B167">Ng and Tang, 2008</xref>; <xref ref-type="bibr" rid="B225">Shin, 2014</xref>).</p>
<p>Alzheimer’s disease is clinically characterized by progressive cognitive impairment and memory loss (<xref ref-type="bibr" rid="B14">Bejanin et al., 2017</xref>). Two classical pathological features of AD are aberrant phosphorylated forms of tau protein and pathologically generated Aβ peptides (<xref ref-type="bibr" rid="B130">Lee et al., 2001</xref>; <xref ref-type="bibr" rid="B2">Alavi Naini and Soussi-Yanicostas, 2015</xref>; <xref ref-type="bibr" rid="B14">Bejanin et al., 2017</xref>; <xref ref-type="bibr" rid="B23">Bourdenx et al., 2017</xref>; <xref ref-type="bibr" rid="B241">Sun et al., 2018</xref>). Rab GTPases are implicated in multiple pathological mechanisms, including Aβ production and accumulation in AD (<xref ref-type="bibr" rid="B135">Li, 2011</xref>; <xref ref-type="bibr" rid="B191">Ridge et al., 2017</xref>; <xref ref-type="bibr" rid="B192">Rodriguez et al., 2017</xref>; <xref ref-type="bibr" rid="B277">Yan et al., 2018</xref>). Rab1B was found to play a key role in APP trafficking from the ER to the Golgi (<xref ref-type="bibr" rid="B60">Dugan et al., 1995</xref>). A study has shown that downregulation of Rab1B blocked APP transport in the ER/Golgi and significantly inhibited Aβ secretion (<xref ref-type="bibr" rid="B60">Dugan et al., 1995</xref>). Upregulation of either the early endosome protein Rab5 or the late endosome protein Rab7 increased Aβ trafficking from the cytoplasm to the lysosomes (<xref ref-type="bibr" rid="B136">Li et al., 2012</xref>). Previous post mortem studies have shown that the levels of Rab7A are elevated in the brains of AD model mice. Furthermore, some recent studies have shown that Rab7A may regulate tau secretion and tangle propagation in AD (<xref ref-type="bibr" rid="B192">Rodriguez et al., 2017</xref>; <xref ref-type="bibr" rid="B285">Zafar et al., 2017</xref>). Moreover, Rab11A-positive recycling vesicles accelerated cellular Aβ accumulation (Li et al., 2012).</p>
<p>A large amount of literature has reported the importance of the interaction between Rab GTPases and LRRK2 in PD (<xref ref-type="bibr" rid="B235">Steger et al., 2016</xref>; <xref ref-type="bibr" rid="B3">Alessi and Sammler, 2018</xref>; <xref ref-type="bibr" rid="B63">Eguchi et al., 2018</xref>; <xref ref-type="bibr" rid="B105">Jeong et al., 2018</xref>; <xref ref-type="bibr" rid="B150">Madero-Perez et al., 2018</xref>; <xref ref-type="bibr" rid="B156">Mir et al., 2018</xref>; <xref ref-type="bibr" rid="B176">Pfeffer, 2018</xref>). It has been reported that autosomal dominant missense mutations within the LRRK2 gene account for 1–2% of all cases of PD (<xref ref-type="bibr" rid="B171">Paisan-Ruiz et al., 2013</xref>). Similarly, variations at the LRRK2 locus also mildly increase the risk for idiopathic PD (<xref ref-type="bibr" rid="B171">Paisan-Ruiz et al., 2013</xref>; <xref ref-type="bibr" rid="B57">Domingo and Klein, 2018</xref>). A previous study verified that LRRK2 phosphorylates a subgroup of Rab GTPases which includes Rab7, Rab8A, and Rab10, and plays a crucial role in membrane and protein traffic (<xref ref-type="bibr" rid="B81">Gomez-Suaga et al., 2014</xref>; <xref ref-type="bibr" rid="B197">Roosen and Cookson, 2016</xref>; <xref ref-type="bibr" rid="B235">Steger et al., 2016</xref>, <xref ref-type="bibr" rid="B234">2017</xref>). Consistently with the importance of LRRK2 for PD, Rab subfamily members can be seen as regulators of membrane trafficking. Furthermore, Rab phosphorylation was found to be altered <italic>in vivo</italic> in all the related pathogenic processes (<xref ref-type="bibr" rid="B235">Steger et al., 2016</xref>, <xref ref-type="bibr" rid="B234">2017</xref>). Some reports showed that Rab35 and Rab39B may be implied in the pathogenesis of PD (<xref ref-type="bibr" rid="B39">Chiu et al., 2016</xref>; <xref ref-type="bibr" rid="B140">Lin et al., 2017</xref>). There is increasing evidence that mutations in Rab29 or Rab39B are related to the impairment of membrane trafficking relevant for PD (<xref ref-type="bibr" rid="B15">Ben-David and Tu, 2015</xref>; <xref ref-type="bibr" rid="B57">Domingo and Klein, 2018</xref>; <xref ref-type="bibr" rid="B185">Purlyte et al., 2018</xref>).</p>
<p>Hearing loss often results in plastic changes in the central auditory pathways, which are also related to members of the Rab family of small GTPase (<xref ref-type="bibr" rid="B58">Dong et al., 2010</xref>; <xref ref-type="bibr" rid="B161">Mulders et al., 2014</xref>). Gene expression of Rab3A and Rab3GAP1 fas found to be decreased in the paraflocculus after acoustic or mechanical cochlear trauma (<xref ref-type="bibr" rid="B58">Dong et al., 2010</xref>; <xref ref-type="bibr" rid="B161">Mulders et al., 2014</xref>). Moreover, early modulation of Rab GTPase gene expression in the paraflocculus may affect auditory processing by regulating the release of neurotransmitters (<xref ref-type="bibr" rid="B161">Mulders et al., 2014</xref>).</p>
<p>Cone-rod dystrophy (CRD) is an inherited retinal dystrophy that belongs to the group of pigmentary retinopathies. It is characterized by primary loss of cone photoreceptors and subsequent or simultaneous loss of rod photoreceptors (<xref ref-type="bibr" rid="B90">Hamel, 2007</xref>; <xref ref-type="bibr" rid="B198">Roosing et al., 2013</xref>). A previous study has shown that mutations in Rab28 are associated with autosomal-recessive cone-rod dystrophy (<xref ref-type="bibr" rid="B198">Roosing et al., 2013</xref>). Rab28 is located in the basal body and ciliary rootlet, where it plays a crucial role in ciliary transport. Other studies have shown that primary ciliogenesis is associated Rab3A, Rab6A, Rab8, and Rab11, which play an indirect role in rhodopsin transport from the photoreceptors’ inner to the outer segments through the connecting cilium (<xref ref-type="bibr" rid="B158">Moritz et al., 2001</xref>; <xref ref-type="bibr" rid="B207">Satoh et al., 2005</xref>; <xref ref-type="bibr" rid="B118">Knodler et al., 2010</xref>).</p>
</sec>
<sec>
<title>The Arf Subfamily in Non-Neoplastic Cerebral Diseases</title>
<p>Arf GTPases are a subfamily of proteins in the Ras superfamily that were identified as cargo displacement factors (<xref ref-type="bibr" rid="B103">Ismail et al., 2011</xref>). The roles of Arf GTPases include protein trafficking, lipid metabolism and trafficking, as well as actin remodeling in eukaryotic cells via their regulated GTP cycle (<xref ref-type="bibr" rid="B59">D’souza-Schorey and Chavrier, 2006</xref>; <xref ref-type="bibr" rid="B104">Jackson and Bouvet, 2014</xref>). According to sequence homology, there are four main classes of Arf proteins in mammals, namely Class I (Arf1–3), Class II (Arf4–5), Class III (Arf6), and unclassified members (<xref ref-type="bibr" rid="B195">Rojas et al., 2012</xref>; <xref ref-type="bibr" rid="B104">Jackson and Bouvet, 2014</xref>). Arf1 is the first member of this small GTPase subfamily, which is viewed as key regulators of eukaryotic cell organization (<xref ref-type="bibr" rid="B110">Kahn and Gilman, 1986</xref>; <xref ref-type="bibr" rid="B104">Jackson and Bouvet, 2014</xref>). Mutations in Arf1 have been shown to be related to autosomal recessive periventricular heterotopia, a disorder that leads to severe malformation of the cerebral cortex (<xref ref-type="bibr" rid="B217">Sheen et al., 2004</xref>).</p>
<p>In the last two decades, a series of cerebral diseases associated with Arf GTPases have been studied (<xref ref-type="table" rid="T3">Table 3</xref>). Previous studies have shown that many Arf-regulated ER–Golgi trafficking processes are defective in ALS (<xref ref-type="bibr" rid="B208">Saxena et al., 2009</xref>; <xref ref-type="bibr" rid="B267">Wang et al., 2011</xref>; <xref ref-type="bibr" rid="B288">Zhai et al., 2015</xref>; <xref ref-type="bibr" rid="B11">Atkin et al., 2017</xref>). Moreover, a study has shown that regulation of Arf signaling reverses mutant protein toxicity in ALS by decreasing ER stress and stimulating various types of autophagy in cell lines and animal models (<xref ref-type="bibr" rid="B288">Zhai et al., 2015</xref>). Recent studies have shown that Arl proteins which belong to Arf GTPases are associated with retinitis pigmentosa (<xref ref-type="bibr" rid="B261">Veltel et al., 2008a</xref>; <xref ref-type="bibr" rid="B289">Zhang H. et al., 2015</xref>; <xref ref-type="bibr" rid="B93">Hanke-Gogokhia et al., 2016b</xref>). In the pathogenetic process of retinitis pigmentosa, Arl2/Arl3 signaling plays important roles in photoreceptor function by regulating lipid-modified membrane-associated proteins (<xref ref-type="bibr" rid="B93">Hanke-Gogokhia et al., 2016b</xref>). The formation of a ternary complex between Arl3, its cognate GAP RP2 and its retinal effector HRG4 is also of great importance for photoreceptor function (<xref ref-type="bibr" rid="B262">Veltel et al., 2008b</xref>). In a rodent model, regulating the activities of Arl3 GAP can reduce the severity of photoreceptor disease (<xref ref-type="bibr" rid="B289">Zhang H. et al., 2015</xref>).</p>
</sec>
<sec>
<title>The Ran Subfamily and Unclassified Ras Superfamily Members in Non-Neoplastic Cerebral Diseases</title>
<p>Ran (Ras-related Nuclear protein) is generally encoded by a single ortholog in eukaryotes (<xref ref-type="bibr" rid="B189">Reiner and Lundquist, 2018</xref>). The classic function of Ran is to regulate the cycle of nuclear import and export (<xref ref-type="bibr" rid="B189">Reiner and Lundquist, 2018</xref>). There are few literature reports on the relationship between Ran and cerebral diseases (<xref ref-type="table" rid="T3">Table 3</xref>). A study indicated that the expression of Ran is reduced in AD, and Ran is a pivotal molecule in nucleocytoplasmic transport in AD pathophysiology (<xref ref-type="bibr" rid="B152">Mastroeni et al., 2013</xref>).</p>
<p>Ran also plays crucial roles in frontotemporal lobe degeneration (FTLD) by regulating TDP-43 induced retinal neurodegeneration (<xref ref-type="bibr" rid="B269">Ward et al., 2014</xref>). FTLD comprises a group of disorders, and is clinically characterized by behavioral and personality changes, language impairment, as well as deficits in executive functioning, and is pathologically associated with degeneration of frontal and temporal lobes (<xref ref-type="bibr" rid="B159">Morris et al., 2012</xref>; <xref ref-type="bibr" rid="B179">Pottier et al., 2016</xref>). The expression of Ran is found to be reduced by nuclear depletion of TDP-43 in a Grn-KO induced rodent model of retinal neuronal loss (<xref ref-type="bibr" rid="B269">Ward et al., 2014</xref>). Retinal neurodegeneration as a new phenotype involves the reciprocal loss of Ran in progranulin-deficient FTLD via an underlying mechanism related to nuclear TDP-43 (<xref ref-type="bibr" rid="B269">Ward et al., 2014</xref>). There are also some unclassified members in the Ras superfamily of small GTPases (<xref ref-type="bibr" rid="B195">Rojas et al., 2012</xref>), and these also play vital roles in cerebral diseases. <xref ref-type="bibr" rid="B78">Gispert et al. (2015)</xref> studied synucleinopathy-induced expression changes in the mouse brain and identified 49 midbrain/brainstem-specific transcriptional dysregulations, including Rabl2A downregulation. Mitochondrial Rho GTPase 1 (MIRO1), which is encoded by the <italic>rhoT1</italic> gene (<xref ref-type="bibr" rid="B71">Fransson et al., 2003</xref>; <xref ref-type="bibr" rid="B243">Tada et al., 2016</xref>; <xref ref-type="bibr" rid="B122">Lahiri and Klionsky, 2017</xref>), is involved in mitochondrial homeostasis and apoptosis, as well as PD and cancer (<xref ref-type="bibr" rid="B4">Anvret et al., 2012</xref>; <xref ref-type="bibr" rid="B106">Jiang et al., 2012</xref>; <xref ref-type="bibr" rid="B212">Schwarz, 2013</xref>; <xref ref-type="bibr" rid="B219">Sheng, 2014</xref>; <xref ref-type="bibr" rid="B259">Van Der Merwe et al., 2015</xref>; <xref ref-type="bibr" rid="B122">Lahiri and Klionsky, 2017</xref>). A recent study showed that MIRO1 is a potential adaptor for microtubule based peroxisome motility in mammalian cells (<xref ref-type="bibr" rid="B31">Castro et al., 2018</xref>). Another study has revealed that Rab20 is related to a genetic mechanism of longitudinal cognitive changes during the transition period from mild cognitive impairment to AD (<xref ref-type="bibr" rid="B126">Lee et al., 2017</xref>). <xref ref-type="bibr" rid="B138">Liang et al. (2012)</xref> found that Rab20 is substantially upregulated during the acute phase of brain inflammation, and also plays crucial roles in the subsequent inflammatory responses in the brain.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Knowledge about the roles of the Ras superfamily of small GTPases in cerebral diseases has considerably grown in the past 30 years. Currently, many research teams all over the world are also trying to identify novel small GTPases, which can be viewed as new regulators and effectors that control the crucial structure and biological functions affected by cerebral diseases. In particular, these important small GTPases have improved the development and applications of cellular and animal disease models. In this review, we mainly discussed how Ras-superfamily GTPases contribute to a range of human cerebral diseases as specific effectors in a series of complex mechanisms. Finally, a helpful summary of all described small GTPases from the Ras superfamily that play a role in cerebral diseases is shown schematically in <xref ref-type="table" rid="T1">Tables 1</xref>–<xref ref-type="table" rid="T1">3</xref>. Therefore, seeking treatment solutions for the related diseases by identifying the as-yet unknown physiological or pathological functions of more than 167 Ras superfamily members will open new research directions and fields in the following decades.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>X-LW and YW designed the study. LQ and CP collected, analyzed data, and wrote the manuscript. S-MH and BL interpreted the data and revised the manuscript. YW edited and polished the manuscript. G-DG and X-LW finalized the manuscript. All authors critically reviewed content and approved final version for publication.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by the National Natural Science Foundation of China (Grant Number 81671366, awarded to X-LW and Grant Number 81572470, awarded to S-MH), the National Science Foundation of China (Grant Number 81601100, awarded to YW), and Science and Technology Innovation Foundation of Tangdu Hospital, Air Force Military Medical University (Grant Number 2017LCYJ002, awarded to X-LW).</p>
</fn>
</fn-group>
<ack>
<p>Special thanks to Dr. Bolin Liu and Dr. Lei Chen for their contributions in the management and coordination of the study. Dr. Yafei Xue, Dr. Tao Zheng, and Dr. Lanfu Zhao have make great effort to the literature service in this study.</p>
</ack>
<sec sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fnmol.2019.00121/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fnmol.2019.00121/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<label>Table S1</label>
<caption>
<p>G-domin regions of 167 small GTPases found in humans.</p>
</caption>
<media xlink:href="Table_1.xlsx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahearn</surname><given-names>I. M.</given-names></name><name><surname>Haigis</surname><given-names>K.</given-names></name><name><surname>Bar-Sagi</surname><given-names>D.</given-names></name><name><surname>Philips</surname><given-names>M. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Regulating the regulator: post-translational modification of RAS.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>13</volume>
<fpage>39</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3255</pub-id>
<pub-id pub-id-type="pmid">22189424</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alavi Naini</surname><given-names>S. M.</given-names></name><name><surname>Soussi-Yanicostas</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative tauopathies?</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2015</volume>:<issue>151979</issue>. <pub-id pub-id-type="pmid">26576216</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alessi</surname><given-names>D. R.</given-names></name><name><surname>Sammler</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>LRRK2 kinase in Parkinson’s disease.</article-title>
<source/><italic>Science</italic>
<volume>360</volume>
<fpage>36</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">29622645</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anvret</surname><given-names>A.</given-names></name><name><surname>Ran</surname><given-names>C.</given-names></name><name><surname>Westerlund</surname><given-names>M.</given-names></name><name><surname>Sydow</surname><given-names>O.</given-names></name><name><surname>Willows</surname><given-names>T.</given-names></name><name><surname>Olson</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Genetic screening of the mitochondrial Rho GTPases MIRO1 and MIRO2 in Parkinson’s disease.</article-title>
<source/><italic>Open Neurol. J.</italic>
<volume>6</volume>
<fpage>1</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.2174/1874205x01206010001</pub-id>
<pub-id pub-id-type="pmid">22496713</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoki</surname><given-names>Y.</given-names></name><name><surname>Niihori</surname><given-names>T.</given-names></name><name><surname>Banjo</surname><given-names>T.</given-names></name><name><surname>Okamoto</surname><given-names>N.</given-names></name><name><surname>Mizuno</surname><given-names>S.</given-names></name><name><surname>Kurosawa</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>93</volume>
<fpage>173</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.05.021</pub-id>
<pub-id pub-id-type="pmid">23791108</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arajarvi</surname><given-names>R.</given-names></name><name><surname>Suvisaari</surname><given-names>J.</given-names></name><name><surname>Suokas</surname><given-names>J.</given-names></name><name><surname>Schreck</surname><given-names>M.</given-names></name><name><surname>Haukka</surname><given-names>J.</given-names></name><name><surname>Hintikka</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Prevalence and diagnosis of schizophrenia based on register, case record and interview data in an isolated Finnish birth cohort born 1940-1969.</article-title>
<source/><italic>Soc. Psychiatry Psychiatr. Epidemiol.</italic>
<volume>40</volume>
<fpage>808</fpage>–<lpage>816</lpage>. <pub-id pub-id-type="doi">10.1007/s00127-005-0951-9</pub-id>
<pub-id pub-id-type="pmid">16177843</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arun</surname><given-names>V.</given-names></name><name><surname>Wiley</surname><given-names>J. C.</given-names></name><name><surname>Kaur</surname><given-names>H.</given-names></name><name><surname>Kaplan</surname><given-names>D. R.</given-names></name><name><surname>Guha</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>A novel neurofibromin (NF1) interaction with the leucine-rich pentatricopeptide repeat motif-containing protein links neurofibromatosis type 1 and the French Canadian variant of Leigh’s syndrome in a common molecular complex.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>91</volume>
<fpage>494</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23189</pub-id>
<pub-id pub-id-type="pmid">23361976</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aspenstrom</surname><given-names>P.</given-names></name><name><surname>Fransson</surname><given-names>A.</given-names></name><name><surname>Saras</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Rho GTPases have diverse effects on the organization of the actin filament system.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>377</volume>
<fpage>327</fpage>–<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1042/bj20031041</pub-id>
<pub-id pub-id-type="pmid">14521508</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atashrazm</surname><given-names>F.</given-names></name><name><surname>Hammond</surname><given-names>D.</given-names></name><name><surname>Perera</surname><given-names>G.</given-names></name><name><surname>Bolliger</surname><given-names>M. F.</given-names></name><name><surname>Matar</surname><given-names>E.</given-names></name><name><surname>Halliday</surname><given-names>G. M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson’s disease patients.</article-title>
<source/><italic>Mov. Disord.</italic>
<volume>34</volume>
<fpage>406</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="pmid">30597610</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atay</surname><given-names>O.</given-names></name><name><surname>Skotheim</surname><given-names>J. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Spatial and temporal signal processing and decision making by MAPK pathways.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>216</volume>
<fpage>317</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201609124</pub-id>
<pub-id pub-id-type="pmid">28043970</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkin</surname><given-names>J. D.</given-names></name><name><surname>Farg</surname><given-names>M. A.</given-names></name><name><surname>Turner</surname><given-names>B. J.</given-names></name><name><surname>Tomas</surname><given-names>D.</given-names></name><name><surname>Lysaght</surname><given-names>J. A.</given-names></name><name><surname>Nunan</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>292</volume>:<issue>12007</issue>. <pub-id pub-id-type="doi">10.1074/jbc.a117.603393</pub-id>
<pub-id pub-id-type="pmid">28710340</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azzarelli</surname><given-names>R.</given-names></name><name><surname>Kerloch</surname><given-names>T.</given-names></name><name><surname>Pacary</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Regulation of cerebral cortex development by Rho GTPases: insights from in vivo studies.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>8</volume>:<issue>445</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00445</pub-id>
<pub-id pub-id-type="pmid">25610373</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banzic</surname><given-names>I.</given-names></name><name><surname>Brankovic</surname><given-names>M.</given-names></name><name><surname>Maksimovic</surname><given-names>Z.</given-names></name><name><surname>Davidovic</surname><given-names>L.</given-names></name><name><surname>Markovic</surname><given-names>M.</given-names></name><name><surname>Rancic</surname><given-names>Z.</given-names></name></person-group> (<year>2017</year>). <article-title>Parkes Weber syndrome-Diagnostic and management paradigms: a systematic review.</article-title>
<source/><italic>Phlebology</italic>
<volume>32</volume>
<fpage>371</fpage>–<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1177/0268355516664212</pub-id>
<pub-id pub-id-type="pmid">27511883</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bejanin</surname><given-names>A.</given-names></name><name><surname>Schonhaut</surname><given-names>D. R.</given-names></name><name><surname>La Joie</surname><given-names>R.</given-names></name><name><surname>Kramer</surname><given-names>J. H.</given-names></name><name><surname>Baker</surname><given-names>S. L.</given-names></name><name><surname>Sosa</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease.</article-title>
<source/><italic>Brain</italic>
<volume>140</volume>
<fpage>3286</fpage>–<lpage>3300</lpage>.<pub-id pub-id-type="pmid">29053874</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-David</surname><given-names>E.</given-names></name><name><surname>Tu</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Genetics of Parkinson disease.</article-title>
<source/><italic>AJNR Am. J. Neuroradiol.</italic>
<volume>36</volume>
<fpage>445</fpage>–<lpage>447</lpage>.<pub-id pub-id-type="pmid">25190200</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertola</surname><given-names>D.</given-names></name><name><surname>Buscarilli</surname><given-names>M.</given-names></name><name><surname>Stabley</surname><given-names>D. L.</given-names></name><name><surname>Baker</surname><given-names>L.</given-names></name><name><surname>Doyle</surname><given-names>D.</given-names></name><name><surname>Bartholomew</surname><given-names>D. W.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Phenotypic spectrum of Costello syndrome individuals harboring the rare HRAS mutation p.Gly13Asp.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>173</volume>
<fpage>1309</fpage>–<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38178</pub-id>
<pub-id pub-id-type="pmid">28371260</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besga</surname><given-names>A.</given-names></name><name><surname>Chyzhyk</surname><given-names>D.</given-names></name><name><surname>Gonzalez-Ortega</surname><given-names>I.</given-names></name><name><surname>Echeveste</surname><given-names>J.</given-names></name><name><surname>Grana-Lecuona</surname><given-names>M.</given-names></name><name><surname>Grana</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>White matter tract integrity in Alzheimer’s disease vs. late onset bipolar disorder and its correlation with systemic inflammation and oxidative stress biomarkers.</article-title>
<source/><italic>Front. Aging Neurosci.</italic>
<volume>9</volume>:<issue>179</issue>
<pub-id pub-id-type="doi">10.3389/fnagi.2017.00179</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bongmba</surname><given-names>O. Y. N.</given-names></name><name><surname>Martinez</surname><given-names>L. A.</given-names></name><name><surname>Elhardt</surname><given-names>M. E.</given-names></name><name><surname>Butler</surname><given-names>K.</given-names></name><name><surname>Tejada-Simon</surname><given-names>M. V.</given-names></name></person-group> (<year>2011</year>). <article-title>Modulation of dendritic spines and synaptic function by Rac1: a possible link to Fragile X syndrome pathology.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1399</volume>
<fpage>79</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2011.05.020</pub-id>
<pub-id pub-id-type="pmid">21645877</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boon</surname><given-names>J. Y.</given-names></name><name><surname>Dusonchet</surname><given-names>J.</given-names></name><name><surname>Trengrove</surname><given-names>C.</given-names></name><name><surname>Wolozin</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Interaction of LRRK2 with kinase and GTPase signaling cascades.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>7</volume>:<issue>64</issue>
<pub-id pub-id-type="doi">10.3389/fnmol.2014.00064</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borrajo</surname><given-names>A.</given-names></name><name><surname>Rodriguez-Perez</surname><given-names>A. I.</given-names></name><name><surname>Villar-Cheda</surname><given-names>B.</given-names></name><name><surname>Guerra</surname><given-names>M. J.</given-names></name><name><surname>Labandeira-Garcia</surname><given-names>J. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>85</volume>
<fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.05.021</pub-id>
<pub-id pub-id-type="pmid">24878243</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bossers</surname><given-names>K.</given-names></name><name><surname>Meerhoff</surname><given-names>G.</given-names></name><name><surname>Balesar</surname><given-names>R.</given-names></name><name><surname>Van Dongen</surname><given-names>J. W.</given-names></name><name><surname>Kruse</surname><given-names>C. G.</given-names></name><name><surname>Swaab</surname><given-names>D. F.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Analysis of gene expression in Parkinson’s disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.</article-title>
<source/><italic>Brain Pathol.</italic>
<volume>19</volume>
<fpage>91</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-3639.2008.00171.x</pub-id>
<pub-id pub-id-type="pmid">18462474</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouquillon</surname><given-names>S.</given-names></name><name><surname>Andrieux</surname><given-names>J.</given-names></name><name><surname>Landais</surname><given-names>E.</given-names></name><name><surname>Duban-Bedu</surname><given-names>B.</given-names></name><name><surname>Boidein</surname><given-names>F.</given-names></name><name><surname>Lenne</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>A 5.3Mb deletion in chromosome 18q12.3 as the smallest region of overlap in two patients with expressive speech delay.</article-title>
<source/><italic>Eur. J. Med. Genet.</italic>
<volume>54</volume>
<fpage>194</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2010.11.009</pub-id>
<pub-id pub-id-type="pmid">21145994</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourdenx</surname><given-names>M.</given-names></name><name><surname>Koulakiotis</surname><given-names>N. S.</given-names></name><name><surname>Sanoudou</surname><given-names>D.</given-names></name><name><surname>Bezard</surname><given-names>E.</given-names></name><name><surname>Dehay</surname><given-names>B.</given-names></name><name><surname>Tsarbopoulos</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies.</article-title>
<source/><italic>Prog. Neurobiol.</italic>
<volume>155</volume>
<fpage>171</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.07.003</pub-id>
<pub-id pub-id-type="pmid">26209472</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boureux</surname><given-names>A.</given-names></name><name><surname>Vignal</surname><given-names>E.</given-names></name><name><surname>Faure</surname><given-names>S.</given-names></name><name><surname>Fort</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Evolution of the Rho family of Ras-like GTPases in eukaryotes.</article-title>
<source/><italic>Mol. Biol. Evol.</italic>
<volume>24</volume>
<fpage>203</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msl145</pub-id>
<pub-id pub-id-type="pmid">17035353</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourne</surname><given-names>H. R.</given-names></name><name><surname>Sanders</surname><given-names>D. A.</given-names></name><name><surname>Mccormick</surname><given-names>F.</given-names></name></person-group> (<year>1991</year>). <article-title>The GTPase superfamily: conserved structure and molecular mechanism.</article-title>
<source/><italic>Nature</italic>
<volume>349</volume>
<fpage>117</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1038/349117a0</pub-id>
<pub-id pub-id-type="pmid">1898771</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brems</surname><given-names>H.</given-names></name><name><surname>Chmara</surname><given-names>M.</given-names></name><name><surname>Sahbatou</surname><given-names>M.</given-names></name><name><surname>Denayer</surname><given-names>E.</given-names></name><name><surname>Taniguchi</surname><given-names>K.</given-names></name><name><surname>Kato</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>39</volume>
<fpage>1120</fpage>–<lpage>1126</lpage>. <pub-id pub-id-type="doi">10.1038/ng2113</pub-id>
<pub-id pub-id-type="pmid">17704776</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buday</surname><given-names>L.</given-names></name><name><surname>Downward</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Many faces of Ras activation.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1786</volume>
<fpage>178</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbcan.2008.05.001</pub-id>
<pub-id pub-id-type="pmid">18541156</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buggia-Prevot</surname><given-names>V.</given-names></name><name><surname>Fernandez</surname><given-names>C. G.</given-names></name><name><surname>Riordan</surname><given-names>S.</given-names></name><name><surname>Vetrivel</surname><given-names>K. S.</given-names></name><name><surname>Roseman</surname><given-names>J.</given-names></name><name><surname>Waters</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase.</article-title>
<source/><italic>Mol. Neurodegener.</italic>
<volume>9</volume>:<issue>1</issue>. <pub-id pub-id-type="doi">10.1186/1750-1326-9-1</pub-id>
<pub-id pub-id-type="pmid">24386896</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bustelo</surname><given-names>X. R.</given-names></name><name><surname>Sauzeau</surname><given-names>V.</given-names></name><name><surname>Berenjeno</surname><given-names>I. M.</given-names></name></person-group> (<year>2007</year>). <article-title>GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo.</article-title>
<source/><italic>Bioessays</italic>
<volume>29</volume>
<fpage>356</fpage>–<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1002/bies.20558</pub-id>
<pub-id pub-id-type="pmid">17373658</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caliskan</surname><given-names>M.</given-names></name><name><surname>Chong</surname><given-names>J. X.</given-names></name><name><surname>Uricchio</surname><given-names>L.</given-names></name><name><surname>Anderson</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>P.</given-names></name><name><surname>Sougnez</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Exome sequencing reveals a novel mutation for autosomal recessive non-syndromic mental retardation in the TECR gene on chromosome 19p13.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>20</volume>
<fpage>1285</fpage>–<lpage>1289</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddq569</pub-id>
<pub-id pub-id-type="pmid">21212097</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>I. G.</given-names></name><name><surname>Richards</surname><given-names>D. M.</given-names></name><name><surname>Metz</surname><given-names>J.</given-names></name><name><surname>Costello</surname><given-names>J. L.</given-names></name><name><surname>Passmore</surname><given-names>J. B.</given-names></name><name><surname>Schrader</surname><given-names>T. A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>A role for Mitochondrial Rho GTPase 1 (MIRO1) in motility and membrane dynamics of peroxisomes.</article-title>
<source/><italic>Traffic</italic>
<volume>19</volume>
<fpage>229</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1111/tra.12549</pub-id>
<pub-id pub-id-type="pmid">29364559</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cawthon</surname><given-names>R. M.</given-names></name><name><surname>Weiss</surname><given-names>R.</given-names></name><name><surname>Xu</surname><given-names>G. F.</given-names></name><name><surname>Viskochil</surname><given-names>D.</given-names></name><name><surname>Culver</surname><given-names>M.</given-names></name><name><surname>Stevens</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>1990</year>). <article-title>A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.</article-title>
<source/><italic>Cell</italic>
<volume>62</volume>
<fpage>193</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(90)90253-b</pub-id><pub-id pub-id-type="pmid">2114220</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cesarini</surname><given-names>L.</given-names></name><name><surname>Alfieri</surname><given-names>P.</given-names></name><name><surname>Pantaleoni</surname><given-names>F.</given-names></name><name><surname>Vasta</surname><given-names>I.</given-names></name><name><surname>Cerutti</surname><given-names>M.</given-names></name><name><surname>Petrangeli</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>149A</volume>, <fpage>140</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.32488</pub-id>
<pub-id pub-id-type="pmid">19133693</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaldakov</surname><given-names>G. N.</given-names></name><name><surname>Tonchev</surname><given-names>A. B.</given-names></name><name><surname>Aloe</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>NGF and BDNF: from nerves to adipose tissue, from neurokines to metabokines.</article-title>
<source/><italic>Riv. Psichiatr.</italic>
<volume>44</volume>
<fpage>79</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="pmid">20066808</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>G.</given-names></name><name><surname>White</surname><given-names>C. C.</given-names></name><name><surname>Winn</surname><given-names>P. A.</given-names></name><name><surname>Cimpean</surname><given-names>M.</given-names></name><name><surname>Replogle</surname><given-names>J. M.</given-names></name><name><surname>Glick</surname><given-names>L. R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Trans-pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci.</article-title>
<source/><italic>Neurol. Genet.</italic>
<volume>2</volume>:<issue>e90</issue>. <pub-id pub-id-type="doi">10.1212/nxg.0000000000000090</pub-id>
<pub-id pub-id-type="pmid">27504496</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Furuya</surname><given-names>S.</given-names></name><name><surname>Doi</surname><given-names>H.</given-names></name><name><surname>Hashimoto</surname><given-names>Y.</given-names></name><name><surname>Kudo</surname><given-names>Y.</given-names></name><name><surname>Higashi</surname><given-names>H.</given-names></name></person-group> (<year>2003</year>). <article-title>Ganglioside/calmodulin kinase II signal inducing cdc42-mediated neuronal actin reorganization.</article-title>
<source/><italic>Neuroscience</italic>
<volume>120</volume>
<fpage>163</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/s0306-4522(03)00259-8</pub-id>
<pub-id pub-id-type="pmid">12849750</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X. W.</given-names></name><name><surname>Leto</surname><given-names>D.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Goss</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Shavit</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Exocyst function is regulated by effector phosphorylation.</article-title>
<source/><italic>Nat. Cell Biol.</italic>
<volume>13</volume>
<fpage>580</fpage>–<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2226</pub-id>
<pub-id pub-id-type="pmid">21516108</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherfils</surname><given-names>J.</given-names></name><name><surname>Zeghouf</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Regulation of small GTPases by GEFs, GAPs, and GDIs.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>93</volume>
<fpage>269</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00003.2012</pub-id>
<pub-id pub-id-type="pmid">23303910</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>C. C.</given-names></name><name><surname>Yeh</surname><given-names>T. H.</given-names></name><name><surname>Lai</surname><given-names>S. C.</given-names></name><name><surname>Weng</surname><given-names>Y. H.</given-names></name><name><surname>Huang</surname><given-names>Y. C.</given-names></name><name><surname>Cheng</surname><given-names>Y. C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Increased Rab35 expression is a potential biomarker and implicated in the pathogenesis of Parkinson’s disease.</article-title>
<source/><italic>Oncotarget</italic>
<volume>7</volume>
<fpage>54215</fpage>–<lpage>54227</lpage>. <pub-id pub-id-type="pmid">27509057</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>J. X.</given-names></name><name><surname>Caputo</surname><given-names>V.</given-names></name><name><surname>Phelps</surname><given-names>I. G.</given-names></name><name><surname>Stella</surname><given-names>L.</given-names></name><name><surname>Worgan</surname><given-names>L.</given-names></name><name><surname>Dempsey</surname><given-names>J. C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Recessive inactivating mutations in TBCK, encoding a Rab GTPase-activating protein, cause severe infantile syndromic encephalopathy.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>98</volume>
<fpage>772</fpage>–<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.01.016</pub-id>
<pub-id pub-id-type="pmid">27040692</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chutna</surname><given-names>O.</given-names></name><name><surname>Goncalves</surname><given-names>S.</given-names></name><name><surname>Villar-Pique</surname><given-names>A.</given-names></name><name><surname>Guerreiro</surname><given-names>P.</given-names></name><name><surname>Marijanovic</surname><given-names>Z.</given-names></name><name><surname>Mendes</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The small GTPase Rab11 co-localizes with alpha-synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>23</volume>
<fpage>6732</fpage>–<lpage>6745</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu391</pub-id>
<pub-id pub-id-type="pmid">25092884</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cingolani</surname><given-names>L. A.</given-names></name><name><surname>Goda</surname><given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title>Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>9</volume>
<fpage>344</fpage>–<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2373</pub-id>
<pub-id pub-id-type="pmid">18425089</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claing</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>beta-Arrestins: modulators of small GTPase activation and function.</article-title>
<source/><italic>Prog. Mol. Biol. Transl. Sci.</italic>
<volume>118</volume>
<fpage>149</fpage>–<lpage>174</lpage>.<pub-id pub-id-type="pmid">23764053</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colicelli</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Human RAS superfamily proteins and related GTPases.</article-title>
<source/><italic>Sci. STKE</italic>
<volume>2004</volume>:<issue>RE13</issue>.</mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costain</surname><given-names>G.</given-names></name><name><surname>Callewaert</surname><given-names>B.</given-names></name><name><surname>Gabriel</surname><given-names>H.</given-names></name><name><surname>Tan</surname><given-names>T. Y.</given-names></name><name><surname>Walker</surname><given-names>S.</given-names></name><name><surname>Christodoulou</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>De novo missense variants in RAC3 cause a novel neurodevelopmental syndrome.</article-title>
<source/><italic>Genet. Med.</italic>
<volume>21</volume>
<fpage>1021</fpage>–<lpage>1026</lpage>. <pub-id pub-id-type="pmid">30293988</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>A. D.</given-names></name><name><surname>Der</surname><given-names>C. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Ras family signaling: therapeutic targeting.</article-title>
<source/><italic>Cancer Biol. Ther.</italic>
<volume>1</volume>
<fpage>599</fpage>–<lpage>606</lpage>. <pub-id pub-id-type="doi">10.4161/cbt.306</pub-id><pub-id pub-id-type="pmid">12642680</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>A. D.</given-names></name><name><surname>Der</surname><given-names>C. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Ras history: the saga continues.</article-title>
<source/><italic>Small GTPases</italic>
<volume>1</volume>
<fpage>2</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.4161/sgtp.1.1.12178</pub-id>
<pub-id pub-id-type="pmid">21686117</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daneshmandpour</surname><given-names>Y.</given-names></name><name><surname>Darvish</surname><given-names>H.</given-names></name><name><surname>Emamalizadeh</surname><given-names>B.</given-names></name></person-group> (<year>2018</year>). <article-title>RIT2: responsible and susceptible gene for neurological and psychiatric disorders.</article-title>
<source/><italic>Mol. Genet. Genomics</italic>
<volume>293</volume>
<fpage>785</fpage>–<lpage>792</lpage>. <pub-id pub-id-type="doi">10.1007/s00438-018-1451-4</pub-id>
<pub-id pub-id-type="pmid">29860660</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dard</surname><given-names>L.</given-names></name><name><surname>Bellance</surname><given-names>N.</given-names></name><name><surname>Lacombe</surname><given-names>D.</given-names></name><name><surname>Rossignol</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>RAS signalling in energy metabolism and rare human diseases.</article-title>
<source/><italic>Biochim. Biophys. Acta Bioenerg.</italic>
<volume>1859</volume>
<fpage>845</fpage>–<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2018.05.003</pub-id>
<pub-id pub-id-type="pmid">29750912</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>A.</given-names></name><name><surname>Gajendra</surname><given-names>S.</given-names></name><name><surname>Falenta</surname><given-names>K.</given-names></name><name><surname>Oudin</surname><given-names>M. J.</given-names></name><name><surname>Peschard</surname><given-names>P.</given-names></name><name><surname>Feng</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>RalA promotes a direct exocyst-Par6 interaction to regulate polarity in neuronal development.</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>127</volume>
<fpage>686</fpage>–<lpage>699</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.145037</pub-id>
<pub-id pub-id-type="pmid">24284074</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Cicco</surname><given-names>M.</given-names></name><name><surname>Kiss</surname><given-names>L.</given-names></name><name><surname>Dames</surname><given-names>S. A.</given-names></name></person-group> (<year>2018</year>). <article-title>NMR analysis of the backbone dynamics of the small GTPase Rheb and its interaction with the regulatory protein FKBP38.</article-title>
<source/><italic>FEBS Lett.</italic>
<volume>592</volume>
<fpage>130</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1002/1873-3468.12925</pub-id>
<pub-id pub-id-type="pmid">29194576</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deguchi</surname><given-names>Y.</given-names></name><name><surname>Harada</surname><given-names>M.</given-names></name><name><surname>Shinohara</surname><given-names>R.</given-names></name><name><surname>Lazarus</surname><given-names>M.</given-names></name><name><surname>Cherasse</surname><given-names>Y.</given-names></name><name><surname>Urade</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>mDia and ROCK mediate actin-dependent presynaptic remodeling regulating synaptic efficacy and anxiety.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>17</volume>
<fpage>2405</fpage>–<lpage>2417</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.10.088</pub-id>
<pub-id pub-id-type="pmid">27880913</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dentici</surname><given-names>M. L.</given-names></name><name><surname>Sarkozy</surname><given-names>A.</given-names></name><name><surname>Pantaleoni</surname><given-names>F.</given-names></name><name><surname>Carta</surname><given-names>C.</given-names></name><name><surname>Lepri</surname><given-names>F.</given-names></name><name><surname>Ferese</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Spectrum of MEK1 and MEK2 gene mutations in cardio-facio-cutaneous syndrome and genotype-phenotype correlations.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>17</volume>
<fpage>733</fpage>–<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2008.256</pub-id>
<pub-id pub-id-type="pmid">19156172</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diekmann</surname><given-names>Y.</given-names></name><name><surname>Seixas</surname><given-names>E.</given-names></name><name><surname>Gouw</surname><given-names>M.</given-names></name><name><surname>Tavares-Cadete</surname><given-names>F.</given-names></name><name><surname>Seabra</surname><given-names>M. C.</given-names></name><name><surname>Pereira-Leal</surname><given-names>J. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Thousands of Rab GTPases for the cell biologist.</article-title>
<source/><italic>PLoS Comput. Biol.</italic>
<volume>7</volume>:<issue>e1002217</issue>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1002217</pub-id>
<pub-id pub-id-type="pmid">22022256</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Digilio</surname><given-names>M. C.</given-names></name><name><surname>Conti</surname><given-names>E.</given-names></name><name><surname>Sarkozy</surname><given-names>A.</given-names></name><name><surname>Mingarelli</surname><given-names>R.</given-names></name><name><surname>Dottorini</surname><given-names>T.</given-names></name><name><surname>Marino</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>71</volume>
<fpage>389</fpage>–<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1086/341528</pub-id>
<pub-id pub-id-type="pmid">12058348</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Digilio</surname><given-names>M. C.</given-names></name><name><surname>Sarkozy</surname><given-names>A.</given-names></name><name><surname>De Zorzi</surname><given-names>A.</given-names></name><name><surname>Pacileo</surname><given-names>G.</given-names></name><name><surname>Limongelli</surname><given-names>G.</given-names></name><name><surname>Mingarelli</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>LEOPARD syndrome: clinical diagnosis in the first year of life.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>140</volume>
<fpage>740</fpage>–<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31156</pub-id>
<pub-id pub-id-type="pmid">16523510</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domingo</surname><given-names>A.</given-names></name><name><surname>Klein</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Genetics of Parkinson disease.</article-title>
<source/><italic>Handb. Clin. Neurol.</italic>
<volume>147</volume>
<fpage>211</fpage>–<lpage>227</lpage>.<pub-id pub-id-type="pmid">29325612</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>S.</given-names></name><name><surname>Mulders</surname><given-names>W. H.</given-names></name><name><surname>Rodger</surname><given-names>J.</given-names></name><name><surname>Woo</surname><given-names>S.</given-names></name><name><surname>Robertson</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>Acoustic trauma evokes hyperactivity and changes in gene expression in guinea-pig auditory brainstem.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>31</volume>
<fpage>1616</fpage>–<lpage>1628</lpage>. <pub-id pub-id-type="pmid">20525074</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’souza-Schorey</surname><given-names>C.</given-names></name><name><surname>Chavrier</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>ARF proteins: roles in membrane traffic and beyond.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>7</volume>
<fpage>347</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1038/nrm1910</pub-id>
<pub-id pub-id-type="pmid">16633337</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dugan</surname><given-names>J. M.</given-names></name><name><surname>Dewit</surname><given-names>C.</given-names></name><name><surname>Mcconlogue</surname><given-names>L.</given-names></name><name><surname>Maltese</surname><given-names>W. A.</given-names></name></person-group> (<year>1995</year>). <article-title>The Ras-related GTP-binding protein, Rab1B, regulates early steps in exocytic transport and processing of beta-amyloid precursor protein.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>270</volume>
<fpage>10982</fpage>–<lpage>10989</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.270.18.10982</pub-id>
<pub-id pub-id-type="pmid">7738040</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebert</surname><given-names>D. H.</given-names></name><name><surname>Greenberg</surname><given-names>M. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Activity-dependent neuronal signalling and autism spectrum disorder.</article-title>
<source/><italic>Nature</italic>
<volume>493</volume>
<fpage>327</fpage>–<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1038/nature11860</pub-id>
<pub-id pub-id-type="pmid">23325215</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eerola</surname><given-names>I.</given-names></name><name><surname>Boon</surname><given-names>L. M.</given-names></name><name><surname>Mulliken</surname><given-names>J. B.</given-names></name><name><surname>Burrows</surname><given-names>P. E.</given-names></name><name><surname>Dompmartin</surname><given-names>A.</given-names></name><name><surname>Watanabe</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>73</volume>
<fpage>1240</fpage>–<lpage>1249</lpage>. <pub-id pub-id-type="doi">10.1086/379793</pub-id>
<pub-id pub-id-type="pmid">14639529</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eguchi</surname><given-names>T.</given-names></name><name><surname>Kuwahara</surname><given-names>T.</given-names></name><name><surname>Sakurai</surname><given-names>M.</given-names></name><name><surname>Komori</surname><given-names>T.</given-names></name><name><surname>Fujimoto</surname><given-names>T.</given-names></name><name><surname>Ito</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>115</volume>
<fpage>E9115</fpage>–<lpage>E9124</lpage>. <pub-id pub-id-type="pmid">30209220</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekvall</surname><given-names>S.</given-names></name><name><surname>Hagenas</surname><given-names>L.</given-names></name><name><surname>Allanson</surname><given-names>J.</given-names></name><name><surname>Anneren</surname><given-names>G.</given-names></name><name><surname>Bondeson</surname><given-names>M. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>155A</volume>, <fpage>1217</fpage>–<lpage>1224</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.33987</pub-id>
<pub-id pub-id-type="pmid">21548061</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekvall</surname><given-names>S.</given-names></name><name><surname>Wilbe</surname><given-names>M.</given-names></name><name><surname>Dahlgren</surname><given-names>J.</given-names></name><name><surname>Legius</surname><given-names>E.</given-names></name><name><surname>Van Haeringen</surname><given-names>A.</given-names></name><name><surname>Westphal</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Mutation in NRAS in familial Noonan syndrome–case report and review of the literature.</article-title>
<source/><italic>BMC Med. Genet.</italic>
<volume>16</volume>:<issue>95</issue>. <pub-id pub-id-type="doi">10.1186/s12881-015-0239-1</pub-id>
<pub-id pub-id-type="pmid">26467218</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emamalizadeh</surname><given-names>B.</given-names></name><name><surname>Jamshidi</surname><given-names>J.</given-names></name><name><surname>Movafagh</surname><given-names>A.</given-names></name><name><surname>Ohadi</surname><given-names>M.</given-names></name><name><surname>Khaniani</surname><given-names>M. S.</given-names></name><name><surname>Kazeminasab</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>RIT2 polymorphisms: is there a differential association?</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>54</volume>
<fpage>2234</fpage>–<lpage>2240</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-016-9815-4</pub-id>
<pub-id pub-id-type="pmid">26941103</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Esmail</surname><given-names>M. A.</given-names></name><name><surname>Ansley</surname><given-names>S. J.</given-names></name><name><surname>Blacque</surname><given-names>O. E.</given-names></name><name><surname>Boroevich</surname><given-names>K.</given-names></name><name><surname>Ross</surname><given-names>A. J.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>36</volume>
<fpage>989</fpage>–<lpage>993</lpage>. <pub-id pub-id-type="doi">10.1038/ng1414</pub-id>
<pub-id pub-id-type="pmid">15314642</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Sauze</surname><given-names>S.</given-names></name><name><surname>Grall</surname><given-names>D.</given-names></name><name><surname>Cseh</surname><given-names>B.</given-names></name><name><surname>Van Obberghen-Schilling</surname><given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>Regulation of fibronectin matrix assembly and capillary morphogenesis in endothelial cells by Rho family GTPases.</article-title>
<source/><italic>Exp. Cell Res.</italic>
<volume>315</volume>
<fpage>2092</fpage>–<lpage>2104</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2009.03.017</pub-id>
<pub-id pub-id-type="pmid">19332054</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flex</surname><given-names>E.</given-names></name><name><surname>Jaiswal</surname><given-names>M.</given-names></name><name><surname>Pantaleoni</surname><given-names>F.</given-names></name><name><surname>Martinelli</surname><given-names>S.</given-names></name><name><surname>Strullu</surname><given-names>M.</given-names></name><name><surname>Fansa</surname><given-names>E. K.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>23</volume>
<fpage>4315</fpage>–<lpage>4327</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu148</pub-id>
<pub-id pub-id-type="pmid">24705357</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>C. A.</given-names></name><name><surname>Pielage</surname><given-names>J.</given-names></name><name><surname>Davis</surname><given-names>G. W.</given-names></name></person-group> (<year>2009</year>). <article-title>A presynaptic homeostatic signaling system composed of the Eph receptor, ephexin, Cdc42, and CaV2.1 calcium channels.</article-title>
<source/><italic>Neuron</italic>
<volume>61</volume>
<fpage>556</fpage>–<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.12.028</pub-id>
<pub-id pub-id-type="pmid">19249276</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fransson</surname><given-names>A.</given-names></name><name><surname>Ruusala</surname><given-names>A.</given-names></name><name><surname>Aspenstrom</surname><given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>Atypical Rho GTPases have roles in mitochondrial homeostasis and apoptosis.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>278</volume>
<fpage>6495</fpage>–<lpage>6502</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m208609200</pub-id>
<pub-id pub-id-type="pmid">12482879</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Wilson</surname><given-names>G. R.</given-names></name><name><surname>Stephenson</surname><given-names>S. E. M.</given-names></name><name><surname>Bozaoglu</surname><given-names>K.</given-names></name><name><surname>Farrer</surname><given-names>M. J.</given-names></name><name><surname>Lockhart</surname><given-names>P. J.</given-names></name></person-group> (<year>2018</year>). <article-title>The emerging role of Rab GTPases in the pathogenesis of Parkinson’s disease.</article-title>
<source/><italic>Mov. Disord.</italic>
<volume>33</volume>
<fpage>196</fpage>–<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1002/mds.27270</pub-id>
<pub-id pub-id-type="pmid">29315801</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garbett</surname><given-names>K.</given-names></name><name><surname>Ebert</surname><given-names>P. J.</given-names></name><name><surname>Mitchell</surname><given-names>A.</given-names></name><name><surname>Lintas</surname><given-names>C.</given-names></name><name><surname>Manzi</surname><given-names>B.</given-names></name><name><surname>Mirnics</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Immune transcriptome alterations in the temporal cortex of subjects with autism.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>30</volume>
<fpage>303</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2008.01.012</pub-id>
<pub-id pub-id-type="pmid">18378158</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Romero</surname><given-names>M. T.</given-names></name><name><surname>Parkin</surname><given-names>P.</given-names></name><name><surname>Lara-Corrales</surname><given-names>I.</given-names></name></person-group> (<year>2016</year>). <article-title>Mosaic neurofibromatosis type 1: a systematic review.</article-title>
<source/><italic>Pediatr. Dermatol.</italic>
<volume>33</volume>
<fpage>9</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1111/pde.12673</pub-id>
<pub-id pub-id-type="pmid">26338194</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginsberg</surname><given-names>S. D.</given-names></name><name><surname>Alldred</surname><given-names>M. J.</given-names></name><name><surname>Counts</surname><given-names>S. E.</given-names></name><name><surname>Cataldo</surname><given-names>A. M.</given-names></name><name><surname>Neve</surname><given-names>R. L.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2010a</year>). <article-title>Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer’s disease progression.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>68</volume>
<fpage>885</fpage>–<lpage>893</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.05.030</pub-id>
<pub-id pub-id-type="pmid">20655510</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginsberg</surname><given-names>S. D.</given-names></name><name><surname>Mufson</surname><given-names>E. J.</given-names></name><name><surname>Counts</surname><given-names>S. E.</given-names></name><name><surname>Wuu</surname><given-names>J.</given-names></name><name><surname>Alldred</surname><given-names>M. J.</given-names></name><name><surname>Nixon</surname><given-names>R. A.</given-names></name><etal></etal></person-group> (<year>2010b</year>). <article-title>Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer’s disease.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>22</volume>
<fpage>631</fpage>–<lpage>639</lpage>. <pub-id pub-id-type="doi">10.3233/jad-2010-101080</pub-id>
<pub-id pub-id-type="pmid">20847427</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginsberg</surname><given-names>S. D.</given-names></name><name><surname>Mufson</surname><given-names>E. J.</given-names></name><name><surname>Alldred</surname><given-names>M. J.</given-names></name><name><surname>Counts</surname><given-names>S. E.</given-names></name><name><surname>Wuu</surname><given-names>J.</given-names></name><name><surname>Nixon</surname><given-names>R. A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Upregulation of select Rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer’s disease.</article-title>
<source/><italic>J. Chem. Neuroanat.</italic>
<volume>42</volume>
<fpage>102</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchemneu.2011.05.012</pub-id>
<pub-id pub-id-type="pmid">21669283</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gispert</surname><given-names>S.</given-names></name><name><surname>Kurz</surname><given-names>A.</given-names></name><name><surname>Brehm</surname><given-names>N.</given-names></name><name><surname>Rau</surname><given-names>K.</given-names></name><name><surname>Walter</surname><given-names>M.</given-names></name><name><surname>Riess</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Complexin-1 and Foxp1 expression changes are novel brain effects of alpha-synuclein pathology.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>52</volume>
<fpage>57</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-014-8844-0</pub-id>
<pub-id pub-id-type="pmid">25112678</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glessner</surname><given-names>J. T.</given-names></name><name><surname>Reilly</surname><given-names>M. P.</given-names></name><name><surname>Kim</surname><given-names>C. E.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Albano</surname><given-names>A.</given-names></name><name><surname>Hou</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Strong synaptic transmission impact by copy number variations in schizophrenia.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>107</volume>
<fpage>10584</fpage>–<lpage>10589</lpage>. <pub-id pub-id-type="pmid">20489179</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goitre</surname><given-names>L.</given-names></name><name><surname>Trapani</surname><given-names>E.</given-names></name><name><surname>Trabalzini</surname><given-names>L.</given-names></name><name><surname>Retta</surname><given-names>S. F.</given-names></name></person-group> (<year>2014</year>). <article-title>The Ras superfamily of small GTPases: the unlocked secrets.</article-title>
<source/><italic>Methods Mol. Biol.</italic>
<volume>1120</volume>
<fpage>1</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-62703-791-4_1</pub-id>
<pub-id pub-id-type="pmid">24470015</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Suaga</surname><given-names>P.</given-names></name><name><surname>Rivero-Rios</surname><given-names>P.</given-names></name><name><surname>Fdez</surname><given-names>E.</given-names></name><name><surname>Blanca Ramirez</surname><given-names>M.</given-names></name><name><surname>Ferrer</surname><given-names>I.</given-names></name><name><surname>Aiastui</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>23</volume>
<fpage>6779</fpage>–<lpage>6796</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu395</pub-id>
<pub-id pub-id-type="pmid">25080504</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govek</surname><given-names>E. E.</given-names></name><name><surname>Hatten</surname><given-names>M. E.</given-names></name><name><surname>Van Aelst</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of Rho GTPase proteins in CNS neuronal migration.</article-title>
<source/><italic>Dev. Neurobiol.</italic>
<volume>71</volume>
<fpage>528</fpage>–<lpage>553</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.20850</pub-id>
<pub-id pub-id-type="pmid">21557504</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grewal</surname><given-names>S. S.</given-names></name><name><surname>Horgan</surname><given-names>A. M.</given-names></name><name><surname>York</surname><given-names>R. D.</given-names></name><name><surname>Withers</surname><given-names>G. S.</given-names></name><name><surname>Banker</surname><given-names>G. A.</given-names></name><name><surname>Stork</surname><given-names>P. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Neuronal calcium activates a Rap1 and B-Raf signaling pathway via the cyclic adenosine monophosphate-dependent protein kinase.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>275</volume>
<fpage>3722</fpage>–<lpage>3728</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.5.3722</pub-id>
<pub-id pub-id-type="pmid">10652372</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gripp</surname><given-names>K. W.</given-names></name><name><surname>Aldinger</surname><given-names>K. A.</given-names></name><name><surname>Bennett</surname><given-names>J. T.</given-names></name><name><surname>Baker</surname><given-names>L.</given-names></name><name><surname>Tusi</surname><given-names>J.</given-names></name><name><surname>Powell-Hamilton</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>170</volume>
<fpage>2237</fpage>–<lpage>2247</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.37781</pub-id>
<pub-id pub-id-type="pmid">27264673</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosshans</surname><given-names>B. L.</given-names></name><name><surname>Ortiz</surname><given-names>D.</given-names></name><name><surname>Novick</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Rabs and their effectors: achieving specificity in membrane traffic.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>11821</fpage>–<lpage>11827</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0601617103</pub-id>
<pub-id pub-id-type="pmid">16882731</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guvenc</surname><given-names>H.</given-names></name><name><surname>Pavlyukov</surname><given-names>M. S.</given-names></name><name><surname>Joshi</surname><given-names>K.</given-names></name><name><surname>Kurt</surname><given-names>H.</given-names></name><name><surname>Banasavadi-Siddegowda</surname><given-names>Y. K.</given-names></name><name><surname>Mao</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex.</article-title>
<source/><italic>Clin. Cancer Res.</italic>
<volume>19</volume>
<fpage>631</fpage>–<lpage>642</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.ccr-12-0647</pub-id>
<pub-id pub-id-type="pmid">23251006</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haass</surname><given-names>C.</given-names></name><name><surname>Selkoe</surname><given-names>D. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>8</volume>
<fpage>101</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2101</pub-id>
<pub-id pub-id-type="pmid">17245412</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Rho family GTPases.</article-title>
<source/><italic>Biochem. Soc. Trans.</italic>
<volume>40</volume>
<fpage>1378</fpage>–<lpage>1382</lpage>.<pub-id pub-id-type="pmid">23176484</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamedani</surname><given-names>S. Y.</given-names></name><name><surname>Gharesouran</surname><given-names>J.</given-names></name><name><surname>Noroozi</surname><given-names>R.</given-names></name><name><surname>Sayad</surname><given-names>A.</given-names></name><name><surname>Omrani</surname><given-names>M. D.</given-names></name><name><surname>Mir</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Ras-like without CAAX 2 (RIT2): a susceptibility gene for autism spectrum disorder.</article-title>
<source/><italic>Metab. Brain Dis.</italic>
<volume>32</volume>
<fpage>751</fpage>–<lpage>755</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-017-9969-4</pub-id>
<pub-id pub-id-type="pmid">28190241</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamel</surname><given-names>C. P.</given-names></name></person-group> (<year>2007</year>). <article-title>Cone rod dystrophies.</article-title>
<source/><italic>Orphanet J. Rare Dis.</italic>
<volume>2</volume>:<issue>7</issue>.</mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname><given-names>J. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Ras proteins: different signals from different locations.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>4</volume>
<fpage>373</fpage>–<lpage>384</lpage>.<pub-id pub-id-type="pmid">12728271</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanke-Gogokhia</surname><given-names>C.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Gerstner</surname><given-names>C. D.</given-names></name><name><surname>Frederick</surname><given-names>J. M.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Baehr</surname><given-names>W.</given-names></name></person-group> (<year>2016a</year>). <article-title>Arf-like protein 3 (ARL3) regulates protein trafficking and ciliogenesis in mouse photoreceptors.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>291</volume>
<fpage>7142</fpage>–<lpage>7155</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m115.710954</pub-id>
<pub-id pub-id-type="pmid">26814127</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanke-Gogokhia</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Frederick</surname><given-names>J. M.</given-names></name><name><surname>Baehr</surname><given-names>W.</given-names></name></person-group> (<year>2016b</year>). <article-title>The function of Arf-like proteins ARL2 and ARL3 in photoreceptors.</article-title>
<source/><italic>Adv. Exp. Med. Biol.</italic>
<volume>854</volume>
<fpage>655</fpage>–<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-17121-0_87</pub-id>
<pub-id pub-id-type="pmid">26427472</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harms</surname><given-names>F. L.</given-names></name><name><surname>Kloth</surname><given-names>K.</given-names></name><name><surname>Bley</surname><given-names>A.</given-names></name><name><surname>Denecke</surname><given-names>J.</given-names></name><name><surname>Santer</surname><given-names>R.</given-names></name><name><surname>Lessel</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Activating mutations in <italic>PAK1</italic>, encoding p21-activated kinase 1, cause a neurodevelopmental disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>103</volume>
<fpage>579</fpage>–<lpage>591</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2018.09.005</pub-id>
<pub-id pub-id-type="pmid">30290153</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>C. D.</given-names></name><name><surname>Yasuda</surname><given-names>R.</given-names></name><name><surname>Zhong</surname><given-names>H.</given-names></name><name><surname>Svoboda</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>The spread of Ras activity triggered by activation of a single dendritic spine.</article-title>
<source/><italic>Science</italic>
<volume>321</volume>
<fpage>136</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1126/science.1159675</pub-id>
<pub-id pub-id-type="pmid">18556515</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heidorn</surname><given-names>S. J.</given-names></name><name><surname>Milagre</surname><given-names>C.</given-names></name><name><surname>Whittaker</surname><given-names>S.</given-names></name><name><surname>Nourry</surname><given-names>A.</given-names></name><name><surname>Niculescu-Duvas</surname><given-names>I.</given-names></name><name><surname>Dhomen</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.</article-title>
<source/><italic>Cell</italic>
<volume>140</volume>
<fpage>209</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.12.040</pub-id>
<pub-id pub-id-type="pmid">20141835</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>W. D.</given-names></name><name><surname>Meyer</surname><given-names>T.</given-names></name></person-group> (<year>2003</year>). <article-title>Switch-of-function mutants based on morphology classification of Ras superfamily small GTPases.</article-title>
<source/><italic>Cell</italic>
<volume>113</volume>
<fpage>315</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(03)00315-5</pub-id>
<pub-id pub-id-type="pmid">12732140</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirata</surname><given-names>Y.</given-names></name><name><surname>Brems</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>M.</given-names></name><name><surname>Kanamori</surname><given-names>M.</given-names></name><name><surname>Okada</surname><given-names>M.</given-names></name><name><surname>Morita</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Interaction between a domain of the negative regulator of the Ras-ERK pathway, SPRED1 protein, and the GTPase-activating protein-related domain of neurofibromin is implicated in legius syndrome and neurofibromatosis type 1.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>291</volume>
<fpage>3124</fpage>–<lpage>3134</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m115.703710</pub-id>
<pub-id pub-id-type="pmid">26635368</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshino</surname><given-names>M.</given-names></name><name><surname>Nakamura</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>The Ras-like small GTP-binding protein Rin is activated by growth factor stimulation.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>295</volume>
<fpage>651</fpage>–<lpage>656</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-291x(02)00731-3</pub-id>
<pub-id pub-id-type="pmid">12099688</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houlden</surname><given-names>H.</given-names></name><name><surname>King</surname><given-names>R. H.</given-names></name><name><surname>Hashemi-Nejad</surname><given-names>A.</given-names></name><name><surname>Wood</surname><given-names>N. W.</given-names></name><name><surname>Mathias</surname><given-names>C. J.</given-names></name><name><surname>Reilly</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>A novel TRK A (NTRK1) mutation associated with hereditary sensory and autonomic neuropathy type V.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>49</volume>
<fpage>521</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1002/ana.103</pub-id><pub-id pub-id-type="pmid">11310631</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huffmeier</surname><given-names>U.</given-names></name><name><surname>Zenker</surname><given-names>M.</given-names></name><name><surname>Hoyer</surname><given-names>J.</given-names></name><name><surname>Fahsold</surname><given-names>R.</given-names></name><name><surname>Rauch</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>140</volume>
<fpage>2749</fpage>–<lpage>2756</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31547</pub-id>
<pub-id pub-id-type="pmid">17103458</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Indo</surname><given-names>Y.</given-names></name></person-group> (<year>2001</year>). <article-title>Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor.</article-title>
<source/><italic>Hum. Mutat.</italic>
<volume>18</volume>
<fpage>462</fpage>–<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1002/humu.1224</pub-id>
<pub-id pub-id-type="pmid">11748840</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ismail</surname><given-names>S. A.</given-names></name><name><surname>Chen</surname><given-names>Y. X.</given-names></name><name><surname>Rusinova</surname><given-names>A.</given-names></name><name><surname>Chandra</surname><given-names>A.</given-names></name><name><surname>Bierbaum</surname><given-names>M.</given-names></name><name><surname>Gremer</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo.</article-title>
<source/><italic>Nat. Chem. Biol.</italic>
<volume>7</volume>
<fpage>942</fpage>–<lpage>949</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.686</pub-id>
<pub-id pub-id-type="pmid">22002721</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>C. L.</given-names></name><name><surname>Bouvet</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Arfs at a glance.</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>127</volume>
<fpage>4103</fpage>–<lpage>4109</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.144899</pub-id>
<pub-id pub-id-type="pmid">25146395</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>G. R.</given-names></name><name><surname>Jang</surname><given-names>E. H.</given-names></name><name><surname>Bae</surname><given-names>J. R.</given-names></name><name><surname>Jun</surname><given-names>S.</given-names></name><name><surname>Kang</surname><given-names>H. C.</given-names></name><name><surname>Park</surname><given-names>C. H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.</article-title>
<source/><italic>Mol. Neurodegener.</italic>
<volume>13</volume>:<issue>8</issue>. <pub-id pub-id-type="pmid">29439717</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name><name><surname>Geng</surname><given-names>S.</given-names></name><name><surname>Sheng</surname><given-names>H.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>RhoT1 and Smad4 are correlated with lymph node metastasis and overall survival in pancreatic cancer.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e42234</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0042234</pub-id>
<pub-id pub-id-type="pmid">22860091</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>D. S.</given-names></name><name><surname>Chen</surname><given-names>Y. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Ras family of small GTPases in immunity and inflammation.</article-title>
<source/><italic>Curr. Opin. Pharmacol.</italic>
<volume>12</volume>
<fpage>458</fpage>–<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2012.02.003</pub-id>
<pub-id pub-id-type="pmid">22401931</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jossin</surname><given-names>Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Polarization of migrating cortical neurons by Rap1 and N-cadherin: revisiting the model for the Reelin signaling pathway.</article-title>
<source/><italic>Small GTPases</italic>
<volume>2</volume>
<fpage>322</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.4161/sgtp.18283</pub-id>
<pub-id pub-id-type="pmid">22545231</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurnak</surname><given-names>F.</given-names></name></person-group> (<year>1985</year>). <article-title>Structure of the GDP domain of EF-Tu and location of the amino acids homologous to ras oncogene proteins.</article-title>
<source/><italic>Science</italic>
<volume>230</volume>
<fpage>32</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1126/science.3898365</pub-id>
<pub-id pub-id-type="pmid">3898365</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahn</surname><given-names>R. A.</given-names></name><name><surname>Gilman</surname><given-names>A. G.</given-names></name></person-group> (<year>1986</year>). <article-title>The protein cofactor necessary for ADP-ribosylation of Gs by cholera toxin is itself a GTP binding protein.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>261</volume>
<fpage>7906</fpage>–<lpage>7911</lpage>.<pub-id pub-id-type="pmid">3086320</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kametani</surname><given-names>F.</given-names></name><name><surname>Usami</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Kume</surname><given-names>H.</given-names></name><name><surname>Mori</surname><given-names>H.</given-names></name></person-group> (<year>2004</year>). <article-title>Mutant presenilin (A260V) affects Rab8 in PC12D cell.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>44</volume>
<fpage>313</fpage>–<lpage>320</lpage>. <pub-id pub-id-type="doi">10.1016/s0197-0186(03)00176-1</pub-id>
<pub-id pub-id-type="pmid">14643748</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanda</surname><given-names>Y.</given-names></name><name><surname>Watanabe</surname><given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>Adrenaline increases glucose transport via a Rap1-p38MAPK pathway in rat vascular smooth muscle cells.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>151</volume>
<fpage>476</fpage>–<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0707247</pub-id>
<pub-id pub-id-type="pmid">17450172</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karimi-Moghadam</surname><given-names>A.</given-names></name><name><surname>Charsouei</surname><given-names>S.</given-names></name><name><surname>Bell</surname><given-names>B.</given-names></name><name><surname>Jabalameli</surname><given-names>M. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Parkinson disease from mendelian forms to genetic susceptibility: new molecular insights into the neurodegeneration process.</article-title>
<source/><italic>Cell. Mol. Neurobiol.</italic>
<volume>38</volume>
<fpage>1153</fpage>–<lpage>1178</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-018-0587-4</pub-id>
<pub-id pub-id-type="pmid">29700661</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karnoub</surname><given-names>A. E.</given-names></name><name><surname>Weinberg</surname><given-names>R. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Ras oncogenes: split personalities.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>9</volume>
<fpage>517</fpage>–<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2438</pub-id>
<pub-id pub-id-type="pmid">18568040</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. K.</given-names></name><name><surname>Lee</surname><given-names>S. Y.</given-names></name><name><surname>Park</surname><given-names>C. W.</given-names></name><name><surname>Park</surname><given-names>S. H.</given-names></name><name><surname>Yin</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Rab3a promotes brain tumor initiation and progression.</article-title>
<source/><italic>Mol. Biol. Rep.</italic>
<volume>41</volume>
<fpage>5903</fpage>–<lpage>5911</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-014-3465-2</pub-id>
<pub-id pub-id-type="pmid">24965146</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>W. Y.</given-names></name><name><surname>Shin</surname><given-names>S. R.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Jeon</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name></person-group> (<year>2009</year>). <article-title>Cocaine regulates ezrin-radixin-moesin proteins and RhoA signaling in the nucleus accumbens.</article-title>
<source/><italic>Neuroscience</italic>
<volume>163</volume>
<fpage>501</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.06.067</pub-id>
<pub-id pub-id-type="pmid">19580848</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knihtila</surname><given-names>R.</given-names></name><name><surname>Holzapfel</surname><given-names>G.</given-names></name><name><surname>Weiss</surname><given-names>K.</given-names></name><name><surname>Meilleur</surname><given-names>F.</given-names></name><name><surname>Mattos</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Neutron crystal structure of RAS GTPase puts in question the protonation state of the GTP gamma-phosphate.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>290</volume>
<fpage>31025</fpage>–<lpage>31036</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m115.679860</pub-id>
<pub-id pub-id-type="pmid">26515069</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knodler</surname><given-names>A.</given-names></name><name><surname>Feng</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Das</surname><given-names>A.</given-names></name><name><surname>Peranen</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Coordination of Rab8 and Rab11 in primary ciliogenesis.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>107</volume>
<fpage>6346</fpage>–<lpage>6351</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1002401107</pub-id>
<pub-id pub-id-type="pmid">20308558</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konno</surname><given-names>M.</given-names></name><name><surname>Hasegawa</surname><given-names>T.</given-names></name><name><surname>Baba</surname><given-names>T.</given-names></name><name><surname>Miura</surname><given-names>E.</given-names></name><name><surname>Sugeno</surname><given-names>N.</given-names></name><name><surname>Kikuchi</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Suppression of dynamin GTPase decreases alpha-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy.</article-title>
<source/><italic>Mol. Neurodegener.</italic>
<volume>7</volume>:<issue>38</issue>. <pub-id pub-id-type="doi">10.1186/1750-1326-7-38</pub-id>
<pub-id pub-id-type="pmid">22892036</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kontaridis</surname><given-names>M. I.</given-names></name><name><surname>Swanson</surname><given-names>K. D.</given-names></name><name><surname>David</surname><given-names>F. S.</given-names></name><name><surname>Barford</surname><given-names>D.</given-names></name><name><surname>Neel</surname><given-names>B. G.</given-names></name></person-group> (<year>2006</year>). <article-title>PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>281</volume>
<fpage>6785</fpage>–<lpage>6792</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m513068200</pub-id>
<pub-id pub-id-type="pmid">16377799</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labandeira-Garcia</surname><given-names>J. L.</given-names></name><name><surname>Rodriguez-Perez</surname><given-names>A. I.</given-names></name><name><surname>Villar-Cheda</surname><given-names>B.</given-names></name><name><surname>Borrajo</surname><given-names>A.</given-names></name><name><surname>Dominguez-Meijide</surname><given-names>A.</given-names></name><name><surname>Guerra</surname><given-names>M. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Rho kinase and dopaminergic degeneration: a promising therapeutic target for Parkinson’s disease.</article-title>
<source/><italic>Neuroscientist</italic>
<volume>21</volume>
<fpage>616</fpage>–<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1177/1073858414554954</pub-id>
<pub-id pub-id-type="pmid">25323761</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahiri</surname><given-names>V.</given-names></name><name><surname>Klionsky</surname><given-names>D. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Functional impairment in RHOT1/Miro1 degradation and mitophagy is a shared feature in familial and sporadic Parkinson disease.</article-title>
<source/><italic>Autophagy</italic>
<volume>13</volume>
<fpage>1259</fpage>–<lpage>1261</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2017.1327512</pub-id>
<pub-id pub-id-type="pmid">28598233</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamprecht</surname><given-names>R.</given-names></name><name><surname>Farb</surname><given-names>C. R.</given-names></name><name><surname>Ledoux</surname><given-names>J. E.</given-names></name></person-group> (<year>2002</year>). <article-title>Fear memory formation involves p190 RhoGAP and ROCK proteins through a GRB2-mediated complex.</article-title>
<source/><italic>Neuron</italic>
<volume>36</volume>
<fpage>727</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(02)01047-4</pub-id>
<pub-id pub-id-type="pmid">12441060</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange-Carter</surname><given-names>C. A.</given-names></name><name><surname>Johnson</surname><given-names>G. L.</given-names></name></person-group> (<year>1994</year>). <article-title>Ras-dependent growth factor regulation of MEK kinase in PC12 cells.</article-title>
<source/><italic>Science</italic>
<volume>265</volume>
<fpage>1458</fpage>–<lpage>1461</lpage>. <pub-id pub-id-type="doi">10.1126/science.8073291</pub-id><pub-id pub-id-type="pmid">8073291</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latourelle</surname><given-names>J. C.</given-names></name><name><surname>Dumitriu</surname><given-names>A.</given-names></name><name><surname>Hadzi</surname><given-names>T. C.</given-names></name><name><surname>Beach</surname><given-names>T. G.</given-names></name><name><surname>Myers</surname><given-names>R. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Evaluation of Parkinson disease risk variants as expression-QTLs.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e46199</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0046199</pub-id>
<pub-id pub-id-type="pmid">23071545</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>E.</given-names></name><name><surname>Giovanello</surname><given-names>K. S.</given-names></name><name><surname>Saykin</surname><given-names>A. J.</given-names></name><name><surname>Xie</surname><given-names>F.</given-names></name><name><surname>Kong</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Single-nucleotide polymorphisms are associated with cognitive decline at Alzheimer’s disease conversion within mild cognitive impairment patients.</article-title>
<source/><italic>Alzheimers Dement.</italic>
<volume>8</volume>
<fpage>86</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.dadm.2017.04.004</pub-id>
<pub-id pub-id-type="pmid">28560309</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Ju</surname><given-names>B. G.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Drosophila arf72A</italic> acts as an essential regulator of endoplasmic reticulum quality control and suppresses autosomal-dominant retinopathy.</article-title>
<source/><italic>Int. J. Biochem. Cell Biol.</italic>
<volume>43</volume>
<fpage>1392</fpage>–<lpage>1401</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2011.06.004</pub-id>
<pub-id pub-id-type="pmid">21693198</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Tecedor</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Y. H.</given-names></name><name><surname>Monteys</surname><given-names>A. M.</given-names></name><name><surname>Sowada</surname><given-names>M. J.</given-names></name><name><surname>Thompson</surname><given-names>L. M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Reinstating aberrant mTORC1 activity in Huntington’s disease mice improves disease phenotypes.</article-title>
<source/><italic>Neuron</italic>
<volume>85</volume>
<fpage>303</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.019</pub-id>
<pub-id pub-id-type="pmid">25556834</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M. N.</given-names></name><name><surname>Ha</surname><given-names>S. H.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Koh</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>C. S.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb.</article-title>
<source/><italic>Mol. Cell Biol.</italic>
<volume>29</volume>
<fpage>3991</fpage>–<lpage>4001</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.00165-09</pub-id>
<pub-id pub-id-type="pmid">19451232</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>V. M.</given-names></name><name><surname>Goedert</surname><given-names>M.</given-names></name><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name></person-group> (<year>2001</year>). <article-title>Neurodegenerative tauopathies.</article-title>
<source/><italic>Annu. Rev. Neurosci.</italic>
<volume>24</volume>
<fpage>1121</fpage>–<lpage>1159</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.24.1.1121</pub-id><pub-id pub-id-type="pmid">11520930</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legius</surname><given-names>E.</given-names></name><name><surname>Marchuk</surname><given-names>D. A.</given-names></name><name><surname>Collins</surname><given-names>F. S.</given-names></name><name><surname>Glover</surname><given-names>T. W.</given-names></name></person-group> (<year>1993</year>). <article-title>Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>3</volume>
<fpage>122</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1038/ng0293-122</pub-id>
<pub-id pub-id-type="pmid">8499945</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lein</surname><given-names>P. J.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Shi</surname><given-names>G. X.</given-names></name><name><surname>Moholt-Siebert</surname><given-names>M.</given-names></name><name><surname>Bruun</surname><given-names>D.</given-names></name><name><surname>Andres</surname><given-names>D. A.</given-names></name></person-group> (<year>2007</year>). <article-title>The novel GTPase Rit differentially regulates axonal and dendritic growth.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>4725</fpage>–<lpage>4736</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.5633-06.2007</pub-id>
<pub-id pub-id-type="pmid">17460085</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lelieveld</surname><given-names>S. H.</given-names></name><name><surname>Reijnders</surname><given-names>M. R.</given-names></name><name><surname>Pfundt</surname><given-names>R.</given-names></name><name><surname>Yntema</surname><given-names>H. G.</given-names></name><name><surname>Kamsteeg</surname><given-names>E. J.</given-names></name><name><surname>De Vries</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>19</volume>
<fpage>1194</fpage>–<lpage>1196</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4352</pub-id>
<pub-id pub-id-type="pmid">27479843</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leoni</surname><given-names>C.</given-names></name><name><surname>Onesimo</surname><given-names>R.</given-names></name><name><surname>Giorgio</surname><given-names>V.</given-names></name><name><surname>Diamanti</surname><given-names>A.</given-names></name><name><surname>Giorgio</surname><given-names>D.</given-names></name><name><surname>Martini</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Understanding growth failure in costello syndrome: increased resting energy expenditure.</article-title>
<source/><italic>J. Pediatr.</italic>
<volume>170</volume>
<fpage>322</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2015.11.076</pub-id>
<pub-id pub-id-type="pmid">26778095</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Rab GTPases, membrane trafficking and diseases.</article-title>
<source/><italic>Curr. Drug Targets</italic>
<volume>12</volume>
<fpage>1188</fpage>–<lpage>1193</lpage>. <pub-id pub-id-type="doi">10.2174/138945011795906561</pub-id><pub-id pub-id-type="pmid">21561417</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Kanekiyo</surname><given-names>T.</given-names></name><name><surname>Shinohara</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Ladu</surname><given-names>M. J.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Differential regulation of amyloid-beta endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>44593</fpage>–<lpage>44601</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m112.420224</pub-id>
<pub-id pub-id-type="pmid">23132858</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Xing</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>G.</given-names></name><name><surname>Su</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Increased expression of Rac1 in epilepsy patients and animal models.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>41</volume>
<fpage>836</fpage>–<lpage>843</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-015-1759-y</pub-id>
<pub-id pub-id-type="pmid">26603293</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>Zou</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Su</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Expression profiling of Rab GTPases reveals the involvement of Rab20 and Rab32 in acute brain inflammation in mice.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>527</volume>
<fpage>110</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2012.08.039</pub-id>
<pub-id pub-id-type="pmid">22960262</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>K. C.</given-names></name><name><surname>Crino</surname><given-names>P. B.</given-names></name></person-group> (<year>2013</year>). <article-title>Focal malformations of cortical development: new vistas for molecular pathogenesis.</article-title>
<source/><italic>Neuroscience</italic>
<volume>252</volume>
<fpage>262</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.07.037</pub-id>
<pub-id pub-id-type="pmid">23892008</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H. H.</given-names></name><name><surname>Wu</surname><given-names>R. M.</given-names></name><name><surname>Lin</surname><given-names>H. I.</given-names></name><name><surname>Chen</surname><given-names>M. L.</given-names></name><name><surname>Tai</surname><given-names>C. H.</given-names></name><name><surname>Lin</surname><given-names>C. H.</given-names></name></person-group> (<year>2017</year>). <article-title>Lack of RAB39B mutations in early-onset and familial Parkinson’s disease in a Taiwanese cohort.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>50</volume>
<issue>169.e3</issue>–<lpage>169.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2016.10.021</pub-id>
<pub-id pub-id-type="pmid">27838047</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linford</surname><given-names>A.</given-names></name><name><surname>Yoshimura</surname><given-names>S.</given-names></name><name><surname>Nunes Bastos</surname><given-names>R.</given-names></name><name><surname>Langemeyer</surname><given-names>L.</given-names></name><name><surname>Gerondopoulos</surname><given-names>A.</given-names></name><name><surname>Rigden</surname><given-names>D. J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Rab14 and its exchange factor FAM116 link endocytic recycling and adherens junction stability in migrating cells.</article-title>
<source/><italic>Dev. Cell</italic>
<volume>22</volume>
<fpage>952</fpage>–<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2012.04.010</pub-id>
<pub-id pub-id-type="pmid">22595670</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W. N.</given-names></name><name><surname>Yan</surname><given-names>M.</given-names></name><name><surname>Chan</surname><given-names>A. M.</given-names></name></person-group> (<year>2017</year>). <article-title>A thirty-year quest for a role of R-Ras in cancer: from an oncogene to a multitasking GTPase.</article-title>
<source/><italic>Cancer Lett.</italic>
<volume>403</volume>
<fpage>59</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2017.06.003</pub-id>
<pub-id pub-id-type="pmid">28610953</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Shimada</surname><given-names>T.</given-names></name><name><surname>Otowa</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>Y. Y.</given-names></name><name><surname>Kawamura</surname><given-names>Y.</given-names></name><name><surname>Tochigi</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Genome-wide association study of autism spectrum disorder in the east asian populations.</article-title>
<source/><italic>Autism Res.</italic>
<volume>9</volume>
<fpage>340</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1536</pub-id>
<pub-id pub-id-type="pmid">26314684</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z. H.</given-names></name><name><surname>Guo</surname><given-names>J. F.</given-names></name><name><surname>Wang</surname><given-names>Y. Q.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Sun</surname><given-names>Q. Y.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Assessment of <italic>RIT2</italic> rs12456492 association with Parkinson’s disease in Mainland China.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>36</volume>
<issue>1600.e9</issue>–<issue>1600.e11</issue>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.12.012</pub-id>
<pub-id pub-id-type="pmid">25559334</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locke</surname><given-names>C. J.</given-names></name><name><surname>Kautu</surname><given-names>B. B.</given-names></name><name><surname>Berry</surname><given-names>K. P.</given-names></name><name><surname>Lee</surname><given-names>S. K.</given-names></name><name><surname>Caldwell</surname><given-names>K. A.</given-names></name><name><surname>Caldwell</surname><given-names>G. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Pharmacogenetic analysis reveals a post-developmental role for Rac GTPases in <italic>Caenorhabditis elegans</italic> GABAergic neurotransmission.</article-title>
<source/><italic>Genetics</italic>
<volume>183</volume>
<fpage>1357</fpage>–<lpage>1372</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.109.106880</pub-id>
<pub-id pub-id-type="pmid">19797046</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Gong</surname><given-names>Y.</given-names></name><name><surname>Cheng</surname><given-names>Z.</given-names></name><name><surname>Loganathan</surname><given-names>S.</given-names></name><name><surname>Kao</surname><given-names>C.</given-names></name><name><surname>Sarkaria</surname><given-names>J. N.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Critical functions of RhoB in support of glioblastoma tumorigenesis.</article-title>
<source/><italic>Neuro. Oncol.</italic>
<volume>17</volume>
<fpage>516</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1093/neuonc/nou228</pub-id>
<pub-id pub-id-type="pmid">25216671</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>M. E.</given-names></name><name><surname>Ambrose</surname><given-names>C. M.</given-names></name><name><surname>Duyao</surname><given-names>M. P.</given-names></name><name><surname>Myers</surname><given-names>R. H.</given-names></name><name><surname>Lin</surname><given-names>C.</given-names></name><name><surname>Srinidhi</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>1993</year>). <article-title>A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group.</article-title>
<source/><italic>Cell</italic>
<volume>72</volume>
<fpage>971</fpage>–<lpage>983</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(93)90585-e</pub-id><pub-id pub-id-type="pmid">8458085</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machida</surname><given-names>N.</given-names></name><name><surname>Umikawa</surname><given-names>M.</given-names></name><name><surname>Takei</surname><given-names>K.</given-names></name><name><surname>Sakima</surname><given-names>N.</given-names></name><name><surname>Myagmar</surname><given-names>B. E.</given-names></name><name><surname>Taira</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Mitogen-activated protein kinase kinase kinase kinase 4 as a putative effector of Rap2 to activate the c-Jun N-terminal kinase.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>279</volume>
<fpage>15711</fpage>–<lpage>15714</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.c300542200</pub-id>
<pub-id pub-id-type="pmid">14966141</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madaule</surname><given-names>P.</given-names></name><name><surname>Axel</surname><given-names>R.</given-names></name></person-group> (<year>1985</year>). <article-title>A novel Ras-related gene family.</article-title>
<source/><italic>Cell</italic>
<volume>41</volume>
<fpage>31</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(85)90058-3</pub-id><pub-id pub-id-type="pmid">3888408</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madero-Perez</surname><given-names>J.</given-names></name><name><surname>Fdez</surname><given-names>E.</given-names></name><name><surname>Fernandez</surname><given-names>B.</given-names></name><name><surname>Lara Ordonez</surname><given-names>A. J.</given-names></name><name><surname>Blanca Ramirez</surname><given-names>M.</given-names></name><name><surname>Gomez-Suaga</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.</article-title>
<source/><italic>Mol. Neurodegener.</italic>
<volume>13</volume>:<issue>3</issue>. <pub-id pub-id-type="pmid">29357897</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>T. M.</given-names></name><name><surname>Keith</surname><given-names>K.</given-names></name><name><surname>Davies</surname><given-names>B.</given-names></name><name><surname>Conner</surname><given-names>D. A.</given-names></name><name><surname>Guha</surname><given-names>P.</given-names></name><name><surname>Kalaitzidis</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>121</volume>
<fpage>1026</fpage>–<lpage>1043</lpage>. <pub-id pub-id-type="doi">10.1172/jci44972</pub-id>
<pub-id pub-id-type="pmid">21339643</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mastroeni</surname><given-names>D.</given-names></name><name><surname>Chouliaras</surname><given-names>L.</given-names></name><name><surname>Grover</surname><given-names>A.</given-names></name><name><surname>Liang</surname><given-names>W. S.</given-names></name><name><surname>Hauns</surname><given-names>K.</given-names></name><name><surname>Rogers</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Reduced RAN expression and disrupted transport between cytoplasm and nucleus; a key event in Alzheimer’s disease pathophysiology.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e53349</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0053349</pub-id>
<pub-id pub-id-type="pmid">23308199</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>F.</given-names></name></person-group> (<year>1998</year>). <article-title>Going for the GAP.</article-title>
<source/><italic>Curr. Biol.</italic>
<volume>8</volume>
<fpage>R673</fpage>–<lpage>R674</lpage>.<pub-id pub-id-type="pmid">9768349</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melser</surname><given-names>S.</given-names></name><name><surname>Chatelain</surname><given-names>E. H.</given-names></name><name><surname>Lavie</surname><given-names>J.</given-names></name><name><surname>Mahfouf</surname><given-names>W.</given-names></name><name><surname>Jose</surname><given-names>C.</given-names></name><name><surname>Obre</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Rheb regulates mitophagy induced by mitochondrial energetic status.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>17</volume>
<fpage>719</fpage>–<lpage>730</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2013.03.014</pub-id>
<pub-id pub-id-type="pmid">23602449</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza-Naranjo</surname><given-names>A.</given-names></name><name><surname>Gonzalez-Billault</surname><given-names>C.</given-names></name><name><surname>Maccioni</surname><given-names>R. B.</given-names></name></person-group> (<year>2007</year>). <article-title>Abeta1-42 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases.</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>120</volume>
<fpage>279</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.03323</pub-id>
<pub-id pub-id-type="pmid">17200137</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mir</surname><given-names>R.</given-names></name><name><surname>Tonelli</surname><given-names>F.</given-names></name><name><surname>Lis</surname><given-names>P.</given-names></name><name><surname>Macartney</surname><given-names>T.</given-names></name><name><surname>Polinski</surname><given-names>N. K.</given-names></name><name><surname>Martinez</surname><given-names>T. N.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>The Parkinson’s disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>475</volume>
<fpage>1861</fpage>–<lpage>1883</lpage>. <pub-id pub-id-type="doi">10.1042/bcj20180248</pub-id>
<pub-id pub-id-type="pmid">29743203</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>N. V.</given-names></name><name><surname>Desjardins</surname><given-names>A.</given-names></name><name><surname>Leclerc</surname><given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title>Tau secretion is correlated to an increase of Golgi dynamics.</article-title>
<source/><italic>PLoS One</italic>
<volume>12</volume>:<issue>e0178288</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0178288</pub-id>
<pub-id pub-id-type="pmid">28552936</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moritz</surname><given-names>O. L.</given-names></name><name><surname>Tam</surname><given-names>B. M.</given-names></name><name><surname>Hurd</surname><given-names>L. L.</given-names></name><name><surname>Peranen</surname><given-names>J.</given-names></name><name><surname>Deretic</surname><given-names>D.</given-names></name><name><surname>Papermaster</surname><given-names>D. S.</given-names></name></person-group> (<year>2001</year>). <article-title>Mutant Rab8 Impairs docking and fusion of rhodopsin-bearing post-Golgi membranes and causes cell death of transgenic <italic>Xenopus</italic> rods.</article-title>
<source/><italic>Mol. Biol. Cell</italic>
<volume>12</volume>
<fpage>2341</fpage>–<lpage>2351</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.12.8.2341</pub-id>
<pub-id pub-id-type="pmid">11514620</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>H. R.</given-names></name><name><surname>Waite</surname><given-names>A. J.</given-names></name><name><surname>Williams</surname><given-names>N. M.</given-names></name><name><surname>Neal</surname><given-names>J. W.</given-names></name><name><surname>Blake</surname><given-names>D. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Recent advances in the genetics of the ALS-FTLD complex.</article-title>
<source/><italic>Curr. Neurol. Neurosci. Rep.</italic>
<volume>12</volume>
<fpage>243</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1007/s11910-012-0268-5</pub-id>
<pub-id pub-id-type="pmid">22477152</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moshiri</surname><given-names>A.</given-names></name><name><surname>Humpal</surname><given-names>D.</given-names></name><name><surname>Leonard</surname><given-names>B. C.</given-names></name><name><surname>Imai</surname><given-names>D. M.</given-names></name><name><surname>Tham</surname><given-names>A.</given-names></name><name><surname>Bower</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Arap1 deficiency causes photoreceptor degeneration in mice.</article-title>
<source/><italic>Invest. Ophthalmol. Vis. Sci.</italic>
<volume>58</volume>
<fpage>1709</fpage>–<lpage>1718</lpage>. <pub-id pub-id-type="pmid">28324111</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulders</surname><given-names>W. H.</given-names></name><name><surname>Rodger</surname><given-names>J.</given-names></name><name><surname>Yates</surname><given-names>C. G.</given-names></name><name><surname>Robertson</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Modulation of gene expression in guinea pig paraflocculus after induction of hearing loss.</article-title>
<source/><italic>F1000Res.</italic>
<volume>3</volume>:<issue>63</issue>. <pub-id pub-id-type="pmid">25352978</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T.</given-names></name><name><surname>Yasuda</surname><given-names>S.</given-names></name><name><surname>Nagai</surname><given-names>H.</given-names></name><name><surname>Koinuma</surname><given-names>S.</given-names></name><name><surname>Morishita</surname><given-names>S.</given-names></name><name><surname>Goto</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Longest neurite-specific activation of Rap1B in hippocampal neurons contributes to polarity formation through RalA and Nore1A in addition to PI3-kinase.</article-title>
<source/><italic>Genes Cells</italic>
<volume>18</volume>
<fpage>1020</fpage>–<lpage>1031</lpage>. <pub-id pub-id-type="doi">10.1111/gtc.12097</pub-id>
<pub-id pub-id-type="pmid">24165023</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakhaei-Rad</surname><given-names>S.</given-names></name><name><surname>Haghighi</surname><given-names>F.</given-names></name><name><surname>Nouri</surname><given-names>P.</given-names></name><name><surname>Rezaei Adariani</surname><given-names>S.</given-names></name><name><surname>Lissy</surname><given-names>J.</given-names></name><name><surname>Kazemein Jasemi</surname><given-names>N. S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Structural fingerprints, interactions, and signaling networks of RAS family proteins beyond RAS isoforms.</article-title>
<source/><italic>Crit. Rev. Biochem. Mol. Biol.</italic>
<volume>53</volume>
<fpage>130</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1080/10409238.2018.1431605</pub-id>
<pub-id pub-id-type="pmid">29457927</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narumiya</surname><given-names>S.</given-names></name><name><surname>Thumkeo</surname><given-names>D.</given-names></name></person-group> (<year>2018</year>). <article-title>Rho signaling research: history, current status and future directions.</article-title>
<source/><italic>FEBS Lett.</italic>
<volume>592</volume>
<fpage>1763</fpage>–<lpage>1776</lpage>. <pub-id pub-id-type="doi">10.1002/1873-3468.13087</pub-id>
<pub-id pub-id-type="pmid">29749605</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navaroli</surname><given-names>D. M.</given-names></name><name><surname>Stevens</surname><given-names>Z. H.</given-names></name><name><surname>Uzelac</surname><given-names>Z.</given-names></name><name><surname>Gabriel</surname><given-names>L.</given-names></name><name><surname>King</surname><given-names>M. J.</given-names></name><name><surname>Lifshitz</surname><given-names>L. M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>13758</fpage>–<lpage>13770</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2649-11.2011</pub-id>
<pub-id pub-id-type="pmid">21957239</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>N.</given-names></name><name><surname>Clark</surname><given-names>G. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling.</article-title>
<source/><italic>Oncotarget</italic>
<volume>7</volume>
<fpage>33821</fpage>–<lpage>33831</lpage>. <pub-id pub-id-type="pmid">27034171</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>E. L.</given-names></name><name><surname>Tang</surname><given-names>B. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Rab GTPases and their roles in brain neurons and glia.</article-title>
<source/><italic>Brain Res. Rev.</italic>
<volume>58</volume>
<fpage>236</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2008.04.006</pub-id>
<pub-id pub-id-type="pmid">18485483</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noonan</surname><given-names>J. A.</given-names></name></person-group> (<year>1968</year>). <article-title>Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease.</article-title>
<source/><italic>Am. J. Dis. Child</italic>
<volume>116</volume>
<fpage>373</fpage>–<lpage>380</lpage>. <pub-id pub-id-type="pmid">4386970</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohba</surname><given-names>Y.</given-names></name><name><surname>Mochizuki</surname><given-names>N.</given-names></name><name><surname>Yamashita</surname><given-names>S.</given-names></name><name><surname>Chan</surname><given-names>A. M.</given-names></name><name><surname>Schrader</surname><given-names>J. W.</given-names></name><name><surname>Hattori</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Regulatory proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>275</volume>
<fpage>20020</fpage>–<lpage>20026</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m000981200</pub-id>
<pub-id pub-id-type="pmid">10777492</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paduch</surname><given-names>M.</given-names></name><name><surname>Jelen</surname><given-names>F.</given-names></name><name><surname>Otlewski</surname><given-names>J.</given-names></name></person-group> (<year>2001</year>). <article-title>Structure of small G proteins and their regulators.</article-title>
<source/><italic>Acta Biochim. Pol.</italic>
<volume>48</volume>
<fpage>829</fpage>–<lpage>850</lpage>.<pub-id pub-id-type="pmid">11995995</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paisan-Ruiz</surname><given-names>C.</given-names></name><name><surname>Lewis</surname><given-names>P. A.</given-names></name><name><surname>Singleton</surname><given-names>A. B.</given-names></name></person-group> (<year>2013</year>). <article-title>LRRK2: cause, risk, and mechanism.</article-title>
<source/><italic>J. Parkinsons Dis.</italic>
<volume>3</volume>
<fpage>85</fpage>–<lpage>103</lpage>.<pub-id pub-id-type="pmid">23938341</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandit</surname><given-names>B.</given-names></name><name><surname>Sarkozy</surname><given-names>A.</given-names></name><name><surname>Pennacchio</surname><given-names>L. A.</given-names></name><name><surname>Carta</surname><given-names>C.</given-names></name><name><surname>Oishi</surname><given-names>K.</given-names></name><name><surname>Martinelli</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>39</volume>
<fpage>1007</fpage>–<lpage>1012</lpage>. <pub-id pub-id-type="doi">10.1038/ng2073</pub-id>
<pub-id pub-id-type="pmid">17603483</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pankratz</surname><given-names>N.</given-names></name><name><surname>Beecham</surname><given-names>G. W.</given-names></name><name><surname>Destefano</surname><given-names>A. L.</given-names></name><name><surname>Dawson</surname><given-names>T. M.</given-names></name><name><surname>Doheny</surname><given-names>K. F.</given-names></name><name><surname>Factor</surname><given-names>S. A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Meta-analysis of Parkinson’s disease: identification of a novel locus, RIT2.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>71</volume>
<fpage>370</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22687</pub-id>
<pub-id pub-id-type="pmid">22451204</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira-Leal</surname><given-names>J. B.</given-names></name><name><surname>Seabra</surname><given-names>M. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Evolution of the Rab family of small GTP-binding proteins.</article-title>
<source/><italic>J. Mol. Biol.</italic>
<volume>313</volume>
<fpage>889</fpage>–<lpage>901</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.2001.5072</pub-id>
<pub-id pub-id-type="pmid">11697911</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peru Y Colón de Portugal</surname><given-names>R. L.</given-names></name><name><surname>Acevedo</surname><given-names>S. F.</given-names></name><name><surname>Rodan</surname><given-names>A. R.</given-names></name><name><surname>Chang</surname><given-names>L. Y.</given-names></name><name><surname>Eaton</surname><given-names>B. A.</given-names></name><name><surname>Rothenfluh</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Adult neuronal Arf6 controls ethanol-induced behavior with Arfaptin downstream of Rac1 and RhoGAP18B.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>17706</fpage>–<lpage>17713</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1944-12.2012</pub-id>
<pub-id pub-id-type="pmid">23223291</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeffer</surname><given-names>S. R.</given-names></name></person-group> (<year>2018</year>). <article-title>LRRK2 and Rab GTPases.</article-title>
<source/><italic>Biochem. Soc. Trans.</italic>
<volume>46</volume>
<fpage>1707</fpage>–<lpage>1712</lpage>. <pub-id pub-id-type="doi">10.1042/bst20180470</pub-id>
<pub-id pub-id-type="pmid">30467121</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierpont</surname><given-names>M. E.</given-names></name><name><surname>Magoulas</surname><given-names>P. L.</given-names></name><name><surname>Adi</surname><given-names>S.</given-names></name><name><surname>Kavamura</surname><given-names>M. I.</given-names></name><name><surname>Neri</surname><given-names>G.</given-names></name><name><surname>Noonan</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines.</article-title>
<source/><italic>Pediatrics</italic>
<volume>134</volume>
<fpage>e1149</fpage>–<lpage>e1162</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2013-3189</pub-id>
<pub-id pub-id-type="pmid">25180280</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piluso</surname><given-names>G.</given-names></name><name><surname>Monteleone</surname><given-names>P.</given-names></name><name><surname>Galderisi</surname><given-names>S.</given-names></name><name><surname>Giugliano</surname><given-names>T.</given-names></name><name><surname>Bertolino</surname><given-names>A.</given-names></name><name><surname>Rocca</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Assessment of de novo copy-number variations in Italian patients with schizophrenia: detection of putative mutations involving regulatory enhancer elements.</article-title>
<source/><italic>World J. Biol. Psychiatry</italic>
<volume>20</volume>
<fpage>126</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1080/15622975.2017.1395072</pub-id>
<pub-id pub-id-type="pmid">29069978</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pottier</surname><given-names>C.</given-names></name><name><surname>Ravenscroft</surname><given-names>T. A.</given-names></name><name><surname>Sanchez-Contreras</surname><given-names>M.</given-names></name><name><surname>Rademakers</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetics of FTLD: overview and what else we can expect from genetic studies.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>138(Suppl. 1)</volume>, <fpage>32</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13622</pub-id>
<pub-id pub-id-type="pmid">27009575</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prabakaran</surname><given-names>S.</given-names></name><name><surname>Swatton</surname><given-names>J. E.</given-names></name><name><surname>Ryan</surname><given-names>M. M.</given-names></name><name><surname>Huffaker</surname><given-names>S. J.</given-names></name><name><surname>Huang</surname><given-names>J. T.</given-names></name><name><surname>Griffin</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>9</volume>
<issue>684–697</issue>, <fpage>643</fpage>.</mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prekeris</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>The art of “cut and run”: the role of Rab14 GTPase in regulating N-cadherin shedding and cell motility.</article-title>
<source/><italic>Dev. Cell</italic>
<volume>22</volume>
<fpage>909</fpage>–<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2012.05.002</pub-id>
<pub-id pub-id-type="pmid">22595666</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prior</surname><given-names>I. A.</given-names></name><name><surname>Hancock</surname><given-names>J. F.</given-names></name></person-group> (<year>2012</year>). <article-title>Ras trafficking, localization and compartmentalized signalling.</article-title>
<source/><italic>Semin. Cell Dev. Biol.</italic>
<volume>23</volume>
<fpage>145</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2011.09.002</pub-id>
<pub-id pub-id-type="pmid">21924373</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryor</surname><given-names>W. M.</given-names></name><name><surname>Biagioli</surname><given-names>M.</given-names></name><name><surname>Shahani</surname><given-names>N.</given-names></name><name><surname>Swarnkar</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>W. C.</given-names></name><name><surname>Page</surname><given-names>D. T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington’s disease.</article-title>
<source/><italic>Sci. Signal.</italic>
<volume>7</volume>:<issue>ra103</issue>. <pub-id pub-id-type="doi">10.1126/scisignal.2005633</pub-id>
<pub-id pub-id-type="pmid">25351248</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulciani</surname><given-names>S.</given-names></name><name><surname>Santos</surname><given-names>E.</given-names></name><name><surname>Lauver</surname><given-names>A. V.</given-names></name><name><surname>Long</surname><given-names>L. K.</given-names></name><name><surname>Aaronson</surname><given-names>S. A.</given-names></name><name><surname>Barbacid</surname><given-names>M.</given-names></name></person-group> (<year>1982</year>). <article-title>Oncogenes in solid human tumours.</article-title>
<source/><italic>Nature</italic>
<volume>300</volume>
<fpage>539</fpage>–<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1038/300539a0</pub-id><pub-id pub-id-type="pmid">7144906</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purlyte</surname><given-names>E.</given-names></name><name><surname>Dhekne</surname><given-names>H. S.</given-names></name><name><surname>Sarhan</surname><given-names>A. R.</given-names></name><name><surname>Gomez</surname><given-names>R.</given-names></name><name><surname>Lis</surname><given-names>P.</given-names></name><name><surname>Wightman</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Rab29 activation of the Parkinson’s disease-associated LRRK2 kinase.</article-title>
<source/><italic>EMBO J.</italic>
<volume>37</volume>
<fpage>1</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.15252/embj.201798099</pub-id>
<pub-id pub-id-type="pmid">29212815</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauen</surname><given-names>K. A.</given-names></name></person-group> (<year>2007</year>). <article-title>HRAS and the Costello syndrome.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>71</volume>
<fpage>101</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2007.00743.x</pub-id>
<pub-id pub-id-type="pmid">17250658</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rees</surname><given-names>E.</given-names></name><name><surname>Walters</surname><given-names>J. T.</given-names></name><name><surname>Chambert</surname><given-names>K. D.</given-names></name><name><surname>O’dushlaine</surname><given-names>C.</given-names></name><name><surname>Szatkiewicz</surname><given-names>J.</given-names></name><name><surname>Richards</surname><given-names>A. L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>23</volume>
<fpage>1669</fpage>–<lpage>1676</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt540</pub-id>
<pub-id pub-id-type="pmid">24163246</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reijnders</surname><given-names>M. R. F.</given-names></name><name><surname>Ansor</surname><given-names>N. M.</given-names></name><name><surname>Kousi</surname><given-names>M.</given-names></name><name><surname>Yue</surname><given-names>W. W.</given-names></name><name><surname>Tan</surname><given-names>P. L.</given-names></name><name><surname>Clarkson</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>RAC1 missense mutations in developmental disorders with diverse phenotypes.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>101</volume>
<fpage>466</fpage>–<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2017.08.007</pub-id>
<pub-id pub-id-type="pmid">28886345</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname><given-names>D. J.</given-names></name><name><surname>Lundquist</surname><given-names>E. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Small GTPases.</article-title>
<source/><italic>WormBook</italic>
<volume>2018</volume>
<fpage>1</fpage>–<lpage>65</lpage>.</mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname><given-names>E.</given-names></name><name><surname>Ahn</surname><given-names>S.</given-names></name><name><surname>Shukla</surname><given-names>A. K.</given-names></name><name><surname>Lefkowitz</surname><given-names>R. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors.</article-title>
<source/><italic>Annu. Rev. Pharmacol. Toxicol.</italic>
<volume>52</volume>
<fpage>179</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.010909.105800</pub-id>
<pub-id pub-id-type="pmid">21942629</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridge</surname><given-names>P. G.</given-names></name><name><surname>Karch</surname><given-names>C. M.</given-names></name><name><surname>Hsu</surname><given-names>S.</given-names></name><name><surname>Arano</surname><given-names>I.</given-names></name><name><surname>Teerlink</surname><given-names>C. C.</given-names></name><name><surname>Ebbert</surname><given-names>M. T. W.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience.</article-title>
<source/><italic>Genome Med.</italic>
<volume>9</volume>:<issue>100</issue>. <pub-id pub-id-type="pmid">29183403</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>L.</given-names></name><name><surname>Mohamed</surname><given-names>N. V.</given-names></name><name><surname>Desjardins</surname><given-names>A.</given-names></name><name><surname>Lippe</surname><given-names>R.</given-names></name><name><surname>Fon</surname><given-names>E. A.</given-names></name><name><surname>Leclerc</surname><given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title>Rab7A regulates tau secretion.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>141</volume>
<fpage>592</fpage>–<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13994</pub-id>
<pub-id pub-id-type="pmid">28222213</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Viciana</surname><given-names>P.</given-names></name><name><surname>Sabatier</surname><given-names>C.</given-names></name><name><surname>Mccormick</surname><given-names>F.</given-names></name></person-group> (<year>2004</year>). <article-title>Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate.</article-title>
<source/><italic>Mol. Cell Biol.</italic>
<volume>24</volume>
<fpage>4943</fpage>–<lpage>4954</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.24.11.4943-4954.2004</pub-id>
<pub-id pub-id-type="pmid">15143186</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Viciana</surname><given-names>P.</given-names></name><name><surname>Tetsu</surname><given-names>O.</given-names></name><name><surname>Tidyman</surname><given-names>W. E.</given-names></name><name><surname>Estep</surname><given-names>A. L.</given-names></name><name><surname>Conger</surname><given-names>B. A.</given-names></name><name><surname>Cruz</surname><given-names>M. S.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.</article-title>
<source/><italic>Science</italic>
<volume>311</volume>
<fpage>1287</fpage>–<lpage>1290</lpage>. <pub-id pub-id-type="doi">10.1126/science.1124642</pub-id>
<pub-id pub-id-type="pmid">16439621</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>A. M.</given-names></name><name><surname>Fuentes</surname><given-names>G.</given-names></name><name><surname>Rausell</surname><given-names>A.</given-names></name><name><surname>Valencia</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>The Ras protein superfamily: evolutionary tree and role of conserved amino acids.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>196</volume>
<fpage>189</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201103008</pub-id>
<pub-id pub-id-type="pmid">22270915</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolfe</surname><given-names>B. E.</given-names></name><name><surname>Worth</surname><given-names>N. F.</given-names></name><name><surname>World</surname><given-names>C. J.</given-names></name><name><surname>Campbell</surname><given-names>J. H.</given-names></name><name><surname>Campbell</surname><given-names>G. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Rho and vascular disease.</article-title>
<source/><italic>Atherosclerosis</italic>
<volume>183</volume>
<fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2005.04.023</pub-id>
<pub-id pub-id-type="pmid">15982657</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roosen</surname><given-names>D. A.</given-names></name><name><surname>Cookson</surname><given-names>M. R.</given-names></name></person-group> (<year>2016</year>). <article-title>LRRK2 at the interface of autophagosomes, endosomes and lysosomes.</article-title>
<source/><italic>Mol. Neurodegener.</italic>
<volume>11</volume>:<issue>73</issue>. <pub-id pub-id-type="pmid">27927216</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roosing</surname><given-names>S.</given-names></name><name><surname>Rohrschneider</surname><given-names>K.</given-names></name><name><surname>Beryozkin</surname><given-names>A.</given-names></name><name><surname>Sharon</surname><given-names>D.</given-names></name><name><surname>Weisschuh</surname><given-names>N.</given-names></name><name><surname>Staller</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Mutations in RAB28, encoding a farnesylated small GTPase, are associated with autosomal-recessive cone-rod dystrophy.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>93</volume>
<fpage>110</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.05.005</pub-id>
<pub-id pub-id-type="pmid">23746546</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>K.</given-names></name><name><surname>Araki</surname><given-names>Y.</given-names></name><name><surname>Kontani</surname><given-names>K.</given-names></name><name><surname>Nishina</surname><given-names>H.</given-names></name><name><surname>Katada</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>Novel role of the small GTPase Rheb: its implication in endocytic pathway independent of the activation of mammalian target of rapamycin.</article-title>
<source/><italic>J. Biochem.</italic>
<volume>137</volume>
<fpage>423</fpage>–<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1093/jb/mvi046</pub-id>
<pub-id pub-id-type="pmid">15809346</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitou</surname><given-names>N.</given-names></name><name><surname>Nei</surname><given-names>M.</given-names></name></person-group> (<year>1987</year>). <article-title>The neighbor-joining method: a new method for reconstructing phylogenetic trees.</article-title>
<source/><italic>Mol. Biol. Evol.</italic>
<volume>4</volume>
<fpage>406</fpage>–<lpage>425</lpage>.<pub-id pub-id-type="pmid">3447015</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salyakina</surname><given-names>D.</given-names></name><name><surname>Cukier</surname><given-names>H. N.</given-names></name><name><surname>Lee</surname><given-names>J. M.</given-names></name><name><surname>Sacharow</surname><given-names>S.</given-names></name><name><surname>Nations</surname><given-names>L. D.</given-names></name><name><surname>Ma</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Copy number variants in extended autism spectrum disorder families reveal candidates potentially involved in autism risk.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e26049</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0026049</pub-id>
<pub-id pub-id-type="pmid">22016809</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>E.</given-names></name><name><surname>Martin-Zanca</surname><given-names>D.</given-names></name><name><surname>Reddy</surname><given-names>E. P.</given-names></name><name><surname>Pierotti</surname><given-names>M. A.</given-names></name><name><surname>Della Porta</surname><given-names>G.</given-names></name><name><surname>Barbacid</surname><given-names>M.</given-names></name></person-group> (<year>1984</year>). <article-title>Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient.</article-title>
<source/><italic>Science</italic>
<volume>223</volume>
<fpage>661</fpage>–<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1126/science.6695174</pub-id><pub-id pub-id-type="pmid">6695174</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saridaki</surname><given-names>T.</given-names></name><name><surname>Nippold</surname><given-names>M.</given-names></name><name><surname>Dinter</surname><given-names>E.</given-names></name><name><surname>Roos</surname><given-names>A.</given-names></name><name><surname>Diederichs</surname><given-names>L.</given-names></name><name><surname>Fensky</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>FYCO1 mediates clearance of alpha-synuclein aggregates through a Rab7-dependent mechanism.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>146</volume>
<fpage>474</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.14461</pub-id>
<pub-id pub-id-type="pmid">29747217</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkozy</surname><given-names>A.</given-names></name><name><surname>Digilio</surname><given-names>M. C.</given-names></name><name><surname>Dallapiccola</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>Leopard syndrome.</article-title>
<source/><italic>Orphanet J. Rare Dis.</italic>
<volume>3</volume>:<issue>13</issue>.</mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathasivam</surname><given-names>K.</given-names></name><name><surname>Neueder</surname><given-names>A.</given-names></name><name><surname>Gipson</surname><given-names>T. A.</given-names></name><name><surname>Landles</surname><given-names>C.</given-names></name><name><surname>Benjamin</surname><given-names>A. C.</given-names></name><name><surname>Bondulich</surname><given-names>M. K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>2366</fpage>–<lpage>2370</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1221891110</pub-id>
<pub-id pub-id-type="pmid">23341618</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T.</given-names></name><name><surname>Akasu</surname><given-names>H.</given-names></name><name><surname>Shimono</surname><given-names>W.</given-names></name><name><surname>Matsu</surname><given-names>C.</given-names></name><name><surname>Fujiwara</surname><given-names>Y.</given-names></name><name><surname>Shibagaki</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Rheb protein binds CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, and dihydroorotase) protein in a GTP- and effector domain-dependent manner and influences its cellular localization and carbamoyl-phosphate synthetase (CPSase) activity.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>290</volume>
<fpage>1096</fpage>–<lpage>1105</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m114.592402</pub-id>
<pub-id pub-id-type="pmid">25422319</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoh</surname><given-names>A. K.</given-names></name><name><surname>O’tousa</surname><given-names>J. E.</given-names></name><name><surname>Ozaki</surname><given-names>K.</given-names></name><name><surname>Ready</surname><given-names>D. F.</given-names></name></person-group> (<year>2005</year>). <article-title>Rab11 mediates post-Golgi trafficking of rhodopsin to the photosensitive apical membrane of Drosophila photoreceptors.</article-title>
<source/><italic>Development</italic>
<volume>132</volume>
<fpage>1487</fpage>–<lpage>1497</lpage>. <pub-id pub-id-type="doi">10.1242/dev.01704</pub-id>
<pub-id pub-id-type="pmid">15728675</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>S.</given-names></name><name><surname>Cabuy</surname><given-names>E.</given-names></name><name><surname>Caroni</surname><given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>12</volume>
<fpage>627</fpage>–<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2297</pub-id>
<pub-id pub-id-type="pmid">19330001</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheper</surname><given-names>W.</given-names></name><name><surname>Hoozemans</surname><given-names>J. J.</given-names></name><name><surname>Hoogenraad</surname><given-names>C. C.</given-names></name><name><surname>Rozemuller</surname><given-names>A. J.</given-names></name><name><surname>Eikelenboom</surname><given-names>P.</given-names></name><name><surname>Baas</surname><given-names>F.</given-names></name></person-group> (<year>2007</year>). <article-title>Rab6 is increased in Alzheimer’s disease brain and correlates with endoplasmic reticulum stress.</article-title>
<source/><italic>Neuropathol. Appl. Neurobiol.</italic>
<volume>33</volume>
<fpage>523</fpage>–<lpage>532</lpage>.<pub-id pub-id-type="pmid">17573808</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoneborn</surname><given-names>H.</given-names></name><name><surname>Raudzus</surname><given-names>F.</given-names></name><name><surname>Coppey</surname><given-names>M.</given-names></name><name><surname>Neumann</surname><given-names>S.</given-names></name><name><surname>Heumann</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Perspectives of RAS and RHEB GTPase signaling pathways in regenerating brain neurons.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>19</volume>:<issue>4052</issue>. <pub-id pub-id-type="pmid">30558189</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>M. A.</given-names></name><name><surname>Shattil</surname><given-names>S. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Signaling networks linking integrins and Rho family GTPases.</article-title>
<source/><italic>Trends Biochem. Sci.</italic>
<volume>25</volume>
<fpage>388</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1016/s0968-0004(00)01605-4</pub-id>
<pub-id pub-id-type="pmid">10916159</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>T. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Mitochondrial trafficking in neurons.</article-title>
<source/><italic>Cold Spring Harb. Perspect. Biol.</italic>
<volume>5</volume>:<issue>a011304</issue>.</mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segev</surname><given-names>N.</given-names></name></person-group> (<year>2001</year>). <article-title>Ypt/rab gtpases: regulators of protein trafficking.</article-title>
<source/><italic>Sci. STKE</italic>
<volume>2001</volume>:<issue>re11</issue>. <pub-id pub-id-type="doi">10.1126/stke.2001.100.re11</pub-id>
<pub-id pub-id-type="pmid">11579231</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahani</surname><given-names>N.</given-names></name><name><surname>Huang</surname><given-names>W. C.</given-names></name><name><surname>Varnum</surname><given-names>M.</given-names></name><name><surname>Page</surname><given-names>D. T.</given-names></name><name><surname>Subramaniam</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Forebrain depletion of Rheb GTPase elicits spatial memory deficits in mice.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>50</volume>
<fpage>134</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2016.11.006</pub-id>
<pub-id pub-id-type="pmid">27960107</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahani</surname><given-names>N.</given-names></name><name><surname>Pryor</surname><given-names>W.</given-names></name><name><surname>Swarnkar</surname><given-names>S.</given-names></name><name><surname>Kholodilov</surname><given-names>N.</given-names></name><name><surname>Thinakaran</surname><given-names>G.</given-names></name><name><surname>Burke</surname><given-names>R. E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Rheb GTPase regulates beta-secretase levels and amyloid beta generation.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>289</volume>
<fpage>5799</fpage>–<lpage>5808</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m113.532713</pub-id>
<pub-id pub-id-type="pmid">24368770</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>H.</given-names></name><name><surname>Andres</surname><given-names>D. A.</given-names></name></person-group> (<year>2000</year>). <article-title>A novel RalGEF-like protein, RGL3, as a candidate effector for Rit and Ras.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>275</volume>
<fpage>26914</fpage>–<lpage>26924</lpage>. <pub-id pub-id-type="pmid">10869344</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheen</surname><given-names>V. L.</given-names></name><name><surname>Ganesh</surname><given-names>V. S.</given-names></name><name><surname>Topcu</surname><given-names>M.</given-names></name><name><surname>Sebire</surname><given-names>G.</given-names></name><name><surname>Bodell</surname><given-names>A.</given-names></name><name><surname>Hill</surname><given-names>R. S.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>36</volume>
<fpage>69</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1038/ng1276</pub-id>
<pub-id pub-id-type="pmid">14647276</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Dou</surname><given-names>Y.</given-names></name><name><surname>Rao</surname><given-names>Z. R.</given-names></name><name><surname>Chen</surname><given-names>Y. R.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Activity-induced rapid synaptic maturation mediated by presynaptic cdc42 signaling.</article-title>
<source/><italic>Neuron</italic>
<volume>50</volume>
<fpage>401</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.03.017</pub-id>
<pub-id pub-id-type="pmid">16675395</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>Z. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Mitochondrial trafficking and anchoring in neurons: new insight and implications.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>204</volume>
<fpage>1087</fpage>–<lpage>1098</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201312123</pub-id>
<pub-id pub-id-type="pmid">24687278</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shenoy</surname><given-names>S. K.</given-names></name><name><surname>Lefkowitz</surname><given-names>R. J.</given-names></name></person-group> (<year>2011</year>). <article-title>beta-Arrestin-mediated receptor trafficking and signal transduction.</article-title>
<source/><italic>Trends Pharmacol. Sci.</italic>
<volume>32</volume>
<fpage>521</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2011.05.002</pub-id>
<pub-id pub-id-type="pmid">21680031</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>G. X.</given-names></name><name><surname>Andres</surname><given-names>D. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Rit contributes to nerve growth factor-induced neuronal differentiation via activation of B-Raf-extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades.</article-title>
<source/><italic>Mol. Cell Biol.</italic>
<volume>25</volume>
<fpage>830</fpage>–<lpage>846</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.25.2.830-846.2005</pub-id>
<pub-id pub-id-type="pmid">15632082</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>G. X.</given-names></name><name><surname>Cai</surname><given-names>W.</given-names></name><name><surname>Andres</surname><given-names>D. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Rit subfamily small GTPases: regulators in neuronal differentiation and survival.</article-title>
<source/><italic>Cell. Signal.</italic>
<volume>25</volume>
<fpage>2060</fpage>–<lpage>2068</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2013.06.002</pub-id>
<pub-id pub-id-type="pmid">23770287</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>G. X.</given-names></name><name><surname>Jin</surname><given-names>L.</given-names></name><name><surname>Andres</surname><given-names>D. A.</given-names></name></person-group> (<year>2011</year>). <article-title>A rit GTPase-p38 mitogen-activated protein kinase survival pathway confers resistance to cellular stress.</article-title>
<source/><italic>Mol. Cell Biol.</italic>
<volume>31</volume>
<fpage>1938</fpage>–<lpage>1948</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.01380-10</pub-id>
<pub-id pub-id-type="pmid">21444726</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimohama</surname><given-names>S.</given-names></name><name><surname>Kamiya</surname><given-names>S.</given-names></name><name><surname>Taniguchi</surname><given-names>T.</given-names></name><name><surname>Sumida</surname><given-names>Y.</given-names></name><name><surname>Fujimoto</surname><given-names>S.</given-names></name></person-group> (<year>1999</year>). <article-title>Differential involvement of small G proteins in Alzheimer’s disease.</article-title>
<source/><italic>Int. J. Mol. Med.</italic>
<volume>3</volume>
<fpage>597</fpage>–<lpage>600</lpage>. <pub-id pub-id-type="pmid">10341289</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>O. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Exocytosis and synaptic vesicle function.</article-title>
<source/><italic>Compr. Physiol.</italic>
<volume>4</volume>
<fpage>149</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1002/cphy.c130021</pub-id>
<pub-id pub-id-type="pmid">24692137</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegfried</surname><given-names>A.</given-names></name><name><surname>Cances</surname><given-names>C.</given-names></name><name><surname>Denuelle</surname><given-names>M.</given-names></name><name><surname>Loukh</surname><given-names>N.</given-names></name><name><surname>Tauber</surname><given-names>M.</given-names></name><name><surname>Cave</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>173</volume>
<fpage>1061</fpage>–<lpage>1065</lpage>. <pub-id pub-id-type="pmid">28328117</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simanshu</surname><given-names>D. K.</given-names></name><name><surname>Nissley</surname><given-names>D. V.</given-names></name><name><surname>Mccormick</surname><given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>RAS proteins and their regulators in human disease.</article-title>
<source/><italic>Cell</italic>
<volume>170</volume>
<fpage>17</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.06.009</pub-id>
<pub-id pub-id-type="pmid">28666118</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slack</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Ras signaling in aging and metabolic regulation.</article-title>
<source/><italic>Nutr. Healthy Aging</italic>
<volume>4</volume>
<fpage>195</fpage>–<lpage>205</lpage>. <pub-id pub-id-type="doi">10.3233/nha-160021</pub-id>
<pub-id pub-id-type="pmid">29276789</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slack</surname><given-names>C.</given-names></name><name><surname>Alic</surname><given-names>N.</given-names></name><name><surname>Foley</surname><given-names>A.</given-names></name><name><surname>Cabecinha</surname><given-names>M.</given-names></name><name><surname>Hoddinott</surname><given-names>M. P.</given-names></name><name><surname>Partridge</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>The Ras-Erk-ETS-signaling pathway is a drug target for longevity.</article-title>
<source/><italic>Cell</italic>
<volume>162</volume>
<fpage>72</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.06.023</pub-id>
<pub-id pub-id-type="pmid">26119340</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolov</surname><given-names>A. M.</given-names></name><name><surname>Seluzicki</surname><given-names>C. M.</given-names></name><name><surname>Morton</surname><given-names>M. C.</given-names></name><name><surname>Feliciano</surname><given-names>D. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Dendrite growth and the effect of ectopic Rheb expression on cortical neurons.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>671</volume>
<fpage>140</fpage>–<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2018.02.021</pub-id>
<pub-id pub-id-type="pmid">29447953</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonmez</surname><given-names>F. M.</given-names></name><name><surname>Uctepe</surname><given-names>E.</given-names></name><name><surname>Aktas</surname><given-names>D.</given-names></name><name><surname>Alikasifoglu</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Microdeletion of chromosome 1q21.3 in fraternal twins is associated with mental retardation, microcephaly, and epilepsy.</article-title>
<source/><italic>Intractable Rare Dis. Res.</italic>
<volume>6</volume>
<fpage>61</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.5582/irdr.2016.01075</pub-id>
<pub-id pub-id-type="pmid">28357185</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spano</surname><given-names>D.</given-names></name><name><surname>Branchi</surname><given-names>I.</given-names></name><name><surname>Rosica</surname><given-names>A.</given-names></name><name><surname>Pirro</surname><given-names>M. T.</given-names></name><name><surname>Riccio</surname><given-names>A.</given-names></name><name><surname>Mithbaokar</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Rhes is involved in striatal function.</article-title>
<source/><italic>Mol. Cell Biol.</italic>
<volume>24</volume>
<fpage>5788</fpage>–<lpage>5796</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.24.13.5788-5796.2004</pub-id>
<pub-id pub-id-type="pmid">15199135</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stankiewicz</surname><given-names>T. R.</given-names></name><name><surname>Linseman</surname><given-names>D. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Rho family GTPases: key players in neuronal development, neuronal survival, and neurodegeneration.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>8</volume>:<issue>314</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00314</pub-id>
<pub-id pub-id-type="pmid">25339865</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steger</surname><given-names>M.</given-names></name><name><surname>Diez</surname><given-names>F.</given-names></name><name><surname>Dhekne</surname><given-names>H. S.</given-names></name><name><surname>Lis</surname><given-names>P.</given-names></name><name><surname>Nirujogi</surname><given-names>R. S.</given-names></name><name><surname>Karayel</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis.</article-title>
<source/><italic>eLife</italic>
<volume>6</volume>:<issue>e31012</issue>. <pub-id pub-id-type="pmid">29125462</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steger</surname><given-names>M.</given-names></name><name><surname>Tonelli</surname><given-names>F.</given-names></name><name><surname>Ito</surname><given-names>G.</given-names></name><name><surname>Davies</surname><given-names>P.</given-names></name><name><surname>Trost</surname><given-names>M.</given-names></name><name><surname>Vetter</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Phosphoproteomics reveals that Parkinson’s disease kinase LRRK2 regulates a subset of Rab GTPases.</article-title>
<source/><italic>eLife</italic>
<volume>5</volume>:<issue>e12813</issue>.</mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>D. A.</given-names></name><name><surname>Viskochil</surname><given-names>D. H.</given-names></name><name><surname>Rope</surname><given-names>A. F.</given-names></name><name><surname>Carey</surname><given-names>J. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>69</volume>
<fpage>246</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2006.00576.x</pub-id>
<pub-id pub-id-type="pmid">16542390</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stornetta</surname><given-names>R. L.</given-names></name><name><surname>Zhu</surname><given-names>J. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Ras and Rap signaling in synaptic plasticity and mental disorders.</article-title>
<source/><italic>Neuroscientist</italic>
<volume>17</volume>
<fpage>54</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1177/1073858410365562</pub-id>
<pub-id pub-id-type="pmid">20431046</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramaniam</surname><given-names>S.</given-names></name><name><surname>Napolitano</surname><given-names>F.</given-names></name><name><surname>Mealer</surname><given-names>R. G.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Errico</surname><given-names>F.</given-names></name><name><surname>Barrow</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>15</volume>
<fpage>191</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2994</pub-id>
<pub-id pub-id-type="pmid">22179112</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramaniam</surname><given-names>S.</given-names></name><name><surname>Sixt</surname><given-names>K. M.</given-names></name><name><surname>Barrow</surname><given-names>R.</given-names></name><name><surname>Snyder</surname><given-names>S. H.</given-names></name></person-group> (<year>2009</year>). <article-title>Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.</article-title>
<source/><italic>Science</italic>
<volume>324</volume>
<fpage>1327</fpage>–<lpage>1330</lpage>. <pub-id pub-id-type="doi">10.1126/science.1172871</pub-id>
<pub-id pub-id-type="pmid">19498170</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiura</surname><given-names>H.</given-names></name><name><surname>Yasuda</surname><given-names>S.</given-names></name><name><surname>Katsurabayashi</surname><given-names>S.</given-names></name><name><surname>Kawano</surname><given-names>H.</given-names></name><name><surname>Endo</surname><given-names>K.</given-names></name><name><surname>Takasaki</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Rheb activation disrupts spine synapse formation through accumulation of syntenin in tuberous sclerosis complex.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>6</volume>:<issue>6842</issue>. <pub-id pub-id-type="pmid">25880340</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Samimi</surname><given-names>H.</given-names></name><name><surname>Gamez</surname><given-names>M.</given-names></name><name><surname>Zare</surname><given-names>H.</given-names></name><name><surname>Frost</surname><given-names>B.</given-names></name></person-group> (<year>2018</year>). <article-title>Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>21</volume>
<fpage>1038</fpage>–<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0194-1</pub-id>
<pub-id pub-id-type="pmid">30038280</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>A. M.</given-names></name><name><surname>Depoy</surname><given-names>L. M.</given-names></name><name><surname>Gourley</surname><given-names>S. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Inhibiting Rho kinase promotes goal-directed decision making and blocks habitual responding for cocaine.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>8</volume>:<issue>1861</issue>. <pub-id pub-id-type="pmid">29187752</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tada</surname><given-names>H.</given-names></name><name><surname>Taira</surname><given-names>Y.</given-names></name><name><surname>Morichika</surname><given-names>K.</given-names></name><name><surname>Kinoshita</surname><given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>Mitochondrial trafficking through Rhot1 is involved in the aggregation of germinal granule components during primordial germ cell formation in Xenopus embryos.</article-title>
<source/><italic>Dev. Growth Differ.</italic>
<volume>58</volume>
<fpage>641</fpage>–<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1111/dgd.12310</pub-id>
<pub-id pub-id-type="pmid">27585825</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tajan</surname><given-names>M.</given-names></name><name><surname>De Rocca Serra</surname><given-names>A.</given-names></name><name><surname>Valet</surname><given-names>P.</given-names></name><name><surname>Edouard</surname><given-names>T.</given-names></name><name><surname>Yart</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>SHP2 sails from physiology to pathology.</article-title>
<source/><italic>Eur. J. Med. Genet.</italic>
<volume>58</volume>
<fpage>509</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2015.08.005</pub-id>
<pub-id pub-id-type="pmid">26341048</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tajan</surname><given-names>M.</given-names></name><name><surname>Paccoud</surname><given-names>R.</given-names></name><name><surname>Branka</surname><given-names>S.</given-names></name><name><surname>Edouard</surname><given-names>T.</given-names></name><name><surname>Yart</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>The RASopathy family: consequences of germline activation of the RAS/MAPK pathway.</article-title>
<source/><italic>Endocr. Rev.</italic>
<volume>39</volume>
<fpage>676</fpage>–<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1210/er.2017-00232</pub-id>
<pub-id pub-id-type="pmid">29924299</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takai</surname><given-names>Y.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Matozaki</surname><given-names>T.</given-names></name></person-group> (<year>2001</year>). <article-title>Small GTP-binding proteins.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>81</volume>
<fpage>153</fpage>–<lpage>208</lpage>.<pub-id pub-id-type="pmid">11152757</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takamori</surname><given-names>S.</given-names></name><name><surname>Holt</surname><given-names>M.</given-names></name><name><surname>Stenius</surname><given-names>K.</given-names></name><name><surname>Lemke</surname><given-names>E. A.</given-names></name><name><surname>Gronborg</surname><given-names>M.</given-names></name><name><surname>Riedel</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Molecular anatomy of a trafficking organelle.</article-title>
<source/><italic>Cell</italic>
<volume>127</volume>
<fpage>831</fpage>–<lpage>846</lpage>.<pub-id pub-id-type="pmid">17110340</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tansey</surname><given-names>K. E.</given-names></name><name><surname>Rees</surname><given-names>E.</given-names></name><name><surname>Linden</surname><given-names>D. E.</given-names></name><name><surname>Ripke</surname><given-names>S.</given-names></name><name><surname>Chambert</surname><given-names>K. D.</given-names></name><name><surname>Moran</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Common alleles contribute to schizophrenia in CNV carriers.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>21</volume>:<issue>1153</issue>. <pub-id pub-id-type="doi">10.1038/mp.2015.170</pub-id>
<pub-id pub-id-type="pmid">26643540</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tartaglia</surname><given-names>M.</given-names></name><name><surname>Gelb</surname><given-names>B. D.</given-names></name><name><surname>Zenker</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Noonan syndrome and clinically related disorders.</article-title>
<source/><italic>Best Pract. Res. Clin. Endocrinol. Metab.</italic>
<volume>25</volume>
<fpage>161</fpage>–<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1016/j.beem.2010.09.002</pub-id>
<pub-id pub-id-type="pmid">21396583</pub-id></mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teodoro</surname><given-names>R. O.</given-names></name><name><surname>Pekkurnaz</surname><given-names>G.</given-names></name><name><surname>Nasser</surname><given-names>A.</given-names></name><name><surname>Higashi-Kovtun</surname><given-names>M. E.</given-names></name><name><surname>Balakireva</surname><given-names>M.</given-names></name><name><surname>Mclachlan</surname><given-names>I. G.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Ral mediates activity-dependent growth of postsynaptic membranes via recruitment of the exocyst.</article-title>
<source/><italic>EMBO J.</italic>
<volume>32</volume>
<fpage>2039</fpage>–<lpage>2055</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2013.147</pub-id>
<pub-id pub-id-type="pmid">23812009</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tidyman</surname><given-names>W. E.</given-names></name><name><surname>Rauen</surname><given-names>K. A.</given-names></name></person-group> (<year>2016a</year>). <article-title>Expansion of the RASopathies.</article-title>
<source/><italic>Curr. Genet. Med. Rep.</italic>
<volume>4</volume>
<fpage>57</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1007/s40142-016-0100-7</pub-id>
<pub-id pub-id-type="pmid">27942422</pub-id></mixed-citation>
</ref>
<ref id="B252">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tidyman</surname><given-names>W. E.</given-names></name><name><surname>Rauen</surname><given-names>K. A.</given-names></name></person-group> (<year>2016b</year>). <article-title>Pathogenetics of the RASopathies.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>25</volume>
<fpage>R123</fpage>–<lpage>R132</lpage>. <pub-id pub-id-type="pmid">27412009</pub-id></mixed-citation>
</ref>
<ref id="B253">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsika</surname><given-names>E.</given-names></name><name><surname>Moore</surname><given-names>D. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Contribution of GTPase activity to LRRK2-associated Parkinson disease.</article-title>
<source/><italic>Small GTPases</italic>
<volume>4</volume>
<fpage>164</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.4161/sgtp.25130</pub-id>
<pub-id pub-id-type="pmid">24025585</pub-id></mixed-citation>
</ref>
<ref id="B254">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyagi</surname><given-names>R.</given-names></name><name><surname>Shahani</surname><given-names>N.</given-names></name><name><surname>Gorgen</surname><given-names>L.</given-names></name><name><surname>Ferretti</surname><given-names>M.</given-names></name><name><surname>Pryor</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>P. Y.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Rheb inhibits protein synthesis by activating the PERK-eIF2alpha signaling cascade.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>10</volume>
<fpage>684</fpage>–<lpage>693</lpage>. <pub-id pub-id-type="pmid">25660019</pub-id></mixed-citation>
</ref>
<ref id="B255">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udayar</surname><given-names>V.</given-names></name><name><surname>Buggia-Prevot</surname><given-names>V.</given-names></name><name><surname>Guerreiro</surname><given-names>R. L.</given-names></name><name><surname>Siegel</surname><given-names>G.</given-names></name><name><surname>Rambabu</surname><given-names>N.</given-names></name><name><surname>Soohoo</surname><given-names>A. L.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>A paired RNAi and RabGAP overexpression screen identifies Rab11 as a regulator of beta-amyloid production.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>5</volume>
<fpage>1536</fpage>–<lpage>1551</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.12.005</pub-id>
<pub-id pub-id-type="pmid">24373285</pub-id></mixed-citation>
</ref>
<ref id="B256">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ullrich</surname><given-names>M.</given-names></name><name><surname>Weber</surname><given-names>M.</given-names></name><name><surname>Post</surname><given-names>A. M.</given-names></name><name><surname>Popp</surname><given-names>S.</given-names></name><name><surname>Grein</surname><given-names>J.</given-names></name><name><surname>Zechner</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB/ERK-MAPK signaling as a result of SPRED2 deficiency.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>23</volume>
<fpage>444</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.232</pub-id>
<pub-id pub-id-type="pmid">28070119</pub-id></mixed-citation>
</ref>
<ref id="B257">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uno</surname><given-names>T.</given-names></name><name><surname>Furutani</surname><given-names>M.</given-names></name><name><surname>Watanabe</surname><given-names>C.</given-names></name><name><surname>Sakamoto</surname><given-names>K.</given-names></name><name><surname>Uno</surname><given-names>Y.</given-names></name><name><surname>Kanamaru</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Rab proteins in the brain and corpus allatum of <italic>Bombyx mori</italic>.</article-title>
<source/><italic>Histochem. Cell Biol.</italic>
<volume>146</volume>
<fpage>59</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1007/s00418-016-1422-y</pub-id>
<pub-id pub-id-type="pmid">26976000</pub-id></mixed-citation>
</ref>
<ref id="B258">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urano</surname><given-names>J.</given-names></name><name><surname>Ellis</surname><given-names>C.</given-names></name><name><surname>Clark</surname><given-names>G. J.</given-names></name><name><surname>Tamanoi</surname><given-names>F.</given-names></name></person-group> (<year>2001</year>). <article-title>Characterization of Rheb functions using yeast and mammalian systems.</article-title>
<source/><italic>Methods Enzymol.</italic>
<volume>333</volume>
<fpage>217</fpage>–<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1016/s0076-6879(01)33058-6</pub-id>
<pub-id pub-id-type="pmid">11400338</pub-id></mixed-citation>
</ref>
<ref id="B259">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Der Merwe</surname><given-names>C.</given-names></name><name><surname>Jalali Sefid Dashti</surname><given-names>Z.</given-names></name><name><surname>Christoffels</surname><given-names>A.</given-names></name><name><surname>Loos</surname><given-names>B.</given-names></name><name><surname>Bardien</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Evidence for a common biological pathway linking three Parkinson’s disease-causing genes: parkin, PINK1 and DJ-1.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>41</volume>
<fpage>1113</fpage>–<lpage>1125</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.12872</pub-id>
<pub-id pub-id-type="pmid">25761903</pub-id></mixed-citation>
</ref>
<ref id="B260">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Trier</surname><given-names>D. C.</given-names></name><name><surname>Rinne</surname><given-names>T.</given-names></name><name><surname>Noordam</surname><given-names>K.</given-names></name><name><surname>Draaisma</surname><given-names>J. M.</given-names></name><name><surname>Van Der Burgt</surname><given-names>I.</given-names></name></person-group> (<year>2017</year>). <article-title>Variable phenotypic expression in a large Noonan syndrome family segregating a novel SOS1 mutation.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>173</volume>
<fpage>2968</fpage>–<lpage>2972</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38466</pub-id>
<pub-id pub-id-type="pmid">28884940</pub-id></mixed-citation>
</ref>
<ref id="B261">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veltel</surname><given-names>S.</given-names></name><name><surname>Gasper</surname><given-names>R.</given-names></name><name><surname>Eisenacher</surname><given-names>E.</given-names></name><name><surname>Wittinghofer</surname><given-names>A.</given-names></name></person-group> (<year>2008a</year>). <article-title>The retinitis pigmentosa 2 gene product is a GTPase-activating protein for Arf-like 3.</article-title>
<source/><italic>Nat. Struct. Mol. Biol.</italic>
<volume>15</volume>
<fpage>373</fpage>–<lpage>380</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.1396</pub-id>
<pub-id pub-id-type="pmid">18376416</pub-id></mixed-citation>
</ref>
<ref id="B262">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veltel</surname><given-names>S.</given-names></name><name><surname>Kravchenko</surname><given-names>A.</given-names></name><name><surname>Ismail</surname><given-names>S.</given-names></name><name><surname>Wittinghofer</surname><given-names>A.</given-names></name></person-group> (<year>2008b</year>). <article-title>Specificity of Arl2/Arl3 signaling is mediated by a ternary Arl3-effector-GAP complex.</article-title>
<source/><italic>FEBS Lett.</italic>
<volume>582</volume>
<fpage>2501</fpage>–<lpage>2507</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2008.05.053</pub-id>
<pub-id pub-id-type="pmid">18588884</pub-id></mixed-citation>
</ref>
<ref id="B263">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigil</surname><given-names>D.</given-names></name><name><surname>Cherfils</surname><given-names>J.</given-names></name><name><surname>Rossman</surname><given-names>K. L.</given-names></name><name><surname>Der</surname><given-names>C. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?</article-title>
<source/><italic>Nat. Rev. Cancer</italic>
<volume>10</volume>
<fpage>842</fpage>–<lpage>857</lpage>. <pub-id pub-id-type="doi">10.1038/nrc2960</pub-id>
<pub-id pub-id-type="pmid">21102635</pub-id></mixed-citation>
</ref>
<ref id="B264">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volk</surname><given-names>L.</given-names></name><name><surname>Chiu</surname><given-names>S. L.</given-names></name><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Huganir</surname><given-names>R. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Glutamate synapses in human cognitive disorders.</article-title>
<source/><italic>Annu. Rev. Neurosci.</italic>
<volume>38</volume>
<fpage>127</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-neuro-071714-033821</pub-id>
<pub-id pub-id-type="pmid">25897873</pub-id></mixed-citation>
</ref>
<ref id="B265">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakioka</surname><given-names>T.</given-names></name><name><surname>Sasaki</surname><given-names>A.</given-names></name><name><surname>Kato</surname><given-names>R.</given-names></name><name><surname>Shouda</surname><given-names>T.</given-names></name><name><surname>Matsumoto</surname><given-names>A.</given-names></name><name><surname>Miyoshi</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Spred is a Sprouty-related suppressor of Ras signalling.</article-title>
<source/><italic>Nature</italic>
<volume>412</volume>
<fpage>647</fpage>–<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1038/35088082</pub-id>
<pub-id pub-id-type="pmid">11493923</pub-id></mixed-citation>
</ref>
<ref id="B266">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.</article-title>
<source/><italic>Oncol. Rep.</italic>
<volume>30</volume>
<fpage>2350</fpage>–<lpage>2356</lpage>. <pub-id pub-id-type="doi">10.3892/or.2013.2730</pub-id>
<pub-id pub-id-type="pmid">24026199</pub-id></mixed-citation>
</ref>
<ref id="B267">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Popko</surname><given-names>B.</given-names></name><name><surname>Roos</surname><given-names>R. P.</given-names></name></person-group> (<year>2011</year>). <article-title>The unfolded protein response in familial amyotrophic lateral sclerosis.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>20</volume>
<fpage>1008</fpage>–<lpage>1015</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddq546</pub-id>
<pub-id pub-id-type="pmid">21159797</pub-id></mixed-citation>
</ref>
<ref id="B268">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Ju</surname><given-names>Y. Y.</given-names></name><name><surname>Zhou</surname><given-names>Q. X.</given-names></name><name><surname>Tang</surname><given-names>J. X.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The small GTPase Rac1 contributes to extinction of aversive memories of drug withdrawal by facilitating GABAA receptor endocytosis in the vmPFC.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>37</volume>
<fpage>7096</fpage>–<lpage>7110</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3859-16.2017</pub-id>
<pub-id pub-id-type="pmid">28630256</pub-id></mixed-citation>
</ref>
<ref id="B269">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>M. E.</given-names></name><name><surname>Taubes</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Miller</surname><given-names>B. L.</given-names></name><name><surname>Sephton</surname><given-names>C. F.</given-names></name><name><surname>Gelfand</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD.</article-title>
<source/><italic>J. Exp. Med.</italic>
<volume>211</volume>
<fpage>1937</fpage>–<lpage>1945</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20140214</pub-id>
<pub-id pub-id-type="pmid">25155018</pub-id></mixed-citation>
</ref>
<ref id="B270">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watabe-Uchida</surname><given-names>M.</given-names></name><name><surname>Govek</surname><given-names>E. E.</given-names></name><name><surname>Van Aelst</surname><given-names>L.</given-names></name></person-group> (<year>2006</year>). <article-title>Regulators of Rho GTPases in neuronal development.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>26</volume>
<fpage>10633</fpage>–<lpage>10635</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4084-06.2006</pub-id><pub-id pub-id-type="pmid">17050702</pub-id></mixed-citation>
</ref>
<ref id="B271">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weis</surname><given-names>K.</given-names></name></person-group> (<year>2003</year>). <article-title>Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle.</article-title>
<source/><italic>Cell</italic>
<volume>112</volume>
<fpage>441</fpage>–<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(03)00082-5</pub-id>
<pub-id pub-id-type="pmid">12600309</pub-id></mixed-citation>
</ref>
<ref id="B272">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wennerberg</surname><given-names>K.</given-names></name><name><surname>Rossman</surname><given-names>K. L.</given-names></name><name><surname>Der</surname><given-names>C. J.</given-names></name></person-group> (<year>2005</year>). <article-title>The Ras superfamily at a glance.</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>118</volume>
<fpage>843</fpage>–<lpage>846</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.01660</pub-id>
<pub-id pub-id-type="pmid">15731001</pub-id></mixed-citation>
</ref>
<ref id="B273">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>V. C.</given-names></name><name><surname>Lucas</surname><given-names>J.</given-names></name><name><surname>Babcock</surname><given-names>M. A.</given-names></name><name><surname>Gutmann</surname><given-names>D. H.</given-names></name><name><surname>Korf</surname><given-names>B.</given-names></name><name><surname>Maria</surname><given-names>B. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Neurofibromatosis type 1 revisited.</article-title>
<source/><italic>Pediatrics</italic>
<volume>123</volume>
<fpage>124</fpage>–<lpage>133</lpage>.<pub-id pub-id-type="pmid">19117870</pub-id></mixed-citation>
</ref>
<ref id="B274">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>G. R.</given-names></name><name><surname>Sim</surname><given-names>J. C.</given-names></name><name><surname>Mclean</surname><given-names>C.</given-names></name><name><surname>Giannandrea</surname><given-names>M.</given-names></name><name><surname>Galea</surname><given-names>C. A.</given-names></name><name><surname>Riseley</surname><given-names>J. R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with alpha-synuclein pathology.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>95</volume>
<fpage>729</fpage>–<lpage>735</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.10.015</pub-id>
<pub-id pub-id-type="pmid">25434005</pub-id></mixed-citation>
</ref>
<ref id="B275">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>F.</given-names></name><name><surname>He</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>X. F.</given-names></name><name><surname>Xi</surname><given-names>Z. Q.</given-names></name><name><surname>Li</surname><given-names>J. M.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>[Overexpression of the Cdc42 in the brain tissue of human with intractable temporal epilepsy].</article-title>
<source/><italic>Zhonghua Yi Xue Za Zhi</italic>
<volume>87</volume>
<fpage>2030</fpage>–<lpage>2032</lpage>.<pub-id pub-id-type="pmid">17925172</pub-id></mixed-citation>
</ref>
<ref id="B276">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Tan</surname><given-names>L.</given-names></name><name><surname>Yu</surname><given-names>J. T.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of PICALM in Alzheimer’s disease.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>52</volume>
<fpage>399</fpage>–<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-014-8878-3</pub-id>
<pub-id pub-id-type="pmid">25186232</pub-id></mixed-citation>
</ref>
<ref id="B277">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Siedlak</surname><given-names>S. L.</given-names></name><name><surname>Huntley</surname><given-names>M. L.</given-names></name><name><surname>Termsarasab</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Rab10 phosphorylation is a prominent pathological feature in Alzheimer’s disease.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>63</volume>
<fpage>157</fpage>–<lpage>165</lpage>. <pub-id pub-id-type="doi">10.3233/jad-180023</pub-id>
<pub-id pub-id-type="pmid">29562525</pub-id></mixed-citation>
</ref>
<ref id="B278">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaoita</surname><given-names>M.</given-names></name><name><surname>Niihori</surname><given-names>T.</given-names></name><name><surname>Mizuno</surname><given-names>S.</given-names></name><name><surname>Okamoto</surname><given-names>N.</given-names></name><name><surname>Hayashi</surname><given-names>S.</given-names></name><name><surname>Watanabe</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.</article-title>
<source/><italic>Hum. Genet.</italic>
<volume>135</volume>
<fpage>209</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-015-1627-5</pub-id>
<pub-id pub-id-type="pmid">26714497</pub-id></mixed-citation>
</ref>
<ref id="B279">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Carew</surname><given-names>T. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Small G protein signaling in neuronal plasticity and memory formation: the specific role of ras family proteins.</article-title>
<source/><italic>Neuron</italic>
<volume>68</volume>
<fpage>340</fpage>–<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.09.013</pub-id>
<pub-id pub-id-type="pmid">21040840</pub-id></mixed-citation>
</ref>
<ref id="B280">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>J. C.</given-names></name><name><surname>Platt</surname><given-names>M. J.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Backx</surname><given-names>P. H.</given-names></name><name><surname>Simpson</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Cellular interplay via cytokine hierarchy causes pathological cardiac hypertrophy in RAF1-mutant Noonan syndrome.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>8</volume>:<issue>15518</issue>. <pub-id pub-id-type="doi">10.1038/ncomms15518</pub-id>
<pub-id pub-id-type="pmid">28548091</pub-id></mixed-citation>
</ref>
<ref id="B281">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>G.</given-names></name><name><surname>Rosenberg</surname><given-names>J.</given-names></name><name><surname>Blaser</surname><given-names>S.</given-names></name><name><surname>Rauen</surname><given-names>K. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Neurological complications of cardio-facio-cutaneous syndrome.</article-title>
<source/><italic>Dev. Med. Child Neurol.</italic>
<volume>49</volume>
<fpage>894</fpage>–<lpage>899</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.2007.00894.x</pub-id>
<pub-id pub-id-type="pmid">18039235</pub-id></mixed-citation>
</ref>
<ref id="B282">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>L. C.</given-names></name><name><surname>Hartig</surname><given-names>N.</given-names></name><name><surname>Boned Del Rio</surname><given-names>I.</given-names></name><name><surname>Sari</surname><given-names>S.</given-names></name><name><surname>Ringham-Terry</surname><given-names>B.</given-names></name><name><surname>Wainwright</surname><given-names>J. R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>115</volume>
<fpage>E10576</fpage>–<lpage>E10585</lpage>. <pub-id pub-id-type="pmid">30348783</pub-id></mixed-citation>
</ref>
<ref id="B283">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>L. C.</given-names></name><name><surname>Hartig</surname><given-names>N.</given-names></name><name><surname>Munoz-Alegre</surname><given-names>M.</given-names></name><name><surname>Oses-Prieto</surname><given-names>J. A.</given-names></name><name><surname>Durdu</surname><given-names>S.</given-names></name><name><surname>Bender</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>52</volume>
<fpage>679</fpage>–<lpage>692</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2013.10.004</pub-id>
<pub-id pub-id-type="pmid">24211266</pub-id></mixed-citation>
</ref>
<ref id="B284">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zafar</surname><given-names>S.</given-names></name><name><surname>Schmitz</surname><given-names>M.</given-names></name><name><surname>Younus</surname><given-names>N.</given-names></name><name><surname>Tahir</surname><given-names>W.</given-names></name><name><surname>Shafiq</surname><given-names>M.</given-names></name><name><surname>Llorens</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Creutzfeldt-jakob disease subtype-specific regional and temporal regulation of ADP ribosylation factor-1-dependent Rho/MLC pathway at pre-clinical stage.</article-title>
<source/><italic>J. Mol. Neurosci.</italic>
<volume>56</volume>
<fpage>329</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-015-0544-3</pub-id>
<pub-id pub-id-type="pmid">25896910</pub-id></mixed-citation>
</ref>
<ref id="B285">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zafar</surname><given-names>S.</given-names></name><name><surname>Younas</surname><given-names>N.</given-names></name><name><surname>Correia</surname><given-names>S.</given-names></name><name><surname>Shafiq</surname><given-names>M.</given-names></name><name><surname>Tahir</surname><given-names>W.</given-names></name><name><surname>Schmitz</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Strain-specific altered regulatory response of Rab7a and tau in creutzfeldt-jakob disease and Alzheimer’s disease.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>54</volume>
<fpage>697</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-016-9694-8</pub-id>
<pub-id pub-id-type="pmid">26768426</pub-id></mixed-citation>
</ref>
<ref id="B286">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zago</surname><given-names>G.</given-names></name><name><surname>Biondini</surname><given-names>M.</given-names></name><name><surname>Camonis</surname><given-names>J.</given-names></name><name><surname>Parrini</surname><given-names>M. C.</given-names></name></person-group> (<year>2017</year>). <article-title>A family affair: a Ral-exocyst-centered network links Ras, Rac, Rho signaling to control cell migration.</article-title>
<source/><italic>Small GTPases</italic>
<pub-id pub-id-type="doi">10.1080/21541248.2017</pub-id>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="pmid">28498728</pub-id></mixed-citation>
</ref>
<ref id="B287">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamboni</surname><given-names>V.</given-names></name><name><surname>Jones</surname><given-names>R.</given-names></name><name><surname>Umbach</surname><given-names>A.</given-names></name><name><surname>Ammoni</surname><given-names>A.</given-names></name><name><surname>Passafaro</surname><given-names>M.</given-names></name><name><surname>Hirsch</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Rho GTPases in intellectual disability: from genetics to therapeutic opportunities.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>19</volume>:<issue>E1821</issue>. <pub-id pub-id-type="pmid">29925821</pub-id></mixed-citation>
</ref>
<ref id="B288">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Mojsilovic-Petrovic</surname><given-names>J.</given-names></name><name><surname>Jian</surname><given-names>X.</given-names></name><name><surname>Thomas</surname><given-names>J.</given-names></name><name><surname>Homma</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Inhibition of cytohesins protects against genetic models of motor neuron disease.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>35</volume>
<fpage>9088</fpage>–<lpage>9105</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.5032-13.2015</pub-id>
<pub-id pub-id-type="pmid">26085633</pub-id></mixed-citation>
</ref>
<ref id="B289">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Hanke-Gogokhia</surname><given-names>C.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Gerstner</surname><given-names>C. D.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Mistrafficking of prenylated proteins causes retinitis pigmentosa 2.</article-title>
<source/><italic>FASEB J.</italic>
<volume>29</volume>
<fpage>932</fpage>–<lpage>942</lpage>. <pub-id pub-id-type="doi">10.1096/fj.14-257915</pub-id>
<pub-id pub-id-type="pmid">25422369</pub-id></mixed-citation>
</ref>
<ref id="B290">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Luan</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group> (<year>2015</year>). <article-title>Inhibition of the small GTPase Cdc42 in regulation of epileptic-seizure in rats.</article-title>
<source/><italic>Neuroscience</italic>
<volume>289</volume>
<fpage>381</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.12.059</pub-id>
<pub-id pub-id-type="pmid">25595978</pub-id></mixed-citation>
</ref>
<ref id="B291">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Petit</surname><given-names>G. H.</given-names></name><name><surname>Gaughwin</surname><given-names>P. M.</given-names></name><name><surname>Hansen</surname><given-names>C.</given-names></name><name><surname>Ranganathan</surname><given-names>S.</given-names></name><name><surname>Zuo</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington’s disease.</article-title>
<source/><italic>J. Huntingtons Dis.</italic>
<volume>2</volume>
<fpage>69</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="pmid">25063430</pub-id></mixed-citation>
</ref>
<ref id="B292">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Ras and Rap signal bidirectional synaptic plasticity via distinct subcellular microdomains.</article-title>
<source/><italic>Neuron</italic>
<volume>98</volume>
<fpage>783</fpage>–<lpage>800.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2018.03.049</pub-id>
<pub-id pub-id-type="pmid">29706584</pub-id></mixed-citation>
</ref>
<ref id="B293">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>T. Y.</given-names></name><name><surname>Yancey</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Y. W.</given-names></name></person-group> (<year>2018</year>). <article-title>Role of Rab GTPases in Alzheimer’s disease.</article-title>
<source/><italic>ACS Chem. Neurosci.</italic>
<volume>10</volume>
<fpage>828</fpage>–<lpage>838</lpage>.<pub-id pub-id-type="pmid">30261139</pub-id></mixed-citation>
</ref>
<ref id="B294">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Sagare</surname><given-names>A. P.</given-names></name><name><surname>Ma</surname><given-names>Q.</given-names></name><name><surname>Halliday</surname><given-names>M. R.</given-names></name><name><surname>Kong</surname><given-names>P.</given-names></name><name><surname>Kisler</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Central role for PICALM in amyloid-beta blood-brain barrier transcytosis and clearance.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>18</volume>
<fpage>978</fpage>–<lpage>987</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4025</pub-id>
<pub-id pub-id-type="pmid">26005850</pub-id></mixed-citation>
</ref>
<ref id="B295">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Liang</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Yao</surname><given-names>R.</given-names></name><name><surname>Bao</surname><given-names>W.</given-names></name><name><surname>Bao</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Current models of mammalian target of rapamycin complex 1 (mTORC1) activation by growth factors and amino acids.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>15</volume>
<fpage>20753</fpage>–<lpage>20769</lpage>. <pub-id pub-id-type="doi">10.3390/ijms151120753</pub-id>
<pub-id pub-id-type="pmid">25402640</pub-id></mixed-citation>
</ref>
<ref id="B296">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Shi</surname><given-names>D. S.</given-names></name><name><surname>Winter</surname><given-names>J. M.</given-names></name><name><surname>Rich</surname><given-names>B. E.</given-names></name><name><surname>Tong</surname><given-names>Z.</given-names></name><name><surname>Sorensen</surname><given-names>L. K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathy.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>127</volume>
<fpage>4569</fpage>–<lpage>4582</lpage>. <pub-id pub-id-type="doi">10.1172/jci91770</pub-id>
<pub-id pub-id-type="pmid">29058688</pub-id></mixed-citation>
</ref>
<ref id="B297">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuo</surname><given-names>C.</given-names></name><name><surname>Hou</surname><given-names>W.</given-names></name><name><surname>Lin</surname><given-names>C.</given-names></name><name><surname>Hu</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Potential value of genomic copy number variations in schizophrenia.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>10</volume>:<issue>204</issue>
<pub-id pub-id-type="doi">10.3389/fnmol.2017.00204</pub-id></mixed-citation>
</ref>
<ref id="B298">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimering</surname><given-names>M. B.</given-names></name></person-group> (<year>2018</year>). <article-title>Circulating Neurotoxic 5-HT2A receptor agonist autoantibodies in adult type 2 diabetes with Parkinson’s disease.</article-title>
<source/><italic>J. Endocrinol. Diab.</italic>
<volume>5</volume>
<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.15226/2374-6890/5/2/00102</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>